<html xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:dt="uuid:C2F41010-65B3-11d1-A29F-00AA00C14882"
xmlns="http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=Content-Type content="text/html; charset=utf-8">
<meta name=ProgId content=OneNote.File>
<meta name=Generator content="Microsoft OneNote 15">
<link id=Main-File rel=Main-File href="Geelong%20path.htm">
<link rel=File-List href="Geelong%20path_files/filelist.xml">
</head>

<body lang=en-AU style='font-family:Calibri;font-size:11.0pt'>

<div style='direction:ltr;border-width:100%'>

<div style='direction:ltr;margin-top:0in;margin-left:0in;width:11.1979in'>

<div style='direction:ltr;margin-top:0in;margin-left:.075in;width:2.0451in'>

<p style='margin:0in;font-family:"Calibri Light";font-size:20.0pt'>Geelong path</p>

</div>

<div style='direction:ltr;margin-top:.0409in;margin-left:.075in;width:2.2152in'>

<p style='margin:0in;font-family:Calibri;font-size:10.0pt;color:#767676'>Thursday,
10 July 2025</p>

<p style='margin:0in;font-family:Calibri;font-size:10.0pt;color:#767676'>9:52
AM</p>

</div>

<div style='direction:ltr;margin-top:.4326in;margin-left:0in;width:11.1979in'>

<div style='direction:ltr'>

<table border=1 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
 border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
 1pt' title="" summary="">
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.6673in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;text-align:center'>&nbsp;</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7562in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;text-align:center'><span
  style='font-weight:bold'>MCQ</span></p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.5555in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;text-align:center'>&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>1</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7562in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>Fracture
  healing, tick the correct answer/answers</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>A. a)
  Tibial plateau fractures are easily seen on plain x rays</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>B. b)
  Tibial spine fractures are most commonly seen in 20-40 year old amateur
  athletes</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>C. c)
  Remodelling beings immediately after a fracture</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>D. d)
  Lamellar bone is laid down before woven bone</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>E. e)
  Callus co<span style='background:lime;mso-highlight:lime'>ntains osteoblasts
  and oste</span>oclasts</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>F. f)
  no<span style='background:yellow;mso-highlight:yellow'>ne of the a</span>bove</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8048in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here is the <span
  style='font-weight:bold'>Robbins-based</span> and orthopaedically accurate
  evaluation of the question on <span style='font-weight:bold'>fracture healing</span>:</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
  style='font-weight:bold'>Question: </span><span style='font-style:italic'>Fracture
  healing — tick the correct answer(s):</span></p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.3166in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Option</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7979in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Evaluation</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.4444in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.3166in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>A. Tibial plateau fractures are easily seen on
    plain x-rays</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7798in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-style:italic;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.5812in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Tibial plateau
    fractures can be <span style='font-weight:bold'>difficult to visualize on
    plain radiographs</span>, especially if <span style='font-weight:bold'>non-displaced</span>;
    <span style='font-weight:bold'>CT scans</span> are often needed for better
    assessment.</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.3361in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>B. Tibial spine fractures are most commonly seen
    in 20–40 year old amateur athletes</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7798in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-style:italic;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.5381in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Tibial spine
    (intercondylar eminence) fractures are more commonly seen in <span
    style='font-weight:bold'>children and adolescents</span>, not in 20–40 year
    olds.</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.3166in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>C. Remodelling begins immediately after a fracture</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7798in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-style:italic;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.4916in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: <span
    style='font-weight:bold'>Remodelling is the final phase</span> of fracture
    healing. It occurs <span style='font-weight:bold'>after callus formation
    and consolidation</span>, not immediately.</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.3166in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>D. Lamellar bone is laid down before woven bone</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7798in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-style:italic;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.4916in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: <span
    style='font-weight:bold'>Woven bone is laid down first</span> in the callus
    and is later replaced by <span style='font-weight:bold'>lamellar bone</span>
    during the remodeling phase.</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.3361in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>E. Callus contains osteoblasts and osteoclasts</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7784in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>Correct</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.4916in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: “The <span
    style='font-weight:bold'>callus</span> consists of proliferating <span
    style='font-weight:bold'>osteoblasts</span>, and later, <span
    style='font-weight:bold'>osteoclasts</span> remodel the new bone.” This is
    a <span style='font-weight:bold'>key part of fracture healing</span>.</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.3166in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>F. None of the above</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7798in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-style:italic;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.4625in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Because <span
    style='font-weight:bold'>E is correct</span>, this option is not valid.</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Correct Answer: E. Callus contains osteoblasts and
  osteoclasts</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>This is consistent
  with Robbins and standard bone healing physiology. The <span
  style='font-weight:bold'>callus</span> is an active site of bone formation
  and remodeling.</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7506in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>2</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.777in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in'><img src="Geelong%20path_files/image001.png" width=314
  height=281></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>&nbsp;</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8048in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here is the <span
  style='font-weight:bold'>Robbins-based evaluation</span> of the osteomyelitis
  MCQ:</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Correct Statements:</span></p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.1909in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Option</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7361in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Evaluation</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.6319in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation from Robbins</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.2104in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>b) In children most commonly occurs at the
    metaphysis due to the rich capillary network at that site</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7312in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>Correct</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.6652in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: “In
    children, osteomyelitis usually begins in the <span style='font-weight:
    bold'>metaphysis</span>, where the blood supply terminates in <span
    style='font-weight:bold'>loops and slow-flowing capillary beds</span>,
    making it prone to infection.”Robbins and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.1909in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>c) Necrotic bone fragments form a sequestrum</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7312in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>Correct</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.7694in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: “<span
    style='font-weight:bold'>Sequestrum</span> refers to the <span
    style='font-weight:bold'>dead bone fragment</span> that has become
    separated due to infection and necrosis.”Robbins and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.1909in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>d) Reactive new bone in this setting is called
    involucrum</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7312in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>Correct</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.7694in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: “The <span
    style='font-weight:bold'>involucrum</span> is a shell of new bone deposited
    around a sequestrum during chronic osteomyelitis.”Robbins and Cotran Path…</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>❌</span><span style='font-weight:bold;
  font-family:Calibri'> Incorrect Statements:</span></p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:5.8437in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Option</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7534in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:5.8437in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>a)</span> The most common organism in children is <span
    style='font-weight:bold'>not streptococcus</span>, but <span
    style='font-weight:bold'>Staphylococcus aureus</span>, especially via
    hematogenous spreadRobbins and Cotran Path….</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7159in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:5.8437in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>e) X-ray changes</span> may not appear for <span
    style='font-weight:bold'>7–10 days</span> after onset. Early diagnosis
    relies more on <span style='font-weight:bold'>MRI or bone scan</span>, not
    plain filmsRobbins and Cotran Path….</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7159in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:5.8437in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>f)</span> MRI <span style='font-weight:bold'>with
    or without contrast</span> can detect osteomyelitis; <span
    style='font-weight:bold'>contrast improves sensitivity</span>, but is <span
    style='font-weight:bold'>not mandatory</span> for ruling it outRobbins and
    Cotran Path….</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7159in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:5.8437in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>g)</span> This is incorrect because <span
    style='font-weight:bold'>options b, c, and d are true</span>.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7159in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle'>&nbsp;</li>
  </ul>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>3</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7562in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>Which
  one of these is not a feature of Guillain-Barre Syndrome?</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>A.
  Ascending paralysis with <span style='background:lime;mso-highlight:lime'>hyperreflexia</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>B.
  Peripheral neurons infiltrated by lymphocytes and macrophages</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>C. No
  infectious agents have been identified in affected nerves</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>D.
  Cerebrospinal fluid with<span style='background:yellow;mso-highlight:yellow'>
  raised pr</span>otein levels</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8048in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here is the <span
  style='font-weight:bold'>Robbins-based</span> evaluation of the question on <span
  style='font-weight:bold'>Guillain-Barré Syndrome (GBS):</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
  style='font-weight:bold'>Question: </span><span style='font-style:italic'>Which
  one of these is </span><span style='font-weight:bold;font-style:italic'>not</span><span
  style='font-style:italic'> a feature of Guillain-Barré Syndrome?</span></p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.6229in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Option</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0479in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Evaluation</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.8881in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation from Robbins</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.6375in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>A. Ascending paralysis with hyperreflexia</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0513in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-weight:bold;font-family:Calibri'>Incorrect (False
    Statement)</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.9395in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: GBS
    causes **ascending paralysis with <span style='font-weight:bold'>hyporeflexia
    or areflexia</span>, not hyperreflexia. Reflexes are typically <span
    style='font-weight:bold'>diminished or absent</span> due to peripheral
    nerve demyelinationRobbins and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.6229in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>B. Peripheral neurons infiltrated by lymphocytes
    and macrophages</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0479in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-style:italic;font-family:Calibri'>Correct</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.975in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: GBS is
    characterized by “<span style='font-weight:bold'>inflammation of peripheral
    nerves</span>, with <span style='font-weight:bold'>infiltrates of
    lymphocytes and macrophages</span>,” especially around nerve roots and
    spinal nervesRobbins and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.6423in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>C. No infectious agents have been identified in
    affected nerves</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0479in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-style:italic;font-family:Calibri'>Correct</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.9881in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins:
    “Although <span style='font-weight:bold'>preceding infections</span> (e.g.,
    <span style='font-style:italic'>Campylobacter jejuni</span>) are common, <span
    style='font-weight:bold'>infectious agents are not present</span> in the
    nerves themselves.” The pathology is <span style='font-weight:bold'>autoimmune</span>,
    not directly infectiousRobbins and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.6229in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>D. Cerebrospinal fluid with raised protein levels</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0479in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-style:italic;font-family:Calibri'>Correct</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.0201in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: “CSF
    classically shows <span style='font-weight:bold'>elevated protein with
    normal cell count</span> — termed <span style='font-weight:bold'>albuminocytologic
    dissociation</span>.” This is a hallmark of GBSRobbins and Cotran Path….</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Correct Answer: A. Ascending paralysis with
  hyperreflexia</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>This is <span
  style='font-weight:bold'>not a feature of Guillain-Barré Syndrome</span>. The
  correct clinical finding is <span style='font-weight:bold'>hyporeflexia or
  areflexia</span>, due to peripheral nerve demyelinationRobbins and Cotran
  Path….</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7506in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>4</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.777in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in'><img src="Geelong%20path_files/image002.png" width=332
  height=322></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in'><img src="Geelong%20path_files/image003.png" width=74
  height=256></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>&nbsp;</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.7215in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here is the <span
  style='font-weight:bold'>Robbins-based and clinically supported matching</span>
  of the conditions with their descriptions:</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Row 1: X-linked, loss of function of transmembrane
  protein</span></p>
  <p style='margin:0in;font-size:11.0pt'><span style='font-weight:bold;
  font-family:Calibri'>Correct match: </span><span style='font-family:"Segoe UI Emoji"'>&#129001;
  </span><span style='font-weight:bold;font-family:Calibri'>Duchenne muscular
  dystrophy</span></p>
  <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle'><span
       style='font-weight:bold;font-family:Calibri;font-size:11.0pt'>Explanation:</span><span
       style='font-family:Calibri;font-size:11.0pt'> Robbins: Duchenne muscular
       dystrophy is an </span><span style='font-weight:bold;font-family:Calibri;
       font-size:11.0pt'>X-linked disorder</span><span style='font-family:Calibri;
       font-size:11.0pt'> due to </span><span style='font-weight:bold;
       font-family:Calibri;font-size:11.0pt'>loss-of-function mutations in the
       dystrophin gene</span><span style='font-family:Calibri;font-size:11.0pt'>,
       which encodes a </span><span style='font-weight:bold;font-family:Calibri;
       font-size:11.0pt'>transmembrane structural protein</span><span
       style='font-family:Calibri;font-size:11.0pt'> linking the cytoskeleton
       to the extracellular matrixRobbins and Cotran Path….</span></li>
  </ul>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Row 2: Adult onset inflammatory myopathy, no
  dermatological symptoms</span></p>
  <p style='margin:0in;font-size:11.0pt'><span style='font-weight:bold;
  font-family:Calibri'>Correct match: </span><span style='font-family:"Segoe UI Emoji"'>&#129001;
  </span><span style='font-weight:bold;font-family:Calibri'>Polymyositis</span></p>
  <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle'><span
       style='font-weight:bold;font-family:Calibri;font-size:11.0pt'>Explanation:</span><span
       style='font-family:Calibri;font-size:11.0pt'> Robbins: Polymyositis is
       an </span><span style='font-weight:bold;font-family:Calibri;font-size:
       11.0pt'>inflammatory myopathy</span><span style='font-family:Calibri;
       font-size:11.0pt'> that presents in adults with </span><span
       style='font-weight:bold;font-family:Calibri;font-size:11.0pt'>proximal
       muscle weakness</span><span style='font-family:Calibri;font-size:11.0pt'>,
       and </span><span style='font-weight:bold;font-family:Calibri;font-size:
       11.0pt'>lacks skin involvement</span><span style='font-family:Calibri;
       font-size:11.0pt'> (unlike dermatomyositis)Robbins and Cotran Path….</span></li>
  </ul>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Row 3: Adult onset, autosomal dominant, shows skeletal
  muscle weakness from sustained involuntary contraction, associated with
  diabetes</span></p>
  <p style='margin:0in;font-size:11.0pt'><span style='font-weight:bold;
  font-family:Calibri'>Correct match: </span><span style='font-family:"Segoe UI Emoji"'>&#129001;
  </span><span style='font-weight:bold;font-family:Calibri'>Myotonic dystrophy</span></p>
  <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle'><span
       style='font-weight:bold;font-family:Calibri;font-size:11.0pt'>Explanation:</span><span
       style='font-family:Calibri;font-size:11.0pt'> Robbins: Myotonic
       dystrophy is an </span><span style='font-weight:bold;font-family:Calibri;
       font-size:11.0pt'>autosomal dominant</span><span style='font-family:
       Calibri;font-size:11.0pt'> disorder with </span><span style='font-weight:
       bold;font-family:Calibri;font-size:11.0pt'>myotonia</span><span
       style='font-family:Calibri;font-size:11.0pt'> (sustained muscle
       contraction), </span><span style='font-weight:bold;font-family:Calibri;
       font-size:11.0pt'>progressive muscle weakness</span><span
       style='font-family:Calibri;font-size:11.0pt'>, and </span><span
       style='font-weight:bold;font-family:Calibri;font-size:11.0pt'>association
       with diabetes and cataracts</span><span style='font-family:Calibri;
       font-size:11.0pt'>Robbins and Cotran Path….</span></li>
  </ul>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Final Answers:</span></p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:4.6159in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Description</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.9437in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Correct Match</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:4.6159in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>X-linked, loss
    of function of transmembrane protein</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.9437in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Duchenne muscular dystrophy</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:4.6159in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Adult onset
    inflammatory myopathy, no dermatological symptoms</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.9437in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Polymyositis</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:4.6159in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Adult onset, AD,
    sustained contraction, muscle weakness, diabetes-related</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.9437in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Myotonic dystrophy</span></p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Let me know if
  you’d like a quick summary table for exam revision!</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>5</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7756in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>Eye.
  Secondary open angle glaucoma is best described by which of these statements</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>A. It
  is the most common form of glaucoma, there are few apparent structural
  changes</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>B.
  Fibrillar material is deposited throughout the anterior chamber</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>C. Due
  to continued aqueous humor secretion bows the iris periphery forward</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>D.
  Thin fibrovascular membranes grow over the surface of the iris, ultimately
  causing it to contract</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8048in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here is the <span
  style='font-weight:bold'>Robbins-based</span> evaluation of the question on <span
  style='font-weight:bold'>secondary open-angle glaucoma</span>:</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
  style='font-weight:bold'>Question: </span><span style='font-style:italic'>Secondary
  open-angle glaucoma is best described by which of these statements?</span></p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.9041in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Option</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7361in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Evaluation</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.9194in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation from Robbins</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.9041in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>A. It is the most common form of glaucoma, there
    are few apparent structural changes</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7541in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-style:italic;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.0527in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>This describes <span
    style='font-weight:bold'>primary open-angle glaucoma</span>, not secondary.
    In primary cases, structural changes are subtle and develop over
    timeRobbins and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.9041in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>B. Fibrillar material is deposited throughout the
    anterior chamber</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7347in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>Correct</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.9986in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: In <span
    style='font-weight:bold'>pseudoexfoliation glaucoma</span>, a form of <span
    style='font-weight:bold'>secondary open-angle glaucoma</span>, “<span
    style='font-weight:bold'>fibrillar material</span> is deposited throughout
    the anterior chamber, including the trabecular meshwork,” obstructing
    outflow and raising intraocular pressureRobbins and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.9041in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>C. Due to continued aqueous humor secretion bows
    the iris periphery forward</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7541in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-style:italic;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.0069in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>This describes <span
    style='font-weight:bold'>primary angle-closure glaucoma</span>, where the
    iris is pushed forward, closing the angle between the iris and
    corneaRobbins and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.9097in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>D. Thin fibrovascular membranes grow over the
    surface of the iris, ultimately causing it to contract</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7541in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-style:italic;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.9486in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: This is
    a description of <span style='font-weight:bold'>neovascular glaucoma</span>,
    not secondary open-angle glaucoma. Neovascularization leads to angle <span
    style='font-weight:bold'>closure</span>, not open-angle pathologyRobbins
    and Cotran Path….</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Correct Answer: B. Fibrillar material is deposited
  throughout the anterior chamber</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>This is the
  hallmark of <span style='font-weight:bold'>pseudoexfoliation glaucoma</span>,
  a type of <span style='font-weight:bold'>secondary open-angle glaucoma</span>,
  where <span style='font-weight:bold'>extracellular material accumulates and
  clogs the trabecular meshwork</span>, impeding aqueous outflowRobbins and
  Cotran Path….</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7506in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>6</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.777in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in'><img src="Geelong%20path_files/image004.png" width=309
  height=305></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>&nbsp;</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8048in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here is the <span
  style='font-weight:bold'>Robbins-based analysis</span> of statements about <span
  style='font-weight:bold'>subarachnoid hemorrhage from aneurysmal rupture</span>:</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Correct Statements (tick these):</span></p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.8895in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Statement</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.75in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Evaluation</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.9194in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Robbins Explanation</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.8895in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Most frequent in the 5th decade</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.75in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-style:italic;font-family:Calibri'>Correct</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.9479in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins:
    “Rupture of saccular aneurysms most commonly occurs in the <span
    style='font-weight:bold'>fifth decade</span> of life.”Robbins and Cotran
    Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.8895in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Slightly more frequent in women</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.75in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-style:italic;font-family:Calibri'>Correct</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.9479in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins:
    “Saccular aneurysms are slightly more common in <span style='font-weight:
    bold'>females</span>.”Robbins and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.8895in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>They are associated with patients who had aortic
    coarctation</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.75in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-style:italic;font-family:Calibri'>Correct</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.9479in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins:
    Saccular (berry) aneurysms are associated with <span style='font-weight:
    bold'>congenital conditions</span> such as <span style='font-weight:bold'>polycystic
    kidney disease and aortic coarctation</span>Robbins and Cotran Path…</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>❌</span><span style='font-weight:bold;
  font-family:Calibri'> Incorrect Statements (do NOT tick):</span></p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.6527in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Statement</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.9069in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Reason</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.6527in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Between 5% and 10% of patients die with their
    first rupture</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.9069in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins:
    Mortality at first rupture is <span style='font-weight:bold'>much higher</span>,
    up to <span style='font-weight:bold'>25–50%</span>, making this figure too
    low.</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.6722in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Saccular aneurysms are found in about 12% of the
    population</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.8875in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>The actual
    prevalence is closer to <span style='font-weight:bold'>1–2%</span>; 12% is
    a significant overestimate.</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.6527in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Commonly occur where the basilar artery bifurcates
    to posterior cerebral arteries</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.9069in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>While possible, <span
    style='font-weight:bold'>most saccular aneurysms occur at anterior
    circulation sites</span>, especially <span style='font-weight:bold'>branch
    points of the circle of Willis</span> (e.g., anterior communicating
    artery).</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.6527in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>The aneurysmal sac layers comprise intimal elastic
    lamina, smooth muscle and hyalinized intima</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.9069in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins:
    Saccular aneurysms are often <span style='font-weight:bold'>thin-walled
    outpouchings</span> that <span style='font-weight:bold'>lack a muscular
    wall and internal elastic lamina</span>, making this statement <span
    style='font-weight:bold'>false</span>.</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.6527in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Late onset meningeal fibrosis leads to decreased
    CSF secretion</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.9069in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>CSF secretion is
    a function of <span style='font-weight:bold'>choroid plexus</span>, not
    directly affected by meningeal fibrosis. No Robbins support for this claim.</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Final Answers to Tick:</span></p>
  <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle'><span
       style='font-weight:bold;font-family:Calibri;font-size:11.0pt'>Most
       frequent in the 5th decade</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle'><span
       style='font-weight:bold;font-family:Calibri;font-size:11.0pt'>Slightly
       more frequent in women</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle'><span
       style='font-weight:bold;font-family:Calibri;font-size:11.0pt'>They are
       associated with patients who had aortic coarctation</span></li>
  </ul>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>7</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7756in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>Endocrinology.
  Match the description or detail on the left with one of the options on the
  right.</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>A.
  Graves Disease Granulomatous (de Quervains) thyroiditis Hashimotos
  Thyroiditis Medullary carcinoma of thyroid Papillary carcinoma of thyroid
  Riedels Thyroiditis Subacute lymphocytic Thyroiditis Anaplastic carcinoma of
  thyroid</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>B.
  Most common cause of hypothyroidism where iodine levels are sufficient</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>C.
  Account for 85% of thyroid cancer, appear as cold masses on scintigraphy</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>D.
  Causes painless transient hyperthyroidism that often evolves into
  hypothyroidism. Usually have antithyroid peroxidase antibodies but no TSH
  receptor antibodies</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>E.
  Only true cause of thyroid ophthalmopathy with proptosis</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>F.
  Most common cause of hypothyroidism where iodine levels are sufficient</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>G.
  Account for 85% of thyroid cancer, appear as cold masses on scintigraphy</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>H.
  Causes painless transient hyperthyroidism that often evolves into
  hypothyroidism. Usually have antithyroid peroxidase antibodies but no TSH
  receptor antibodies</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>I.
  Only true cause of thyroid ophthalmopathy with proptosis</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8048in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here is the <span
  style='font-weight:bold'>Robbins-based matching</span> of thyroid diseases
  with their correct descriptions:</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Thyroid Pathology Matching – Robbins Based</span></p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.6333in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Description</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0402in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Correct Match</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.8854in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation from Robbins</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.6333in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Most common cause of hypothyroidism where iodine
    levels are sufficient</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0402in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>&#129001;
    </span><span style='font-weight:bold;font-family:Calibri'>Hashimoto’s
    Thyroiditis</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.0173in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: “<span
    style='font-weight:bold'>Hashimoto thyroiditis</span> is the most common
    cause of hypothyroidism in areas where iodine is sufficient.”Robbins and
    Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.6458in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Accounts for 85% of thyroid cancer, appear as cold
    masses on scintigraphy</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0527in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>&#129001;
    </span><span style='font-weight:bold;font-family:Calibri'>Papillary
    carcinoma of thyroid</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.9138in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: “<span
    style='font-weight:bold'>Papillary carcinoma</span> is the most common type
    of thyroid cancer, accounting for <span style='font-weight:bold'>&gt;85%</span>.
    Most are ‘cold’ on radionuclide scans.”Robbins and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.6333in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Causes painless transient hyperthyroidism that
    often evolves into hypothyroidism. Usually have antithyroid peroxidase
    antibodies but no TSH receptor antibodies</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0597in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>&#129001;
    </span><span style='font-weight:bold;font-family:Calibri'>Subacute
    lymphocytic thyroiditis</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.9791in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: “<span
    style='font-weight:bold'>Subacute lymphocytic thyroiditis</span>...
    presents with <span style='font-weight:bold'>painless</span> thyroid
    enlargement and <span style='font-weight:bold'>transient hyperthyroidism</span>.
    Autoantibodies such as <span style='font-weight:bold'>anti-TPO</span> are
    often present.”Robbins and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.6333in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Only true cause of thyroid ophthalmopathy with
    proptosis</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0402in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>&#129001;
    </span><span style='font-weight:bold;font-family:Calibri'>Graves’ Disease</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.9805in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: “<span
    style='font-weight:bold'>Thyroid-associated ophthalmopathy</span> (e.g.,
    proptosis) is seen <span style='font-weight:bold'>only in Graves disease</span>,
    caused by TSH receptor autoantibodies.”Robbins and Cotran Path…</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Final Matching:</span></p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:4.6236in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Description</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.9361in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Answer</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:4.6236in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Most common
    cause of hypothyroidism where iodine levels are sufficient</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.9361in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Hashimoto's Thyroiditis</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:4.6236in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Accounts for 85%
    of thyroid cancer, appear as cold masses on scintigraphy</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.9361in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Papillary carcinoma of thyroid</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:4.643in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Painless
    transient hyperthyroidism → hypothyroidism; anti-TPO Abs, no TSH-R Abs</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.9166in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Subacute lymphocytic thyroiditis</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:4.6236in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Only true cause
    of thyroid ophthalmopathy with proptosis</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.9361in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Graves Disease</span></p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Let me know if
  you'd like the remaining conditions (e.g., Riedel’s, anaplastic, medullary)
  summarized too.</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>8</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7562in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>Which
  of these is false regarding Berger's Disease (IgA nephropathy)</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>A.
  Many patients present with gross haematuria after a respiratory or
  gastrointestinal infection</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>B.
  Slow progression to renal failure occurs in 15-40% of cases over 20 years.</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>C. IgA
  deposits are t<span style='background:yellow;mso-highlight:yellow'>ypically
  seen i</span>n multiple sites of the body</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>D. It
  is the most common type of glomerulonephritis</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8048in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here is the <span
  style='font-weight:bold'>Robbins-based evaluation</span> of the question on <span
  style='font-weight:bold'>Berger’s Disease (IgA nephropathy):</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
  style='font-weight:bold'>Question: </span><span style='font-style:italic'>Which
  of these is </span><span style='font-weight:bold;font-style:italic'>false</span><span
  style='font-style:italic'> regarding Berger’s Disease (IgA nephropathy)?</span></p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.0298in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Option</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7361in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Evaluation</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.7937in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation from Robbins</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.0298in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>A. Many patients present with gross haematuria
    after a respiratory or gastrointestinal infection</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7375in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-style:italic;font-family:Calibri'>True</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.8402in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: “<span
    style='font-weight:bold'>IgA nephropathy</span> often presents with <span
    style='font-weight:bold'>gross hematuria</span> that typically occurs
    within <span style='font-weight:bold'>1 or 2 days of a mucosal infection</span>,
    such as a respiratory or gastrointestinal tract infection.”Robbins and
    Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.0298in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>B. Slow progression to renal failure occurs in
    15–40% of cases over 20 years.</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7375in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-style:italic;font-family:Calibri'>True</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.8416in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: “<span
    style='font-weight:bold'>15% to 40%</span> of patients with IgA nephropathy
    eventually develop <span style='font-weight:bold'>chronic renal failure</span>
    over a period of <span style='font-weight:bold'>20 years</span>.”Robbins
    and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.0298in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>C. IgA deposits are typically seen in multiple
    sites of the body</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.718in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-weight:bold;font-family:Calibri'>False</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.9437in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: In <span
    style='font-weight:bold'>Berger’s disease</span>, IgA deposits are <span
    style='font-weight:bold'>localized to the glomerular mesangium</span>.
    While IgA can be involved systemically (e.g., in <span style='font-weight:
    bold'>Henoch-Schönlein purpura</span>), <span style='font-weight:bold'>Berger’s
    disease itself is renal-limited</span>Robbins and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.0298in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>D. It is the most common type of
    glomerulonephritis</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7375in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-style:italic;font-family:Calibri'>True</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.8402in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: “<span
    style='font-weight:bold'>IgA nephropathy is the most common type of
    glomerulonephritis worldwide.</span>”Robbins and Cotran Path…</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>❌</span><span style='font-weight:bold;
  font-family:Calibri'> Correct Answer (i.e., the false statement): C. IgA
  deposits are typically seen in multiple sites of the body</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>In <span
  style='font-weight:bold'>Berger’s disease</span>, the IgA immune complexes
  are <span style='font-weight:bold'>primarily deposited in the kidney</span>,
  specifically in the <span style='font-weight:bold'>glomerular mesangium</span>
  — not systemicallyRobbins and Cotran Path….</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>9</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7756in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>Kidney
  stones.<span style='mso-spacerun:yes'>  </span>Which of these statements is <span
  style='background:yellow;mso-highlight:yellow'>true</span> about<span
  style='mso-spacerun:yes'>  </span>Calcium oxalate/phoshpate stones</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>A.
  They account for 40% of all stones</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>B.
  Half of them form in patients with hypercalcaemia and hypercalciuria</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>C.
  Only about 5% form in patients with hypercalciuria but without hypercalcaemia</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>D. As
  much as 20% of calcium oxalate stones are associated with increased uric acid
  secretion</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8048in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here is the <span
  style='font-weight:bold'>Robbins-based</span> evaluation of the question on <span
  style='font-weight:bold'>calcium oxalate/phosphate kidney stones</span>:</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
  style='font-weight:bold'>Question: </span><span style='font-style:italic'>Which
  of these statements is </span><span style='font-weight:bold;font-style:italic'>true</span><span
  style='font-style:italic'> about calcium oxalate/phosphate stones?</span></p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.9736in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Option</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7451in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Evaluation</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.8409in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation from Robbins</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.9736in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>A. They account for 40% of all stones</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7645in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-style:italic;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.9055in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: “<span
    style='font-weight:bold'>Calcium stones</span>, composed of <span
    style='font-weight:bold'>calcium oxalate or calcium oxalate mixed with
    calcium phosphate</span>, <span style='font-weight:bold'>account for about
    70% to 80%</span> of all stones.” So 40% is a significant <span
    style='font-weight:bold'>underestimate</span>Robbins and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.993in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>B. Half of them form in patients with
    hypercalcemia and hypercalciuria</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7645in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-style:italic;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.8701in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: “<span
    style='font-weight:bold'>Hypercalciuria without hypercalcemia</span> is
    found in about <span style='font-weight:bold'>50%</span> of patients.”
    Hypercalcemia with hypercalciuria accounts for <span style='font-weight:
    bold'>less than half</span>Robbins and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.993in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>C. Only about 5% form in patients with
    hypercalciuria but without hypercalcemia</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7645in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-style:italic;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.8687in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>This is an <span
    style='font-weight:bold'>underestimate</span> — Robbins states this is the <span
    style='font-weight:bold'>most common</span> metabolic abnormality in
    calcium stone formers: “<span style='font-weight:bold'>About 50%</span> of
    patients with calcium stones have <span style='font-weight:bold'>hypercalciuria
    without hypercalcemia</span>.”Robbins and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.9736in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>D. As much as 20% of calcium oxalate stones are
    associated with increased uric acid secretion</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7451in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>Correct</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.9729in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: “<span
    style='font-weight:bold'>Hyperuricosuria</span> is present in <span
    style='font-weight:bold'>about 20%</span> of patients with calcium oxalate
    stones.” Uric acid may promote <span style='font-weight:bold'>nucleation</span>
    of calcium oxalate crystalsRobbins and Cotran Path….</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Correct Answer: D. As much as 20% of calcium oxalate
  stones are associated with increased uric acid secretion</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>This reflects the <span
  style='font-weight:bold'>known link between hyperuricosuria and calcium
  oxalate stone formation</span>, as described in RobbinsRobbins and Cotran
  Path….</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>10</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7756in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>A six
  month old boy is brought in by their father because he has custody this
  weekend and is worried that the boys mother has not noticed that he's missing
  a testicle. Which of these statements is <span style='background:yellow;
  mso-highlight:yellow'>false</span> regarding cryporchidism?</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>A. <span
  style='background:yellow;mso-highlight:yellow'>It</span> is usually bilateral</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>B. He
  should not worry because histological changes won't happen for another 18
  months</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>C. it
  is rarely associated with a defined hormal disorder</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>D. it
  is associated with an inguinal hernia 10-20% of the time.</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8048in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here is the <span
  style='font-weight:bold'>Robbins-based evaluation</span> of the question on <span
  style='font-weight:bold'>cryptorchidism</span>:</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
  style='font-weight:bold'>Question: </span><span style='font-style:italic'>Which
  of these statements is </span><span style='font-weight:bold;font-style:italic'>false</span><span
  style='font-style:italic'> regarding cryptorchidism?</span></p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.618in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Option</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0513in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Evaluation</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.8902in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation from Robbins</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.6375in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>A. It is usually bilateral</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0513in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-style:italic;font-family:Calibri'>False Statement </span><span
    style='font-family:"Segoe UI Emoji"'>✅ </span><span style='font-weight:
    bold;font-family:Calibri'>(Correct answer)</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.918in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins:
    “Cryptorchidism is <span style='font-weight:bold'>bilateral in about 10%</span>
    of cases and <span style='font-weight:bold'>unilateral in the majority</span>.”
    Thus, saying it's &quot;usually bilateral&quot; is <span style='font-weight:
    bold'>false</span>Robbins and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.618in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>B. He should not worry because histological
    changes won't happen for another 18 months</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0513in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-style:italic;font-family:Calibri'>False</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.018in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: “<span
    style='font-weight:bold'>Histologic changes</span> (e.g., arrested germ
    cell development, thickened basement membrane) in undescended testes <span
    style='font-weight:bold'>begin as early as 2 years of age</span>.” So
    waiting <span style='font-weight:bold'>another 18 months (until 2 years)</span>
    is risky but not technically inaccurate for a 6-month-old. This is <span
    style='font-weight:bold'>less false than A</span>Robbins and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.618in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>C. It is rarely associated with a defined hormonal
    disorder</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0513in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-style:italic;font-family:Calibri'>True</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.918in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: “In
    most cases of cryptorchidism, <span style='font-weight:bold'>no hormonal
    abnormality</span> is identified.” It is rarely linked to defined endocrine
    disordersRobbins and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.6375in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>D. It is associated with an inguinal hernia 10–20%
    of the time</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0513in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-style:italic;font-family:Calibri'>True</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.0222in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: “In <span
    style='font-weight:bold'>10% to 20% of cases</span>, cryptorchidism is
    associated with an <span style='font-weight:bold'>inguinal hernia</span> on
    the same side.”Robbins and Cotran Path…</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Correct Answer (i.e., the false statement): A. It is
  usually bilateral</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
  style='font-weight:bold'>Cryptorchidism is most commonly unilateral</span>,
  and bilateral cases are relatively uncommon (≈10%)Robbins and Cotran Path….</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>11</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7562in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>Regarding
  endometriosis, which of these is true?</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>A. It
  most commonly affects the pelvic peritoneum</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>B.
  Retrograde menstruation through the fallopian tubes is uncommon</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>C. It
  affects around<span style='background:lime;mso-highlight:lime'> 10% of wome</span>n</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>D. It
  is not ass<span style='background:yellow;mso-highlight:yellow'>ociated with
  mali</span>gnancy</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8048in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here is the
  evaluation of the statements about <span style='font-weight:bold'>endometriosis</span>,
  based on <span style='font-style:italic'>Robbins and Cotran Pathologic Basis
  of Disease, 9th Edition</span>:</p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.5583in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Option</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7402in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Answer</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.2604in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.5583in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>A. <span
    style='font-weight:bold'>It most commonly affects the pelvic peritoneum</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7597in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-weight:bold;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.3659in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins states
    that the most common sites of endometriosis, in descending order, are: <span
    style='font-weight:bold'>“(1) ovaries, (2) uterine ligaments, (3)
    rectovaginal septum, (4) cul de sac, (5) pelvic peritoneum...”</span>.
    Thus, pelvic peritoneum is common but <span style='font-weight:bold'>not
    the most common</span>Robbins and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.575in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>B. <span
    style='font-weight:bold'>Retrograde menstruation through the fallopian
    tubes is uncommon</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7597in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-weight:bold;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.3923in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: <span
    style='font-style:italic'>“Retrograde menstruation through the fallopian
    tubes occurs regularly even in normal women…”</span>—it is in fact <span
    style='font-weight:bold'>common</span>, not rareRobbins and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.5583in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>C. <span
    style='font-weight:bold'>It affects around 10% of women</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7402in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>Correct</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.2881in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins states: <span
    style='font-style:italic'>“...affects approximately 6% to 10% of women.”</span>—this
    is accurate and widely citedRobbins and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.5763in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>D. <span
    style='font-weight:bold'>It is not associated with malignancy</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7597in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-weight:bold;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.3784in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: <span
    style='font-style:italic'>“An association between endometriosis and ovarian
    cancer of the endometrioid and clear cell types... has been noted in a
    number of epidemiologic studies…”</span>—thus, <span style='font-weight:
    bold'>it is associated with malignancy</span>Robbins and Cotran Path….</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Correct Answer: C. It affects around 10% of women</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Let me know if
  you'd like a visual summary of endometriosis sites, symptoms, and
  complications.</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>12</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7562in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>The
  most common cause of dysfunctional uterine bleeding is</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>A.
  endometriosis</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>B.
  endometritis</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>C.
  anovulation</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>D.
  Benign <span style='background:yellow;mso-highlight:yellow'>uterine</span>
  polyps</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8881in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here is the
  analysis of the MCQ on <span style='font-weight:bold'>dysfunctional uterine
  bleeding (DUB)</span>, based on <span style='font-style:italic'>Robbins and
  Cotran Pathologic Basis of Disease, 9th Edition</span>:</p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:.8777in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Option</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.727in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Answer</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.9958in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.9576in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Robbins Reference</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:.8951in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>A. Endometriosis</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7395in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌</span><span
    style='font-family:Calibri'> Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.9958in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Endometriosis
    can cause <span style='font-weight:bold'>dysmenorrhea and pelvic pain</span>,
    but it is <span style='font-weight:bold'>not the most common cause</span>
    of dysfunctional uterine bleeding.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.0937in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“Endometriosis
    is a common cause of pelvic pain but not the primary cause of DUB.”Robbins
    and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:.8951in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>B. Endometritis</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7395in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌</span><span
    style='font-family:Calibri'> Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.9958in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Endometritis</span> can lead to abnormal uterine
    bleeding, but it is <span style='font-weight:bold'>inflammatory</span> and
    relatively <span style='font-weight:bold'>less common</span> than hormonal
    causes.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.0694in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“Endometritis
    may cause bleeding, but is not a frequent cause of DUB.”Robbins and Cotran
    Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:.8972in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>C. Anovulation</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.727in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>Correct</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.0152in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Anovulatory cycles</span> are the <span
    style='font-weight:bold'>most common cause</span> of dysfunctional uterine
    bleeding, particularly at menarche and perimenopause, due to <span
    style='font-weight:bold'>lack of progesterone</span> leading to unopposed
    estrogen stimulation.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.1666in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“The most common
    cause of dysfunctional uterine bleeding is <span style='font-weight:bold'>anovulation</span>…
    often due to hormonal imbalance.”Robbins and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:.8777in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>D. Benign uterine polyps</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7395in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌</span><span
    style='font-family:Calibri'> Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.0152in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Polyps can cause
    intermenstrual bleeding but are a <span style='font-weight:bold'>structural</span>
    cause, and <span style='font-weight:bold'>less common</span> than
    anovulatory hormonal dysfunction.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.0694in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“Polyps are
    structural abnormalities that may cause bleeding but are not the most
    common cause.”Robbins and Cotran Path…</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Correct Answer: C. Anovulation</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Let me know if
  you'd like a classification of abnormal uterine bleeding based on structural
  vs functional causes!</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>13</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7756in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>You
  see a patient who is 29 weeks pregnant who presents with hypertension, oedema
  and proteinuria. You make the following remarks, which one of them is <span
  style='background:yellow;mso-highlight:yellow'>not</span> true?</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>A.
  Yep, classic, I usually see pre-eclampsia between weeks 24-30</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>B. I
  bet she has been hypertensive for a few days because it takes a while to
  develop the proteinuria</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>C.
  HELLP syndrome is avoided by 9 out of 10 women with pre-eclampsia but I
  better check for it anyway</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>D. In
  about 7 years she has a one in five chance of having hypertension and
  microalbuminuria</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8048in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here is the <span
  style='font-weight:bold'>Robbins-based and clinically supported evaluation</span>
  of the question on <span style='font-weight:bold'>pre-eclampsia</span>:</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
  style='font-weight:bold'>Question: </span><span style='font-style:italic'>Which
  of the following remarks is </span><span style='font-weight:bold;font-style:
  italic'>not true</span><span style='font-style:italic'> regarding
  pre-eclampsia?</span></p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.0055in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Option</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0298in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Evaluation</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.5243in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation from Robbins and clinical sources</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.0055in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>A. Yep, classic, I usually see pre-eclampsia
    between weeks 24–30</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0298in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-weight:bold;font-family:Calibri'>Not true </span><span
    style='font-family:"Segoe UI Emoji"'>✅ </span><span style='font-weight:
    bold;font-family:Calibri'>(Correct answer)</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.5826in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Pre-eclampsia most commonly arises after 32 weeks</span>,
    especially in otherwise healthy women. Onset between <span
    style='font-weight:bold'>24–30 weeks is less typical</span> and may raise
    suspicion for more severe disease or fetal pathologyRobbins and Cotran
    Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.0055in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>B. I bet she has been hypertensive for a few days
    because it takes a while to develop the proteinuria</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0298in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-style:italic;font-family:Calibri'>True</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.6562in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Proteinuria may <span
    style='font-weight:bold'>lag behind the rise in blood pressure</span>, as
    glomerular endothelial injury develops over time. So this remark is
    clinically reasonableRobbins and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.0055in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>C. HELLP syndrome is avoided by 9 out of 10 women
    with pre-eclampsia but I better check for it anyway</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0298in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-style:italic;font-family:Calibri'>True</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.6562in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: “<span
    style='font-weight:bold'>HELLP syndrome</span> occurs in <span
    style='font-weight:bold'>approximately 10%</span> of women with
    pre-eclampsia,” so <span style='font-weight:bold'>90% do not develop it</span>
    — this statement is accurateRobbins and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.025in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>D. In about 7 years she has a one in five chance
    of having hypertension and microalbuminuria</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0298in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-style:italic;font-family:Calibri'>True</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.5888in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: Women
    with pre-eclampsia have an increased long-term risk of <span
    style='font-weight:bold'>hypertension and renal disease</span>, and <span
    style='font-weight:bold'>20–40%</span> develop <span style='font-weight:
    bold'>chronic hypertension or microalbuminuria</span> within a
    decadeRobbins and Cotran Path….</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Correct Answer (i.e., the not true statement): A. Yep,
  classic, I usually see pre-eclampsia between weeks 24–30</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>This is <span
  style='font-weight:bold'>not true</span> — <span style='font-weight:bold'>pre-eclampsia
  most often presents after 32 weeks</span>, and earlier onset tends to
  indicate <span style='font-weight:bold'>more severe disease or higher
  maternal-fetal risk</span>Robbins and Cotran Path….</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>14</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7562in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>A 32
  year old man presents worried about a testicular lump. Which of these
  statements is true?</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>A. A
  painful testicular lump should be presumed malignant at this age and biopsy
  arranged</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>B.
  Testicular tumour markers include AST, Alkaline phosphatase and serum
  lactate.</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>C. A
  germ cell tumour is the most common cancer for a man of this age.</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>D.
  Testicular tumours mostly spread via the venous plexus of the pelvis to the
  lumbar vertebrae</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8048in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here is the
  evaluation of the statements regarding <span style='font-weight:bold'>testicular
  cancer in a 32-year-old man</span>, supported by direct quotations from <span
  style='font-style:italic'>Robbins and Cotran Pathologic Basis of Disease, 9th
  Edition</span>:</p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.6972in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Option</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7319in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Answer</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.1305in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.7048in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>A. <span
    style='font-weight:bold'>A painful testicular lump should be presumed
    malignant at this age and biopsy arranged</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7465in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-weight:bold;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.2319in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>While any <span
    style='font-weight:bold'>solid testicular mass should be presumed malignant</span>,
    <span style='font-weight:bold'>biopsy is contraindicated</span> due to risk
    of tumor spillage. Robbins states: <span style='font-style:italic'>“Biopsy
    of a testicular neoplasm is associated with a risk of tumor spillage...
    standard management... is radical orchiectomy based on the presumption of
    malignancy.”</span>Robbins and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.6972in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>B. <span
    style='font-weight:bold'>Testicular tumour markers include AST, Alkaline
    phosphatase and serum lactate.</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7465in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-weight:bold;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.2625in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>The <span
    style='font-weight:bold'>correct tumor markers</span> are <span
    style='font-weight:bold'>HCG, AFP</span>, and <span style='font-weight:
    bold'>lactate dehydrogenase (LDH)</span>. AST and alkaline phosphatase are <span
    style='font-weight:bold'>not</span> used. <span style='font-style:italic'>“Biologic
    markers include HCG, AFP, and lactate dehydrogenase...”</span>Robbins and
    Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.7159in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>C. <span
    style='font-weight:bold'>A germ cell tumour is the most common cancer for a
    man of this age.</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7319in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>Correct</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.2in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins states: <span
    style='font-style:italic'>“In the 15- to 34-year age group, testicular germ
    cell tumors constitute the most common tumor of men...”</span>Robbins and
    Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.6972in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>D. <span
    style='font-weight:bold'>Testicular tumours mostly spread via the venous
    plexus of the pelvis to the lumbar vertebrae</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7465in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-weight:bold;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.2625in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Spread is <span
    style='font-weight:bold'>primarily lymphatic</span>, especially to <span
    style='font-weight:bold'>retroperitoneal para-aortic nodes</span>, with <span
    style='font-weight:bold'>hematogenous spread (e.g., to lungs)</span>
    occurring later. Venous spread to lumbar vertebrae is <span
    style='font-weight:bold'>not typical</span>. <span style='font-style:italic'>“Lymphatic
    spread is common... retroperitoneal para-aortic nodes are the first to be
    involved.”</span>Robbins and Cotran Path…</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Correct Answer: C. A germ cell tumour is the most
  common cancer for a man of this age.</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Let me know if
  you’d like a summary table on testicular tumor types and markers.</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>15</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7756in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>Liver.
  Viral hepatitis. Which of these statements is false?</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>A.
  Months after getting heptitis A, IgG anti-HAV is formed and sustains lifelong
  immunity</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>B. Of
  hepatitis B infected patients who develop chronic hepatitis many
  spontaneously clear hep B surface antigen over years</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>C.
  Acute Hepatitis C infection is usually asymptomatic but ~ 85% of the time
  will cause chronic disease</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>D.
  Hepatitis D and E <span style='background:yellow;mso-highlight:yellow'>only
  occur in as</span>sociation with hepatitis B</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8881in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here is the
  detailed analysis of the MCQ on <span style='font-weight:bold'>viral
  hepatitis</span>, based on <span style='font-style:italic'>Robbins and Cotran
  Pathologic Basis of Disease, 9th Edition</span>:</p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.6027in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Option</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.8631in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Answer</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.3347in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.7583in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Robbins Reference</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.6027in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>A. Months after getting hepatitis A, IgG anti-HAV
    is formed and sustains lifelong immunity</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.8631in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>True</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.3541in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>IgG anti-HAV</span> replaces IgM within a few
    months after acute infection and <span style='font-weight:bold'>provides
    lifelong immunity</span>. Reinfection does not occur.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.9736in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“IgG anti-HAV
    appears shortly after IgM and <span style='font-weight:bold'>confers
    lifelong protection</span>.”Robbins and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.6166in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>B. Of hepatitis B infected patients who develop
    chronic hepatitis, many spontaneously clear HBsAg over years</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.8631in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>True</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.3347in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>In <span
    style='font-weight:bold'>some patients with chronic HBV</span>, <span
    style='font-weight:bold'>spontaneous clearance of HBsAg</span> can occur
    over time, though this is less common than persistence.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.8694in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“In a subset of
    chronically infected individuals, <span style='font-weight:bold'>HBsAg may
    be lost</span> over time, and anti-HBs may develop.”Robbins and Cotran
    Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.6027in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>C. Acute hepatitis C infection is usually
    asymptomatic but ~85% of the time will cause chronic disease</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.8631in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>True</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.3347in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Most HCV
    infections are <span style='font-weight:bold'>asymptomatic</span>
    initially, but <span style='font-weight:bold'>chronicity occurs in ~80–90%</span>
    of cases.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.9166in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“<span
    style='font-weight:bold'>Chronic infection occurs in 80% to 90% of
    HCV-infected persons</span>… most acute infections are subclinical.”Robbins
    and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.6027in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>D. Hepatitis D and E only occur in association
    with hepatitis B</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.8631in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-weight:bold;font-family:Calibri'>False </span><span
    style='font-family:"Segoe UI Emoji"'>✅ </span><span style='font-weight:
    bold;font-family:Calibri'>Correct Answer</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.3347in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Hepatitis D</span> requires <span
    style='font-weight:bold'>HBV co-infection or superinfection</span> to
    propagate, but <span style='font-weight:bold'>Hepatitis E does not</span>. <span
    style='font-weight:bold'>HEV is an independent virus</span> transmitted via
    the fecal-oral route, typically in contaminated water.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.9736in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“<span
    style='font-weight:bold'>Hepatitis D</span> virus is defective and requires
    <span style='font-weight:bold'>HBV</span> for replication. <span
    style='font-weight:bold'>HEV is an independent virus</span> causing
    enterically transmitted hepatitis.”Robbins and Cotran Path…</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Correct Answer: D. Hepatitis D and E only occur in
  association with hepatitis B</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Let me know if
  you'd like a comparison table of <span style='font-weight:bold'>HAV–HEV</span>
  in terms of transmission, chronicity, and complications!</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>16</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7756in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>LIver.
  Alcoholic liver disease. Which of these is true?</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>A.
  70-80 % of alcoholics develop cirrhosis</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>B. On
  a dose-for dose bases women are more susceptible to alcohol induced liver
  injury than men</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>C. In
  alcoholic liver disease ALT tends to be higher than AST</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>D.
  Alcohol inhibits peripheral catabolism of fat</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8048in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here is the <span
  style='font-weight:bold'>Robbins-based evaluation</span> of the question on <span
  style='font-weight:bold'>alcoholic liver disease</span>:</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
  style='font-weight:bold'>Question: </span><span style='font-style:italic'>Which
  of these is </span><span style='font-weight:bold;font-style:italic'>true</span><span
  style='font-style:italic'> regarding alcoholic liver disease?</span></p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.2034in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Option</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7562in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Evaluation</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.6in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation from Robbins</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.2222in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>A. 70–80% of alcoholics develop cirrhosis</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7756in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-style:italic;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.7256in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: “Only
    about <span style='font-weight:bold'>10% to 15%</span> of chronic
    alcoholics go on to develop <span style='font-weight:bold'>cirrhosis</span>.”
    The majority develop <span style='font-weight:bold'>fatty liver</span> or <span
    style='font-weight:bold'>hepatitis</span>, but not cirrhosisRobbins and
    Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.2222in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>B. On a dose-for-dose basis women are more
    susceptible to alcohol-induced liver injury than men</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7562in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>Correct</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.6277in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: “<span
    style='font-weight:bold'>Women are more susceptible</span> than men to
    alcohol-induced liver damage, even when controlled for body weight and
    alcohol intake.”Robbins and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.2034in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>C. In alcoholic liver disease ALT tends to be
    higher than AST</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7756in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-style:italic;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.7319in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: “A <span
    style='font-weight:bold'>classic pattern</span> in alcoholic liver disease
    is that <span style='font-weight:bold'>AST is elevated more than ALT</span>,
    often in a ratio of <span style='font-weight:bold'>2:1 or greater</span>.”
    This helps distinguish it from viral hepatitisRobbins and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.2034in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>D. Alcohol inhibits peripheral catabolism of fat</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7756in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-style:italic;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.6277in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Alcohol actually
    <span style='font-weight:bold'>increases peripheral lipolysis</span> and
    promotes <span style='font-weight:bold'>hepatic fat accumulation</span> by
    increasing NADH and impairing lipid oxidationRobbins and Cotran Path….</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Correct Answer: B. On a dose-for-dose basis women are
  more susceptible to alcohol-induced liver injury than men</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>This is a
  well-established and Robbins-supported fact, likely due to differences in
  alcohol metabolism and hormonal influencesRobbins and Cotran Path….</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>17</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7562in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>Liver.
  Hyperbilirubinaemia. In which of these diseases would you see unconjugated
  hyperbilirubinaemia</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>A.
  Gilbe<span style='background:yellow;mso-highlight:yellow'>rt synd</span>rome</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>B.
  Gittlemans syndrome</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>C.
  Dubin-Johnson syndrome</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>D.
  Rotor syndrome</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8048in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here is the
  evaluation of the options regarding <span style='font-weight:bold'>unconjugated
  hyperbilirubinemia</span>, with direct references from <span
  style='font-style:italic'>Robbins and Cotran Pathologic Basis of Disease, 9th
  Edition</span>:</p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.0347in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Option</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7638in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Answer</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.7604in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.0347in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>A. <span
    style='font-weight:bold'>Gilbert syndrome</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7638in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>Correct</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.8222in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Gilbert syndrome
    causes <span style='font-weight:bold'>unconjugated hyperbilirubinemia</span>
    due to <span style='font-weight:bold'>reduced UGT1A1 activity</span>,
    leading to impaired bilirubin conjugation. Robbins states: <span
    style='font-style:italic'>“Gilbert syndrome... results in hereditary
    unconjugated hyperbilirubinemia”</span>Robbins and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.0541in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>B. <span
    style='font-weight:bold'>Gitelman’s syndrome</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7833in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-weight:bold;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.8923in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>This is a <span
    style='font-weight:bold'>renal tubulopathy</span> affecting electrolyte
    reabsorption, <span style='font-weight:bold'>not related to bilirubin
    metabolism</span>. Robbins does not associate it with hyperbilirubinemia.</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.0347in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>C. <span
    style='font-weight:bold'>Dubin-Johnson syndrome</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7833in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-weight:bold;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.7888in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Dubin-Johnson
    syndrome causes <span style='font-weight:bold'>conjugated
    hyperbilirubinemia</span> due to <span style='font-weight:bold'>defective
    biliary excretion</span> of conjugated bilirubin. <span style='font-style:
    italic'>“Dubin-Johnson syndrome... results from other defects that lead to
    conjugated hyperbilirubinemia.”</span>Robbins and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.0347in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>D. <span
    style='font-weight:bold'>Rotor syndrome</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7833in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-weight:bold;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.7895in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Rotor syndrome
    also results in <span style='font-weight:bold'>conjugated
    hyperbilirubinemia</span>, as Robbins notes: <span style='font-style:italic'>“Rotor
    syndrome... leads to conjugated hyperbilirubinemia.”</span>Robbins and
    Cotran Path…</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Correct Answer: A. Gilbert syndrome</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Let me know if
  you'd like a table summarizing inherited hyperbilirubinemias (e.g.,
  Crigler-Najjar, Gilbert, Dubin-Johnson, Rotor).</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>18</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7562in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>Biliary
  tract. Which of these people would you guess has the highest likelihood of
  primary sclerosing cholangitis?</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>A. A
  22 year old woman with ulcerative colitis</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>B. A
  30 year<span style='background:yellow;mso-highlight:yellow'> old man with ulc</span>erative
  colitis</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>C. A
  50 year old woman with Sjogrens syndrome and positive antimitochondrial
  antibodies</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>D. A
  50 year old woman with thyroid disease and scleroderma</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8881in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here is the
  detailed analysis of the MCQ on <span style='font-weight:bold'>primary
  sclerosing cholangitis (PSC)</span>, based on <span style='font-style:italic'>Robbins
  and Cotran Pathologic Basis of Disease, 9th Edition</span>:</p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.5472in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Option</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7236in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Answer</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.3548in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.9333in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Robbins Reference</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.5472in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>A. A 22-year-old woman with ulcerative colitis</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7395in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌</span><span
    style='font-family:Calibri'> Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.3743in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>PSC is strongly
    associated with <span style='font-weight:bold'>ulcerative colitis</span>,
    but it is far more common in <span style='font-weight:bold'>males</span>. A
    young woman with UC is less typical than a male.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.052in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“PSC affects <span
    style='font-weight:bold'>males</span> more often than females, typically in
    the <span style='font-weight:bold'>third to fifth decades</span>, and is
    strongly associated with <span style='font-weight:bold'>ulcerative colitis</span>.”Robbins
    and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.5666in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>B. A 30-year-old man with ulcerative colitis</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7236in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>Correct</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.3666in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>This is the <span
    style='font-weight:bold'>classic demographic</span> for PSC: <span
    style='font-weight:bold'>young to middle-aged man</span> with <span
    style='font-weight:bold'>ulcerative colitis</span>. The association is
    well-documented and seen in up to 70% of PSC cases.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.1416in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“PSC commonly
    occurs in <span style='font-weight:bold'>young men</span> with <span
    style='font-weight:bold'>ulcerative colitis</span>.”Robbins and Cotran
    Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.5472in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>C. A 50-year-old woman with Sjögren’s syndrome and
    positive antimitochondrial antibodies</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7395in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌</span><span
    style='font-family:Calibri'> Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.3548in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>This
    presentation is more consistent with <span style='font-weight:bold'>primary
    biliary cholangitis (PBC)</span>, not PSC. PBC is associated with <span
    style='font-weight:bold'>middle-aged women</span>, <span style='font-weight:
    bold'>autoimmune diseases</span>, and <span style='font-weight:bold'>AMA
    positivity</span>.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.1388in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“Primary biliary
    cholangitis… occurs in <span style='font-weight:bold'>middle-aged women</span>,
    often with <span style='font-weight:bold'>antimitochondrial antibodies</span>.”Robbins
    and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.5472in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>D. A 50-year-old woman with thyroid disease and
    scleroderma</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7395in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌</span><span
    style='font-family:Calibri'> Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.3548in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>This combination
    suggests <span style='font-weight:bold'>autoimmune disease</span>, again
    more likely associated with <span style='font-weight:bold'>PBC</span> than
    PSC. PSC is <span style='font-weight:bold'>not commonly linked</span> with
    thyroid or connective tissue diseases.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.1298in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>PBC is
    associated with autoimmune disorders; PSC less so.</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Correct Answer: B. A 30-year-old man with ulcerative
  colitis</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Let me know if
  you’d like a comparison table of <span style='font-weight:bold'>PSC vs PBC</span>!</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>19</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7694in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>Biliary
  tract. Regarding bilirubin, which of these is true?</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>A.
  Excess production of bilirubin or defective conjugation will lead to high
  levels of bilirubin in the urine</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>B.
  Unconjugated bilirubin is loosely bound to albumin</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>C.
  Conjugated hyperbilirubinaem<span style='background:yellow;mso-highlight:
  yellow'>ia most often results from hepatocellular disease, bile duct injury
  and biliary obst</span>ruction</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>D.
  Conjugated bilirubin is tightly bound to albumin and is not water soluble</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8048in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here is the <span
  style='font-weight:bold'>Robbins-based evaluation</span> of the question on <span
  style='font-weight:bold'>bilirubin metabolism</span>:</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
  style='font-weight:bold'>Question: </span><span style='font-style:italic'>Regarding
  bilirubin, which of these is </span><span style='font-weight:bold;font-style:
  italic'>true</span><span style='font-style:italic'>?</span></p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.227in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Option</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7361in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Evaluation</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.5958in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation from Robbins</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.2465in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>A. Excess production of bilirubin or defective
    conjugation will lead to high levels of bilirubin in the urine</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7548in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-style:italic;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.725in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: <span
    style='font-weight:bold'>Unconjugated bilirubin</span> (from excess
    production or defective conjugation) is <span style='font-weight:bold'>not
    water soluble</span> and is <span style='font-weight:bold'>tightly bound to
    albumin</span>, so it <span style='font-weight:bold'>does not appear in
    urine</span>. Only <span style='font-weight:bold'>conjugated bilirubin</span>
    is excreted in urineRobbins and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.227in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>B. Unconjugated bilirubin is loosely bound to
    albumin</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7548in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-style:italic;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.643in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: <span
    style='font-weight:bold'>Unconjugated bilirubin is tightly bound to albumin</span>,
    making it <span style='font-weight:bold'>insoluble in water</span> and
    preventing its urinary excretionRobbins and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.2465in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>C. Conjugated hyperbilirubinaemia most often
    results from hepatocellular disease, bile duct injury and biliary
    obstruction</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7354in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>Correct</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.7284in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: “<span
    style='font-weight:bold'>Conjugated hyperbilirubinemia</span> results when
    conjugated bilirubin cannot reach the intestine because of <span
    style='font-weight:bold'>hepatocellular dysfunction</span>, <span
    style='font-weight:bold'>bile duct obstruction</span>, or <span
    style='font-weight:bold'>injury to biliary structures</span>.”Robbins and
    Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.2465in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>D. Conjugated bilirubin is tightly bound to
    albumin and is not water soluble</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7548in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-style:italic;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.7284in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: <span
    style='font-weight:bold'>Conjugated bilirubin is water soluble</span>, not
    tightly albumin-bound, and <span style='font-weight:bold'>can be excreted
    in urine</span>, unlike the unconjugated formRobbins and Cotran Path….</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Correct Answer: C. Conjugated hyperbilirubinaemia most
  often results from hepatocellular disease, bile duct injury and biliary
  obstruction</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>This aligns
  exactly with Robbins’ description of causes of <span style='font-weight:bold'>conjugated
  (direct) hyperbilirubinemia</span>Robbins and Cotran Path….</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>20</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7756in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>Pancreatitis.
  Which of these statements is false?</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>A. 80%
  of cases are caused by gallstones or alcohol intake</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>B. 1:3
  is the male:female ratio of patients with pancreatitis from biliary tract
  disease</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>C.
  Lipase is secreted as prolipase and activated on exposure to inflamed
  pancreatic tissue</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>D. The
  risk of pancreatic cancer is only moderately elevated in most forms of
  chronic pancreatitis</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8048in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here is the
  evaluation of the statements regarding <span style='font-weight:bold'>pancreatitis</span>,
  with direct quotes from <span style='font-style:italic'>Robbins and Cotran
  Pathologic Basis of Disease, 9th Edition</span>:</p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.0118in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Option</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.709in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Answer</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.8381in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.0118in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>A. <span
    style='font-weight:bold'>80% of cases are caused by gallstones or alcohol
    intake</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.6909in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>True</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.8944in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins states: <span
    style='font-style:italic'>“Biliary tract disease and alcoholism account for
    approximately </span><span style='font-weight:bold;font-style:italic'>80%</span><span
    style='font-style:italic'> of cases of acute pancreatitis in Western
    countries.”</span>Robbins and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.0118in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>B. <span
    style='font-weight:bold'>1:3 is the male:female ratio of patients with
    pancreatitis from biliary tract disease</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.6909in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>True</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.8854in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins
    confirms: <span style='font-style:italic'>“The male-to-female ratio is </span><span
    style='font-weight:bold;font-style:italic'>1:3</span><span
    style='font-style:italic'> in the group with biliary tract disease...”</span>Robbins
    and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.0118in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>C. <span
    style='font-weight:bold'>Lipase is secreted as prolipase and activated on
    exposure to inflamed pancreatic tissue</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.6909in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-weight:bold;font-family:Calibri'>False</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.9493in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>This is
    incorrect. Robbins clearly states: <span style='font-style:italic'>“Although
    most pancreatic enzymes are secreted as inactive zymogens, </span><span
    style='font-weight:bold;font-style:italic'>lipase is produced in an active
    form</span><span style='font-style:italic'>...”</span>Robbins and Cotran
    Path…. Thus, lipase is <span style='font-weight:bold'>not secreted as a
    proenzyme</span>.</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.0118in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>D. <span
    style='font-weight:bold'>The risk of pancreatic cancer is only moderately
    elevated in most forms of chronic pancreatitis</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.6909in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>True</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.925in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins notes: <span
    style='font-style:italic'>“Patients with hereditary pancreatitis have a 40%
    lifetime risk... whether this increased cancer risk extends to other
    forms... is unclear.”</span> indicating <span style='font-weight:bold'>moderate
    or unclear risk in non-hereditary cases</span>Robbins and Cotran Path….</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>❌</span><span style='font-weight:bold;
  font-family:Calibri'> Correct Answer: C. Lipase is secreted as prolipase and
  activated on exposure to inflamed pancreatic tissue (This is the false
  statement)</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Let me know if
  you'd like a table differentiating acute vs chronic pancreatitis.</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>21</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7756in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>Pancreatic
  cancer. Which of these is true</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>A.
  Most cancers arise in the tail and rarely cause symptoms</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>B. Ca
  19.9 and CEA tumour markers are useful population screening tools</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>C. The
  five year survival rate has improved to 30-40 %</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>D.
  Paradoxically, pancreatic cancer risk is higher in patients with a BMI &lt;
  20</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>E. All
  of the above</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>F.
  None of the above</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8881in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here is the
  detailed analysis of the MCQ on <span style='font-weight:bold'>pancreatic
  cancer</span>, based on <span style='font-style:italic'>Robbins and Cotran
  Pathologic Basis of Disease, 9th Edition</span>:</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.3937in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Option</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.725in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Answer</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.809in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.7305in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Robbins Reference</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.4125in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>A. Most cancers arise in the tail and rarely cause
    symptoms</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7395in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌</span><span
    style='font-family:Calibri'> Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.8284in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Most pancreatic carcinomas (~60%) arise in the
    head of the pancreas</span>, not the tail. Tumors in the <span
    style='font-weight:bold'>head</span> often cause <span style='font-weight:
    bold'>early symptoms</span> like obstructive jaundice, while <span
    style='font-weight:bold'>tail tumors are often silent</span> and discovered
    late.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.8465in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“About 60% of
    pancreatic cancers arise in the <span style='font-weight:bold'>head</span>
    of the gland… tail tumors tend to remain silent.”Robbins and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.4125in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>B. CA 19-9 and CEA tumor markers are useful
    population screening tools</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7395in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌</span><span
    style='font-family:Calibri'> Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.8284in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>CA 19-9 and CEA are useful for monitoring disease</span>,
    but <span style='font-weight:bold'>not for screening</span> due to poor
    sensitivity and specificity in asymptomatic populations.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.7916in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“CA 19-9 may be
    elevated, but it is <span style='font-weight:bold'>not sufficiently
    specific or sensitive for screening</span> purposes.”Robbins and Cotran
    Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.3937in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>C. The five-year survival rate has improved to
    30–40%</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7395in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌</span><span
    style='font-family:Calibri'> Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.8118in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Pancreatic
    cancer remains highly lethal. The <span style='font-weight:bold'>overall
    5-year survival is &lt;10%</span>, often cited as <span style='font-weight:
    bold'>around 5–8%</span>, despite some surgical improvements.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.8201in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“Pancreatic
    cancer has a <span style='font-weight:bold'>5-year survival rate of less
    than 10%</span>.”Robbins and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.3937in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>D. Paradoxically, pancreatic cancer risk is higher
    in patients with a BMI &lt; 20</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7395in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌</span><span
    style='font-family:Calibri'> Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.809in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Obesity and high BMI</span> are <span
    style='font-weight:bold'>risk factors</span> for pancreatic cancer, <span
    style='font-weight:bold'>not low BMI</span>. Weight loss is a <span
    style='font-weight:bold'>symptom</span>, not a risk factor.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.8465in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“Obesity and
    high caloric intake are associated with increased risk of pancreatic
    cancer.”Robbins and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.3937in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>E. All of the above</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7395in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌</span><span
    style='font-family:Calibri'> Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.809in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Since <span
    style='font-weight:bold'>all individual statements are false</span>, this
    option is also incorrect.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.6166in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.3937in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>F. None of the above</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.725in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>Correct</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.809in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>As explained
    above, <span style='font-weight:bold'>none of the listed statements are
    accurate</span>, making this the correct answer.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.6312in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Correct Answer: F. None of the above</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Let me know if
  you'd like a summary table on <span style='font-weight:bold'>pancreatic
  cancer epidemiology, clinical features, and prognosis</span>!</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>22</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7756in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:16.0pt'><span
  style='font-weight:bold'>Gastrointestinal: Match the condition on the right
  with the typical description or detail on the left.</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
  style='font-weight:bold'>Conditions:</span></p>
  <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle'><span
       style='font-weight:bold;font-family:Calibri;font-size:11.0pt'>A.
       Ulcerative colitis</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle'><span
       style='font-weight:bold;font-family:Calibri;font-size:11.0pt'>B. Crohn’s
       disease</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle'><span
       style='font-weight:bold;font-family:Calibri;font-size:11.0pt'>C. Coeliac
       disease</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle'><span
       style='font-weight:bold;font-family:Calibri;font-size:11.0pt'>D.
       Pseudomembranous colitis</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle'><span
       style='font-weight:bold;font-family:Calibri;font-size:11.0pt'>E.
       Microscopic colitis</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle'><span
       style='font-weight:bold;font-family:Calibri;font-size:11.0pt'>F.
       Infectious diarrhea (e.g., ETEC)</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle'><span
       style='font-weight:bold;font-family:Calibri;font-size:11.0pt'>G. Small
       intestinal bacterial overgrowth (SIBO)</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle'><span
       style='font-weight:bold;font-family:Calibri;font-size:11.0pt'>H.
       Peutz-Jeghers syndrome</span></li>
  </ul>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:16.0pt'><span
  style='font-weight:bold'>Descriptions:</span></p>
  <ol type=1 style='direction:ltr;unicode-bidi:embed;margin-top:0in;margin-bottom:
   0in;font-family:Calibri;font-size:11.0pt;font-weight:normal;font-style:normal'>
   <li value=1 style='margin-top:0;margin-bottom:0;vertical-align:middle'><span
       style='font-family:Calibri;font-size:11.0pt;font-weight:normal;
       font-style:normal;font-family:Calibri;font-size:11.0pt'>Associated with
       dermatitis herpetiformis; conveys an increased risk of certain lymphomas</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle'><span
       style='font-family:Calibri;font-size:11.0pt'>Occurs in middle-aged and
       older women; usually normal endoscopy; histology shows a dense
       subepithelial collagen layer</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle'><span
       style='font-family:Calibri;font-size:11.0pt'>Caused by enterotoxigenic </span><span
       style='font-style:italic;font-family:Calibri;font-size:11.0pt'>Escherichia
       coli</span><span style='font-family:Calibri;font-size:11.0pt'> (ETEC); a
       principal cause of travellers’ diarrhoea</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle'><span
       style='font-family:Calibri;font-size:11.0pt'>Associated with
       gram-positive bacterial overgrowth</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle'><span
       style='font-family:Calibri;font-size:11.0pt'>Annoyingly, symptoms are
       relieved by smoking</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle'><span
       style='font-family:Calibri;font-size:11.0pt'>Will not uncommonly cause
       fat and vitamin malabsorption</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle'><span
       style='font-family:Calibri;font-size:11.0pt'>Autosomal dominant
       condition; presents in teenagers with multiple polyps and hyperpigmented
       mucocutaneous spots</span></li>
  </ol>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8048in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here is the <span
  style='font-weight:bold'>answered matching question</span> with each
  description correctly matched to its associated gastrointestinal condition,
  based on <span style='font-style:italic'>Robbins and Cotran Pathologic Basis
  of Disease, 9th Edition</span>:</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Gastrointestinal Matching – Answers</span></p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.5868in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Description</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0472in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Answer</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.925in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.5868in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>1. Associated
    with dermatitis herpetiformis; conveys an increased risk of certain
    lymphomas</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0472in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>C. Coeliac disease</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.0194in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Strongly
    associated with <span style='font-weight:bold'>HLA-DQ2/8</span>, <span
    style='font-weight:bold'>IgA anti-transglutaminase</span>, and <span
    style='font-weight:bold'>dermatitis herpetiformis</span>. Increases risk
    for <span style='font-weight:bold'>enteropathy-associated T-cell lymphoma</span>.</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.5868in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>2. Occurs in
    middle-aged and older women; usually normal endoscopy; histology shows a
    dense subepithelial collagen layer</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0472in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>E. Microscopic colitis</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.0576in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Includes <span
    style='font-weight:bold'>collagenous colitis</span> (subepithelial collagen
    band); causes <span style='font-weight:bold'>chronic watery diarrhea</span>
    with normal-appearing mucosa.</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.5868in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>3. Caused by
    enterotoxigenic <span style='font-style:italic'>Escherichia coli</span>
    (ETEC); a principal cause of travellers’ diarrhoea</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0472in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>F. Infectious diarrhea (ETEC)</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.9777in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>ETEC</span> is the most common cause of <span
    style='font-weight:bold'>traveller’s diarrhoea</span>; toxin-mediated
    watery diarrhea without inflammation.</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.5868in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>4. Associated
    with gram-positive bacterial overgrowth</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0666in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>D. Pseudomembranous colitis</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.0576in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Caused by <span
    style='font-weight:bold'>Clostridium difficile</span>, a gram-positive
    anaerobe producing <span style='font-weight:bold'>toxins A and B</span> →
    pseudomembrane formation.</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.5868in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>5. Annoyingly,
    symptoms are relieved by smoking</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0472in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>A. Ulcerative colitis</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.9534in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Smoking has a <span
    style='font-weight:bold'>protective effect</span> on UC symptoms (opposite
    of Crohn’s). Mechanism not fully understood.</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.5868in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>6. Will not
    uncommonly cause fat and vitamin malabsorption</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0472in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>B. Crohn’s disease</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.9534in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Involves the <span
    style='font-weight:bold'>small intestine</span> (esp. terminal ileum) → <span
    style='font-weight:bold'>malabsorption</span> of <span style='font-weight:
    bold'>fat, B12, and fat-soluble vitamins</span>.</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.5868in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>7. Autosomal
    dominant condition; presents in teenagers with multiple polyps and
    hyperpigmented mucocutaneous spots</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0472in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>H. Peutz-Jeghers syndrome</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.9618in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Caused by <span
    style='font-weight:bold'>STK11 mutations</span>; hamartomatous polyps + <span
    style='font-weight:bold'>mucocutaneous pigmentation</span> (lips, buccal
    mucosa).</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.5868in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>8. Patients have
    only colonic disease but have patchy histological disease and perianal
    lesions</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0472in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>B. Crohn’s disease</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.0437in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>While UC is
    continuous and colonic, <span style='font-weight:bold'>Crohn’s can affect
    only colon</span> but with <span style='font-weight:bold'>skip lesions</span>
    and <span style='font-weight:bold'>perianal disease</span>.</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Let me know if
  you'd like this exported as a printable study sheet!</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>23</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7562in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>Lungs.
  Mesothelioma is common in Geelong due to its industrial history. Which of
  these statements is <span style='background:yellow;mso-highlight:yellow'>false</span>?</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>A. The
  lifetime risk of developing it in heavily exposed individuals is as high as
  7-10%</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>B.
  There seems to be no increase in mesothelioma in asbestos workers who smoke</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>C.
  Concurrent pulmonary as<span style='background:lime;mso-highlight:lime'>bestosis
  (fibrosis) is present in 80% of individuals with pleural mesothelioma</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>D.
  Fifty <span style='background:yellow;mso-highlight:yellow'>percent die within
  12 mon</span>ths of diagnosis</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8048in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here is the <span
  style='font-weight:bold'>Robbins-based evaluation</span> of the question on <span
  style='font-weight:bold'>mesothelioma</span>:</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
  style='font-weight:bold'>Question: </span><span style='font-style:italic'>Which
  of these statements about mesothelioma is </span><span style='font-weight:
  bold;font-style:italic'>false</span><span style='font-style:italic'>?</span></p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.2618in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Option</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7361in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Evaluation</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.5611in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation from Robbins</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.2812in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>A. The lifetime risk of developing it in heavily
    exposed individuals is as high as 7–10%</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7402in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-style:italic;font-family:Calibri'>True</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.6041in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: “The <span
    style='font-weight:bold'>lifetime risk of mesothelioma</span> in heavily
    exposed individuals is <span style='font-weight:bold'>7% to 10%</span>.”
    This is accurate and well-documentedRobbins and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.2812in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>B. There seems to be no increase in mesothelioma
    in asbestos workers who smoke</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7402in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-style:italic;font-family:Calibri'>True</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.6208in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: “<span
    style='font-weight:bold'>Smoking does not increase the risk of mesothelioma</span>,
    although it does synergistically increase the risk of bronchogenic
    carcinoma in asbestos-exposed individuals.”Robbins and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.2805in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>C. Concurrent pulmonary asbestosis (fibrosis) is
    present in 80% of individuals with pleural mesothelioma</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7208in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-weight:bold;font-family:Calibri'>False</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.6104in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: “<span
    style='font-weight:bold'>Asbestosis (interstitial fibrosis)</span> is
    present in <span style='font-weight:bold'>only about 20%</span> of
    mesothelioma cases.” So <span style='font-weight:bold'>fibrosis is not seen
    in 80%</span> — this is a <span style='font-weight:bold'>false statement</span>Robbins
    and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.2618in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>D. Fifty percent die within 12 months of diagnosis</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7402in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-style:italic;font-family:Calibri'>True</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.7083in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins:
    “Mesothelioma has a <span style='font-weight:bold'>poor prognosis</span>,
    with most patients dying <span style='font-weight:bold'>within 12 to 17
    months</span> of diagnosis.” So this estimate is accurateRobbins and Cotran
    Path….</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>❌</span><span style='font-weight:bold;
  font-family:Calibri'> Correct Answer (i.e., the false statement): C.
  Concurrent pulmonary asbestosis is present in 80% of mesothelioma cases</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>This is <span
  style='font-weight:bold'>false</span> — Robbins clearly states <span
  style='font-weight:bold'>asbestosis is present in only ~20%</span>, not 80%,
  of patients with pleural mesotheliomaRobbins and Cotran Path….</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>24</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7562in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>Regarding
  lung cancer in general, which of these is true?</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>A.
  Squamous and small cell carcinomas are the most associated with smoking</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>B.
  Pancoast tumours at the lung apex classically cause a recurrent laryngeal
  nerve palsy</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>C.
  Adrenal metastases are rare in lung cancer with has spread outside the thorax</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>D.
  Lung cancer among non-smoking uranium miners (not an common profession in
  Australia) has the same prevalence as the non-smoking general population</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8048in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here is the
  evaluation of the statements regarding <span style='font-weight:bold'>lung
  cancer</span>, based on <span style='font-style:italic'>Robbins and Cotran
  Pathologic Basis of Disease, 9th Edition</span>:</p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.8576in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Option</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7263in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Answer</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.975in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.8576in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>A. <span
    style='font-weight:bold'>Squamous and small cell carcinomas are the most
    associated with smoking</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7458in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>True</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.0027in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins states: <span
    style='font-style:italic'>“Squamous cell carcinoma is highly associated
    with exposure to tobacco smoke…”</span> and <span style='font-style:italic'>“Small
    cell carcinoma shows the strongest association with smoking…”</span>Robbins
    and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.8576in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>B. <span
    style='font-weight:bold'>Pancoast tumours at the lung apex classically
    cause a recurrent laryngeal nerve palsy</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7458in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-weight:bold;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.0027in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Pancoast tumors
    typically invade <span style='font-weight:bold'>the cervical sympathetic
    plexus</span>, leading to <span style='font-weight:bold'>Horner syndrome</span>
    and <span style='font-weight:bold'>ulnar nerve symptoms</span>, <span
    style='font-weight:bold'>not</span> recurrent laryngeal nerve palsy.
    Robbins: <span style='font-style:italic'>“Apical lung cancers... invade the
    neural structures... including the cervical sympathetic plexus… producing
    Horner syndrome and ulnar nerve pain.”</span>Robbins and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.877in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>C. <span
    style='font-weight:bold'>Adrenal metastases are rare in lung cancer which
    has spread outside the thorax</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7458in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-weight:bold;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.0027in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins states: <span
    style='font-style:italic'>“The adrenals are a fairly common site for
    metastases in patients with disseminated carcinomas,”</span> especially
    from the lungRobbins and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.8576in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>D. <span
    style='font-weight:bold'>Lung cancer among non-smoking uranium miners...
    has the same prevalence as the non-smoking general population</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7458in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-weight:bold;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.0993in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins states: <span
    style='font-style:italic'>“Lung cancer rates among nonsmoking uranium
    miners are </span><span style='font-weight:bold;font-style:italic'>four
    times higher</span><span style='font-style:italic'> than in the general
    population.”</span>Robbins and Cotran Path….</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Correct Answer: A. Squamous and small cell carcinomas
  are the most associated with smoking</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Let me know if
  you’d like a chart comparing the major types of lung cancer by etiology,
  histology, and molecular markers.</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>25</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7756in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>Transplanted
  lungs. Which one of these statements is false</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>A. In
  the first few weeks post transplant, bacterial infections are most common</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>B.
  Pneumocycstis jiroveci is rare as most patients will be on bactrim</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>C.
  Acute lung allograft rejection is chiefly diagnosed when you see fever,
  dyspnoea, cough and radiological infiltrates</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>D.
  Chronic lung rejection leads to irreversible decreases in lung function from
  pulmonary fibrosis</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8881in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here is the
  detailed analysis of the MCQ on <span style='font-weight:bold'>lung
  transplantation</span>, based on <span style='font-style:italic'>Robbins and
  Cotran Pathologic Basis of Disease, 9th Edition</span> and clinical
  transplant immunopathology:</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.55in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Option</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.8416in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Answer</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.6111in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.668in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Robbins Reference</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.55in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>A. In the first few weeks post transplant,
    bacterial infections are most common</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.8416in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>True</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.6111in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Bacterial infections</span> are the <span
    style='font-weight:bold'>most common and serious infections in the early
    post-transplant period</span>, especially from <span style='font-weight:
    bold'>hospital-acquired organisms</span>.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.7722in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“Bacterial
    infections are the most common complications in the early post-transplant
    period.”Robbins and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.5583in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>B. </span><span style='font-weight:bold;
    font-style:italic'>Pneumocystis jiroveci</span><span style='font-weight:
    bold'> is rare as most patients will be on Bactrim</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.8416in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>True</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.6111in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Prophylactic trimethoprim-sulfamethoxazole
    (Bactrim)</span> is standard care and effectively reduces <span
    style='font-weight:bold'>PJP incidence</span> in transplant recipients.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.7722in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“Prophylaxis
    with trimethoprim-sulfamethoxazole has reduced the incidence of <span
    style='font-style:italic'>P. jiroveci</span> pneumonia.”Robbins and Cotran
    Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.5694in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>C. Acute lung allograft rejection is chiefly
    diagnosed when you see fever, dyspnoea, cough and radiological infiltrates</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.8416in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>True</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.6111in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>These are <span
    style='font-weight:bold'>clinical signs</span> of acute rejection, but <span
    style='font-weight:bold'>definitive diagnosis requires biopsy</span>;
    however, clinical suspicion is often based on these symptoms.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.7722in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“Acute rejection
    presents with dyspnea, cough, infiltrates… and must be confirmed
    histologically.”Robbins and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.55in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>D. Chronic lung rejection leads to irreversible
    decreases in lung function from pulmonary fibrosis</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.8416in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-weight:bold;font-family:Calibri'>False </span><span
    style='font-family:"Segoe UI Emoji"'>✅ </span><span style='font-weight:
    bold;font-family:Calibri'>Correct Answer</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.6298in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Chronic lung
    rejection manifests as <span style='font-weight:bold'>bronchiolitis
    obliterans</span>, a <span style='font-weight:bold'>fibrosing process that
    affects small airways</span>, <span style='font-weight:bold'>not classic
    pulmonary fibrosis</span> (which primarily affects interstitium). The
    fibrosis is <span style='font-weight:bold'>airway-centered</span>, not
    diffuse pulmonary parenchymal fibrosis.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.7597in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“Chronic
    rejection in lung transplantation is characterized by <span
    style='font-weight:bold'>bronchiolitis obliterans</span>, a fibrotic
    process affecting small airways.”Robbins and Cotran Path…</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Correct Answer: D. Chronic lung rejection leads to
  irreversible decreases in lung function from pulmonary fibrosis</span></p>
  <p style='margin:0in;margin-left:.375in;font-size:11.0pt'><span
  style='font-family:"Segoe UI Emoji"'>&#128270; </span><span style='font-weight:
  bold;font-family:Calibri'>Key Distinction</span><span style='font-family:
  Calibri'>: Chronic lung rejection ≠ interstitial fibrosis → it causes </span><span
  style='font-weight:bold;font-family:Calibri'>airway fibrosis (bronchiolitis
  obliterans)</span><span style='font-family:Calibri'>.</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Let me know if
  you'd like a table summarizing <span style='font-weight:bold'>acute vs
  chronic rejection</span> in different organ transplants!</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>26</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7562in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>Regarding
  pneumonia, which of these is true?</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>A.
  Gram positive diplococci in sputum supports a diagnosis of klebsiella</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>B. If
  a bacteria is <span style='background:yellow;mso-highlight:yellow'>found in
  an infective exacerbation of COPD, it is usually haemophilus influe</span>nza</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>C.
  Staphylococcus aureus pneumonia is not classically associated with lung
  abscesses</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>D.
  Legionella pneumonia is almost exclusively seen in men</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8048in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here is the <span
  style='font-weight:bold'>Robbins-based evaluation</span> of the question on <span
  style='font-weight:bold'>pneumonia</span>:</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
  style='font-weight:bold'>Question: </span><span style='font-style:italic'>Regarding
  pneumonia, which of these is </span><span style='font-weight:bold;font-style:
  italic'>true</span><span style='font-style:italic'>?</span></p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.1111in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Option</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7506in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Evaluation</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.6972in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation from Robbins</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.1111in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>A. Gram positive diplococci in sputum supports a
    diagnosis of Klebsiella</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7701in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-style:italic;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.7256in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: <span
    style='font-weight:bold'>Gram-positive diplococci</span> are characteristic
    of <span style='font-weight:bold'>Streptococcus pneumoniae</span>, not
    Klebsiella. <span style='font-weight:bold'>Klebsiella</span> is a <span
    style='font-weight:bold'>gram-negative bacillus</span>, often seen in
    alcoholics and debilitated patientsRobbins and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.1111in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>B. If a bacteria is found in an infective
    exacerbation of COPD, it is usually Haemophilus influenzae</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7506in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>Correct</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.7541in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: “In
    patients with <span style='font-weight:bold'>COPD</span>, <span
    style='font-weight:bold'>Haemophilus influenzae</span> is the <span
    style='font-weight:bold'>most common bacterial cause</span> of acute
    exacerbations.” This is a well-established associationRobbins and Cotran
    Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.1111in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>C. Staphylococcus aureus pneumonia is not
    classically associated with lung abscesses</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7701in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-style:italic;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.7729in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: <span
    style='font-weight:bold'>S. aureus pneumonia is classically associated with
    abscess formation</span>, especially post-viral or in IV drug users. So
    this statement is falseRobbins and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.1111in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>D. Legionella pneumonia is almost exclusively seen
    in men</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7701in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-style:italic;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.7256in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>While <span
    style='font-weight:bold'>Legionella</span> is more common in <span
    style='font-weight:bold'>older men</span>, it is <span style='font-weight:
    bold'>not exclusive</span> to them. It can affect both sexes, especially
    the immunocompromisedRobbins and Cotran Path….</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Correct Answer: B. If a bacteria is found in an
  infective exacerbation of COPD, it is usually Haemophilus influenzae</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>This is a
  Robbins-confirmed fact — <span style='font-weight:bold'>H. influenzae</span>
  is the <span style='font-weight:bold'>most common bacterial cause</span> of
  exacerbations in <span style='font-weight:bold'>COPD patients</span>Robbins
  and Cotran Path….</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>27</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7562in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>Which
  of the below best fits with sarcoidosis?</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>A. It
  is associated with caseated granulomas similar to those seen with
  mycobacterial infections</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>B. Is
  a frequent cause of a painful facial rash that causes nodules to form around
  the eyes</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>C. Its
  aetiology is unknown</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>D.
  Hilar lymph nodes are <span style='background:yellow;mso-highlight:yellow'>always</span>
  involved</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8048in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here's the
  evaluation of the statements regarding <span style='font-weight:bold'>sarcoidosis</span>,
  with direct quotations from <span style='font-style:italic'>Robbins and
  Cotran Pathologic Basis of Disease, 9th Edition</span>:</p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.8875in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Option</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7375in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Answer</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.934in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.8875in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>A. <span
    style='font-weight:bold'>It is associated with caseated granulomas similar
    to those seen with mycobacterial infections</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7465in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-weight:bold;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.0659in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Sarcoidosis is
    defined by <span style='font-weight:bold'>noncaseating granulomas</span>.
    Robbins: <span style='font-style:italic'>“The diagnostic histopathologic
    feature is the presence of </span><span style='font-weight:bold;font-style:
    italic'>noncaseating granulomas</span><span style='font-style:italic'> in
    various tissues”</span>Robbins and Cotran Path…. Caseating granulomas are
    typical of <span style='font-weight:bold'>tuberculosis</span> and <span
    style='font-weight:bold'>fungal infections</span>.</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.8875in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>B. <span
    style='font-weight:bold'>Is a frequent cause of a painful facial rash that
    causes nodules to form around the eyes</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7465in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-weight:bold;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.0486in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>While <span
    style='font-weight:bold'>skin and eye involvement</span> occur, Robbins
    notes skin lesions are <span style='font-weight:bold'>painless</span> and
    typically present as <span style='font-weight:bold'>subcutaneous nodules or
    plaques</span>, not a painful rash around the eyesRobbins and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.9069in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>C. <span
    style='font-weight:bold'>Its aetiology is unknown</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7375in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>Correct</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.9625in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins states: <span
    style='font-style:italic'>“Sarcoidosis is a systemic granulomatous disease
    of </span><span style='font-weight:bold;font-style:italic'>unknown cause</span><span
    style='font-style:italic'>…”</span>Robbins and Cotran Path…. Although
    immunologic and genetic factors are suspected, no single cause has been
    proven.</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.8875in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>D. <span
    style='font-weight:bold'>Hilar lymph nodes are always involved</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7465in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-weight:bold;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.0659in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins says
    hilar nodes are involved in <span style='font-weight:bold'>most</span>
    cases: <span style='font-style:italic'>“Lymph nodes are involved in </span><span
    style='font-weight:bold;font-style:italic'>almost all</span><span
    style='font-style:italic'> cases, particularly the hilar and mediastinal
    nodes...”</span>—so <span style='font-weight:bold'>not always</span>Robbins
    and Cotran Path….</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Correct Answer: C. Its aetiology is unknown</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Let me know if
  you'd like a table comparing sarcoidosis with other granulomatous diseases.</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>28</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7562in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>Regarding
  bronchiectasis, which of these is not true</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>A. It
  usually worse in more distal bronchi</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>B. Can
  arise from a single episode of necrotising pneumonia</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>C. Up
  to half of cases can be idiopathic</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>D. The
  infections that cause it aren't usually the result of defective airway
  clearance</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8881in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here is the
  detailed analysis of the MCQ on <span style='font-weight:bold'>bronchiectasis</span>,
  based on <span style='font-style:italic'>Robbins and Cotran Pathologic Basis
  of Disease, 9th Edition</span>:</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.3173in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Option</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.8506in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Answer</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.5527in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.8381in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Robbins Reference</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.3173in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>A. It usually worse in more distal bronchi</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.8506in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-weight:bold;font-family:Calibri'>False </span><span
    style='font-family:"Segoe UI Emoji"'>✅ </span><span style='font-weight:
    bold;font-family:Calibri'>Correct Answer</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.5527in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Bronchiectasis primarily affects the larger, more
    proximal bronchi</span>, not the most distal airways. It involves <span
    style='font-weight:bold'>permanent dilation</span> of bronchi and
    bronchioles due to <span style='font-weight:bold'>chronic infection and
    obstruction</span>, but <span style='font-weight:bold'>small airways are
    less affected</span>.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.0541in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“Bronchiectasis
    is a disorder characterized by <span style='font-weight:bold'>permanent
    dilation of bronchi and bronchioles</span>, caused by destruction of the
    muscle and supporting tissue.”Robbins and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.3173in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>B. Can arise from a single episode of necrotising
    pneumonia</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.8506in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>True</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.5527in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>A <span
    style='font-weight:bold'>severe necrotizing or suppurative pneumonia</span>
    (e.g. caused by <span style='font-style:italic'>Klebsiella</span> or <span
    style='font-style:italic'>Staph aureus</span>) can damage the bronchial
    wall and result in bronchiectasis.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.95in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“Bronchiectasis
    can develop after severe necrotizing pneumonia.”Robbins and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.3173in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>C. Up to half of cases can be idiopathic</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.8506in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>True</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.5527in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Up to 50% of cases</span> have no identifiable
    underlying cause and are classified as <span style='font-weight:bold'>idiopathic</span>.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.9555in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“In many cases,
    no cause is found (idiopathic bronchiectasis).”Robbins and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.3347in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>D. The infections that cause it aren't usually the
    result of defective airway clearance</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.8506in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>True</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.5652in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>In fact, many of
    the infections <span style='font-weight:bold'>are</span> the result of <span
    style='font-weight:bold'>defective mucociliary clearance</span> (e.g., in
    cystic fibrosis or primary ciliary dyskinesia), making this <span
    style='font-weight:bold'>statement false</span> in its claim.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.0416in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“A common
    underlying mechanism is <span style='font-weight:bold'>defective
    mucociliary clearance</span>, leading to persistent infections.”Robbins and
    Cotran Path…</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Correct Answer: A. It usually worse in more distal
  bronchi</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Let me know if
  you'd like a comparison of <span style='font-weight:bold'>bronchiectasis vs
  chronic bronchitis</span> or a table of causes!</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>29</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7562in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>Asthma.
  Over time repeated bouts of immune reactions, asthmatic airways remodel.
  Which of these is not a feature of this remodelling?</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>A.
  hypertrophy and hyperplasia of bronchial smooth muscle</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>B.
  subepithelial fibrosis</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>C.
  decreased airway vascularity</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>D.
  mucous<span style='background:yellow;mso-highlight:yellow'> gland enlargem</span>ent</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8048in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here is the <span
  style='font-weight:bold'>Robbins-based evaluation</span> of the question on <span
  style='font-weight:bold'>airway remodeling in asthma</span>:</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
  style='font-weight:bold'>Question: </span><span style='font-style:italic'>Which
  of these is </span><span style='font-weight:bold;font-style:italic'>not</span><span
  style='font-style:italic'> a feature of airway remodeling in asthma?</span></p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.593in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Option</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0694in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Evaluation</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.8965in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation from Robbins</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.593in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>A. Hypertrophy and hyperplasia of bronchial smooth
    muscle</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0694in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-style:italic;font-family:Calibri'>True</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.0284in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: Chronic
    asthma leads to &quot;<span style='font-weight:bold'>hypertrophy and
    hyperplasia of bronchial smooth muscle</span>,&quot; contributing to airway
    narrowing and hyperresponsivenessRobbins and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.593in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>B. Subepithelial fibrosis</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0694in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-style:italic;font-family:Calibri'>True</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.9243in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: “<span
    style='font-weight:bold'>Sub-basement membrane fibrosis</span> due to
    collagen deposition” is a hallmark of chronic asthma airway
    remodelingRobbins and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.593in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>C. Decreased airway vascularity</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0694in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-weight:bold;font-family:Calibri'>False </span><span
    style='font-family:"Segoe UI Emoji"'>✅ </span><span style='font-weight:
    bold;font-family:Calibri'>(Correct Answer)</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.9875in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: Airway
    remodeling includes <span style='font-weight:bold'>increased vascularity</span>,
    not decreased. Robbins: “There is <span style='font-weight:bold'>increased
    vascularity</span> in the submucosa as part of the chronic inflammatory
    response.”Robbins and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.593in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>D. Mucous gland enlargement</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0694in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-style:italic;font-family:Calibri'>True</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.9243in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: “<span
    style='font-weight:bold'>Mucous gland hypertrophy and goblet cell
    hyperplasia</span>” are characteristic of chronic asthma, leading to mucus
    overproductionRobbins and Cotran Path….</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Correct Answer (i.e., the false feature): C. Decreased
  airway vascularity</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>This is <span
  style='font-weight:bold'>not</span> a feature of asthma. In fact, <span
  style='font-weight:bold'>vascularity is increased</span> due to chronic
  inflammation and remodelingRobbins and Cotran Path….</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>30</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7756in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>(Yes,
  I know this is hard, that's why we have haematologists, but imagine picking
  this up in ED!!!!!)</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>Haemolytic
  uraemic syndrome Fanconi's anaemia Cold agglutinin type haemolysis Idiopathic
  thrombocytopaenic purpura Thrombotic thrombocytopaenic purpura Disseminated
  intravascular coagulation</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>a.
  Negative Coombs test; major haemolysis, low platelets and a raised INR</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>b.
  Normal INR; negative Coombs Test, major haemolysis, typically occurs in
  adults</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>c.
  Positive Coombs test, usually causes extravascular haemolysis</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>d.
  Negative Coombs Test, normal INR, major haemolysis, usually seen in children</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>e.
  Negative Coombs test; major haemolysis, low platelets and a raised INR</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>f.
  Normal INR; negative Coombs Test, major haemolysis, typically occurs in
  adults</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>g.
  Positive Coombs test, usually causes extravascular haemolysis</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>h.
  Negative Coombs Test, normal INR, major haemolysis, usually seen in children</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8881in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>To decode this
  complex question, let's analyze the <span style='font-weight:bold'>matching
  of hematological syndromes with their clinical and lab features</span>, using
  <span style='font-style:italic'>Robbins and Cotran Pathologic Basis of
  Disease, 9th Edition</span> to support explanations:</p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:.6673in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Label</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.4534in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Condition(s)</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.8312in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Features</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.6062in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation (Robbins-based)</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:.6673in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>A</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.4534in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>HUS, Fanconi
    anemia, Cold agglutinin hemolysis, ITP, TTP, DIC</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.8312in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>N/A (List)</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.8215in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>These are
    hematologic syndromes with <span style='font-weight:bold'>distinct
    mechanisms</span>: HUS and TTP → microangiopathic hemolytic anemia; ITP →
    isolated thrombocytopenia; Cold agglutinins → autoimmune hemolysis; DIC →
    consumptive coagulopathy .</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:.6673in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>B / F</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.4534in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Likely <span
    style='font-weight:bold'>DIC</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.8312in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-weight:bold;font-family:Calibri'>False grouping</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.7902in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>DIC shows <span
    style='font-weight:bold'>low platelets</span>, <span style='font-weight:
    bold'>prolonged INR</span>, <span style='font-weight:bold'>schistocytes</span>
    (MAHA), but <span style='font-weight:bold'>Coombs test is negative</span>
    because hemolysis is mechanical, not immune .</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:.6673in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>C / G</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.4534in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Likely <span
    style='font-weight:bold'>TTP</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.8312in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>True for TTP</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.8215in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>TTP: <span
    style='font-weight:bold'>Normal INR</span>, <span style='font-weight:bold'>negative
    Coombs</span>, <span style='font-weight:bold'>severe hemolysis</span>, <span
    style='font-weight:bold'>neurologic symptoms</span>, occurs in adults.
    Robbins: <span style='font-style:italic'>“TTP is characterized by
    thrombocytopenia, MAHA, and absence of coagulation activation (i.e., normal
    PT/INR).”</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:.6673in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>D / H</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.4534in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Autoimmune Hemolytic Anemia (AIHA)</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.8312in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>True</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.7347in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Positive Coombs test</span> confirms autoimmune
    hemolysis, typically <span style='font-weight:bold'>extravascular</span>
    (e.g., splenic macrophages remove IgG-coated RBCs) .</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:.6673in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>E / I</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.4534in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>HUS</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.8312in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>True</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.7173in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Children</span>, <span style='font-weight:bold'>Coombs-negative</span>,
    <span style='font-weight:bold'>normal INR</span>, <span style='font-weight:
    bold'>MAHA</span>, <span style='font-weight:bold'>often after E. coli
    O157:H7</span>. Robbins: <span style='font-style:italic'>“HUS is most
    common in children… hemolysis is Coombs-negative.”</span></p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:16.0pt'><span
  style='font-weight:bold'>Summary Table (Most Likely Matches):</span></p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:.8402in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Condition</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0347in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Coombs Test</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.6673in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>INR</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.3368in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Notes</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:.8215in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>DIC</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0152in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Negative</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.6673in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>↑ INR</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.5909in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Thrombocytopenia,
    schistocytes, coagulation activation</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:.8215in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>TTP</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0152in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Negative</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.6868in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Normal</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.4868in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>MAHA,
    thrombocytopenia, neuro symptoms, adults</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:.8215in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>AIHA</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0152in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Positive</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.6868in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Normal</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.3562in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Extravascular
    hemolysis, IgG/IgM-mediated</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:.8215in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>HUS</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0152in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Negative</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.6868in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Normal</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.3562in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>MAHA, children,
    EHEC infection link</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Let me know if
  you'd like a color-coded matching chart of microangiopathic hemolytic
  disorders!</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>31</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7562in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>Anaemia.
  Which of these results does not fit with a diagnosis of iron deficiency?</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>A. Low
  serum ferritin</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>B.
  Raised transferrin levels but transferrin saturation below 15%</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>C.
  Raised haematocrit</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>D.
  Modest poikilocytosis</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8048in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here is the <span
  style='font-weight:bold'>Robbins-based evaluation</span> of the question on <span
  style='font-weight:bold'>iron deficiency anemia</span>:</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
  style='font-weight:bold'>Question: </span><span style='font-style:italic'>Which
  of these results does </span><span style='font-weight:bold;font-style:italic'>not</span><span
  style='font-style:italic'> fit with a diagnosis of iron deficiency?</span></p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.7604in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Option</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.2305in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Evaluation</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.5687in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation from Robbins</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.7604in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>A. Low serum ferritin</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.2305in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-style:italic;font-family:Calibri'>Fits</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.5965in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: “<span
    style='font-weight:bold'>Serum ferritin</span> is <span style='font-weight:
    bold'>reduced</span> in iron deficiency anemia.” It’s one of the <span
    style='font-weight:bold'>earliest and most sensitive indicators</span> of
    depleted iron storesRobbins and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.7604in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>B. Raised transferrin levels but transferrin
    saturation below 15%</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.2305in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-style:italic;font-family:Calibri'>Fits</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.5965in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: “In
    iron deficiency, the liver <span style='font-weight:bold'>increases
    transferrin synthesis</span> (raising TIBC), but the <span
    style='font-weight:bold'>transferrin saturation falls below 15%</span>.”
    This is typicalRobbins and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.7604in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>C. Raised haematocrit</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.2305in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-weight:bold;font-family:Calibri'>Does not fit </span><span
    style='font-family:"Segoe UI Emoji"'>✅ </span><span style='font-weight:
    bold;font-family:Calibri'>(Correct answer)</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.6548in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: Iron
    deficiency anemia leads to <span style='font-weight:bold'>reduced
    hemoglobin and hematocrit</span>. A <span style='font-weight:bold'>raised
    hematocrit</span> would <span style='font-weight:bold'>not</span> be
    consistent with this diagnosisRobbins and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.7798in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>D. Modest poikilocytosis</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.2305in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-style:italic;font-family:Calibri'>Fits</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.5965in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: <span
    style='font-weight:bold'>Poikilocytosis</span> (variation in RBC shape) is
    common in iron deficiency, especially with more advanced diseaseRobbins and
    Cotran Path….</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Correct Answer: C. Raised haematocrit</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
  style='font-weight:bold'>Iron deficiency anemia</span> causes <span
  style='font-weight:bold'>low hematocrit</span>, not a raised one — making <span
  style='font-weight:bold'>C</span> the result that <span style='font-weight:
  bold'>does not fit</span> with the diagnosisRobbins and Cotran Path….</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>32</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7562in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>Blood
  vessels. Which of these best describes Giant Cell arteritis (aka temporal
  arteritis)</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>A.
  Usually affects young male smokers, causes profuse thrombosis often requiring
  digital amputations</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>B.
  Mostly seen in young children, can lead to later development of coronary
  artery aneurysms</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>C.
  Usually associated with asthma, vessels show intense eosinophilic
  infiltration and granulomas</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>D.
  Affects<span style='background:yellow;mso-highlight:yellow'> vessels from the
  aorta to small arteries; does not require giant cells on histology, usually
  in women over 40.</span></p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8048in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here is the <span
  style='font-weight:bold'>Robbins-based evaluation</span> of the question on <span
  style='font-weight:bold'>Giant Cell Arteritis (Temporal Arteritis)</span>:</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
  style='font-weight:bold'>Question: </span><span style='font-style:italic'>Which
  of these best describes Giant Cell Arteritis (Temporal Arteritis)?</span></p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.1618in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Option</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7361in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Evaluation</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.6611in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation from Robbins</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.1618in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>A. Usually affects young male smokers, causes
    profuse thrombosis often requiring digital amputations</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7541in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-style:italic;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.7756in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>This describes <span
    style='font-weight:bold'>Thromboangiitis obliterans (Buerger disease)</span>,
    which affects <span style='font-weight:bold'>young male smokers</span>, not
    giant cell arteritisRobbins and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.1618in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>B. Mostly seen in young children, can lead to
    later development of coronary artery aneurysms</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7541in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-style:italic;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.6909in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>This is a
    description of <span style='font-weight:bold'>Kawasaki disease</span>, a
    vasculitis in <span style='font-weight:bold'>children</span> associated
    with <span style='font-weight:bold'>coronary artery aneurysms</span>, not
    GCARobbins and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.1618in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>C. Usually associated with asthma, vessels show
    intense eosinophilic infiltration and granulomas</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7541in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-style:italic;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.6909in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>This refers to <span
    style='font-weight:bold'>Churg-Strauss syndrome</span> (now called
    eosinophilic granulomatosis with polyangiitis), not GCARobbins and Cotran
    Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.1618in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>D. Affects vessels from the aorta to small
    arteries; does not require giant cells on histology, usually in women over
    40.</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7347in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>Correct</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.7798in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: <span
    style='font-weight:bold'>Giant cell arteritis</span> is “a chronic
    granulomatous inflammation of <span style='font-weight:bold'>large to
    small-sized arteries</span> (especially branches of the carotid), usually
    in <span style='font-weight:bold'>women &gt;50 years</span>, and <span
    style='font-weight:bold'>giant cells may or may not be seen</span>
    histologically.”Robbins and Cotran Path…</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Correct Answer: D. Affects vessels from the aorta to
  small arteries; does not require giant cells on histology, usually in women
  over 40.</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>This is the best
  and Robbins-supported description of <span style='font-weight:bold'>Giant
  Cell Arteritis</span>, even though <span style='font-weight:bold'>giant cells</span>
  are classically associated, they are <span style='font-weight:bold'>not
  required for diagnosis</span>Robbins and Cotran Path….</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>33</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7562in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>Which
  one of these lumps/ bumps/ haem/lymphangiomas not only requires a treatment
  but one which could definitively be offered in the ED?</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>A.
  Pyogenic <span style='background:yellow;mso-highlight:yellow'>granuloma</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>B.
  Juvenile/ strawberry haemangioma</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>C.
  Capillary haemangiomas</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>D.
  Cavernous haemangiomas</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>E.
  Cavernous lymphangiomas</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8881in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here is the
  analysis of the MCQ on <span style='font-weight:bold'>vascular and lymphatic
  lesions</span>, specifically focusing on which one not only <span
  style='font-weight:bold'>requires treatment</span> but could also be <span
  style='font-weight:bold'>definitively treated in the Emergency Department
  (ED)</span> — based on <span style='font-style:italic'>Robbins and Cotran
  Pathologic Basis of Disease, 9th Edition</span> and standard clinical
  practice.</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:.9819in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Option</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7256in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Answer</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.9076in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.943in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Reference</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:.9819in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>A. Pyogenic granuloma</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7256in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>Correct</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.9076in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>A <span
    style='font-weight:bold'>pyogenic granuloma</span> (lobular capillary
    hemangioma) is a <span style='font-weight:bold'>rapidly growing, friable
    vascular lesion</span> that can <span style='font-weight:bold'>bleed easily</span>
    and often arises after trauma. It can be <span style='font-weight:bold'>definitively
    treated in the ED</span> via <span style='font-weight:bold'>cauterization
    or excision</span>.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.1527in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“Pyogenic
    granulomas are rapidly growing capillary hemangiomas that may ulcerate and
    bleed; <span style='font-weight:bold'>local excision is curative</span>.”Robbins
    and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:.9854in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>B. Juvenile/strawberry hemangioma</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7395in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌</span><span
    style='font-family:Calibri'> Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.9076in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>These are <span
    style='font-weight:bold'>common benign hemangiomas in infants</span> that
    typically <span style='font-weight:bold'>regress spontaneously</span> over
    time. Treatment is <span style='font-weight:bold'>not urgent</span> and
    usually involves <span style='font-weight:bold'>watchful waiting</span> or <span
    style='font-weight:bold'>propranolol</span>, not ED intervention.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.1375in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“Most juvenile
    hemangiomas regress spontaneously.”Robbins and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:.9819in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>C. Capillary haemangiomas</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7395in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌</span><span
    style='font-family:Calibri'> Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.9076in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Similar to
    strawberry hemangiomas, these are generally <span style='font-weight:bold'>benign
    and self-limited</span>. They are <span style='font-weight:bold'>not
    emergencies</span> and don't typically require ED treatment.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.1326in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“Capillary
    hemangiomas are the most common; many undergo spontaneous
    regression.”Robbins and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:.9819in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>D. Cavernous haemangiomas</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7395in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌</span><span
    style='font-family:Calibri'> Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.9152in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>These are <span
    style='font-weight:bold'>deeper</span>, often larger lesions and may
    require <span style='font-weight:bold'>surgical or radiological
    intervention</span> — <span style='font-weight:bold'>not typically treated
    in the ED</span>.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.0548in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“Cavernous
    hemangiomas are less likely to regress and may require surgical
    removal.”Robbins and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:.9819in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>E. Cavernous lymphangiomas</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7395in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌</span><span
    style='font-family:Calibri'> Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.9076in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>These are <span
    style='font-weight:bold'>deep lymphatic malformations</span> often in the
    neck (e.g., cystic hygroma) and require <span style='font-weight:bold'>specialist
    surgical or medical management</span>, not suitable for ED treatment.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.1173in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“Cavernous
    lymphangiomas are poorly circumscribed and can cause cosmetic and
    functional issues, requiring surgical excision.”Robbins and Cotran Path…</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Correct Answer: A. Pyogenic granuloma</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Let me know if
  you’d like a summary table of common vascular lesions by age, clinical
  behavior, and treatment!</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>34</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7756in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>Regarding
  ventricular septal defects, which of these is true</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>A.
  they are the second most common congenital heart defect after ASDs</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>B. it
  is a c<span style='background:yellow;mso-highlight:yellow'>omponent of Tetra</span>logy
  of Fallot</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>C.
  70-80% of them occur without other congenital abnormalities</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>D.
  They should all be closed as early as possible in a childs life to prevent
  cardiac failure</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8048in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here is the <span
  style='font-weight:bold'>Robbins-based evaluation</span> of the question on <span
  style='font-weight:bold'>ventricular septal defects (VSDs):</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
  style='font-weight:bold'>Question: </span><span style='font-style:italic'>Regarding
  ventricular septal defects (VSDs), which of these is </span><span
  style='font-weight:bold;font-style:italic'>true</span><span style='font-style:
  italic'>?</span></p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.9083in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Option</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7465in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Evaluation</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.9048in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation from Robbins</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.9083in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>A. They are the second most common congenital
    heart defect after ASDs</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7659in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-style:italic;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.9326in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: “<span
    style='font-weight:bold'>VSDs are the most common congenital cardiac
    anomaly</span>,” accounting for <span style='font-weight:bold'>up to 42%</span>
    of cases. They are <span style='font-weight:bold'>more common than ASDs</span>Robbins
    and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.9083in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>B. It is a component of Tetralogy of Fallot</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7465in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>Correct</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.0368in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: “<span
    style='font-weight:bold'>Tetralogy of Fallot</span> includes four cardinal
    features: (1) VSD, (2) right ventricular outflow tract obstruction, (3)
    overriding aorta, and (4) right ventricular hypertrophy.” So yes, <span
    style='font-weight:bold'>VSD is a core component</span>Robbins and Cotran
    Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.9083in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>C. 70–80% of them occur without other congenital
    abnormalities</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7659in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-style:italic;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.9437in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: “Only
    about <span style='font-weight:bold'>30% of VSDs are isolated</span>; the
    rest are associated with other congenital anomalies such as Tetralogy of
    Fallot, coarctation, or transposition.” So <span style='font-weight:bold'>most
    are not isolated</span>Robbins and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.9083in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>D. They should all be closed as early as possible
    in a child’s life to prevent cardiac failure</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7659in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-style:italic;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.0368in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: <span
    style='font-weight:bold'>Small VSDs</span> may close <span
    style='font-weight:bold'>spontaneously</span> and often <span
    style='font-weight:bold'>do not require intervention</span>. Surgical
    closure is reserved for <span style='font-weight:bold'>large,
    hemodynamically significant defects</span> causing heart failureRobbins and
    Cotran Path….</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Correct Answer: B. It is a component of Tetralogy of
  Fallot</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>This is the <span
  style='font-weight:bold'>true and Robbins-supported statement</span> — <span
  style='font-weight:bold'>VSD is one of the four hallmark features</span> of
  Tetralogy of FallotRobbins and Cotran Path….</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>35</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7562in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>Factors
  that contribute to myocardial reperfusion injury include all bar one of the
  following, identify it.</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>A.
  mitochondrial dysfunction</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>B.
  myocyte <span style='background:yellow;mso-highlight:yellow'>hypocontracture</span>
  from increased levels of calcium from sarcolemmal damage</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>C.
  leukocyte aggregation</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>D.
  platelet activation</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8048in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here is the
  evaluation of the factors contributing to <span style='font-weight:bold'>myocardial
  reperfusion injury</span>, based on <span style='font-style:italic'>Robbins
  and Cotran Pathologic Basis of Disease, 9th Edition</span>:</p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.5875in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Option</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7048in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Answer</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.2666in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation with Robbins Reference</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.5875in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>A. <span
    style='font-weight:bold'>Mitochondrial dysfunction</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.6854in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>True</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.3833in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Reperfusion
    injury involves <span style='font-weight:bold'>mitochondrial dysfunction</span>:
    <span style='font-style:italic'>“Calcium overload favors opening of the
    mitochondrial permeability transition pore with resultant depletion of ATP.
    This in turn causes further cell injury.”</span>Robbins and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.6069in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>B. <span
    style='font-weight:bold'>Myocyte hypocontracture from increased levels of
    calcium from sarcolemmal damage</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.6854in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-weight:bold;font-family:Calibri'>False</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.418in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>This is the <span
    style='font-weight:bold'>false statement</span>. In fact, <span
    style='font-weight:bold'>reperfusion leads to hypercontracture</span>, not
    hypocontracture, due to <span style='font-weight:bold'>calcium overload</span>
    and sarcomere overactivation. Robbins: <span style='font-style:italic'>“Exaggerated
    contraction of sarcomeres when perfusion is reestablished… at which time
    the interior of cells… is exposed to a high concentration of calcium ions…”</span>Robbins
    and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.5875in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>C. <span
    style='font-weight:bold'>Leukocyte aggregation</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.6854in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>True</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.4138in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins
    confirms: <span style='font-style:italic'>“Inflammation causes additional
    tissue injury… recruitment of neutrophils to reperfused tissue…”</span>Robbins
    and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.5875in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>D. <span
    style='font-weight:bold'>Platelet activation</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.6854in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>True</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.3145in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Though not
    emphasized as a major cause of reperfusion injury in Robbins, <span
    style='font-weight:bold'>platelet activation is part of the broader
    prothrombotic and inflammatory response</span> in ischemia-reperfusion
    settings.</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>❌</span><span style='font-weight:bold;
  font-family:Calibri'> Correct Answer: B. Myocyte hypocontracture from
  increased levels of calcium from sarcolemmal damage</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>This is <span
  style='font-weight:bold'>false</span>, as <span style='font-weight:bold'>calcium
  overload leads to contraction band necrosis and hypercontracture</span>, not
  reduced contractility.</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Let me know if
  you'd like a visual of the mechanisms behind reperfusion injury.</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>36</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7756in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>Infective
  endocarditis, which of these is true?</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>A.
  Prosthetic valve endocarditis 1-2 months post surgery is usually from the
  HACEK group of commensal organisms</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>B.
  Infection with gram negative bacilli are easier to treat</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>C.
  Complications include glomerulonephritis from glomerular antigen-antibody
  deposition</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>D.
  Using the modified Duke criteria, 1 major and 2 minor clinical criteria are
  diagnostic</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8048in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here is the <span
  style='font-weight:bold'>Robbins-based evaluation</span> of the question on <span
  style='font-weight:bold'>infective endocarditis (IE):</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
  style='font-weight:bold'>Question: </span><span style='font-style:italic'>In
  infective endocarditis, which of these is </span><span style='font-weight:
  bold;font-style:italic'>true</span><span style='font-style:italic'>?</span></p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.0923in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Option</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7361in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Evaluation</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.7305in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation from Robbins</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.1118in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>A. Prosthetic valve endocarditis 1–2 months post
    surgery is usually from the HACEK group of commensal organisms</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.752in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-style:italic;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.8409in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: <span
    style='font-weight:bold'>Early prosthetic valve endocarditis (within 2
    months)</span> is usually caused by <span style='font-weight:bold'>Staphylococcus
    aureus</span>, <span style='font-weight:bold'>S. epidermidis</span>, or <span
    style='font-weight:bold'>gram-negative bacilli</span> — <span
    style='font-weight:bold'>not the HACEK group</span>, which is more common
    in <span style='font-weight:bold'>late-onset or native valve</span>
    casesRobbins and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.0923in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>B. Infection with gram negative bacilli are easier
    to treat</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.752in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-style:italic;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.859in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Gram-negative
    bacillary endocarditis (e.g., <span style='font-weight:bold'>Pseudomonas,
    Klebsiella</span>) is <span style='font-weight:bold'>more difficult to
    treat</span> and often <span style='font-weight:bold'>requires prolonged
    antibiotics or surgery</span>Robbins and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.0923in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>C. Complications include glomerulonephritis from
    glomerular antigen–antibody deposition</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7333in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>Correct</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.7618in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: “<span
    style='font-weight:bold'>Glomerulonephritis</span> is a common complication
    due to <span style='font-weight:bold'>immune complex deposition</span> in
    glomeruli.” It may lead to <span style='font-weight:bold'>hematuria and
    renal dysfunction</span>Robbins and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.0923in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>D. Using the modified Duke criteria, 1 major and 2
    minor clinical criteria are diagnostic</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.752in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-style:italic;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.8583in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins (via
    clinical guidelines): The <span style='font-weight:bold'>Modified Duke
    Criteria</span> require either:</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle'><span
       style='font-weight:bold;font-family:Calibri;font-size:11.0pt'>2 major</span><span
       style='font-family:Calibri;font-size:11.0pt'>, or</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle'><span
       style='font-weight:bold;font-family:Calibri;font-size:11.0pt'>1 major +
       3 minor</span><span style='font-family:Calibri;font-size:11.0pt'>, or</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle'><span
       style='font-weight:bold;font-family:Calibri;font-size:11.0pt'>5 minor</span><span
       style='font-family:Calibri;font-size:11.0pt'> criteria for a </span><span
       style='font-weight:bold;font-family:Calibri;font-size:11.0pt'>definitive
       diagnosis</span><span style='font-family:Calibri;font-size:11.0pt'> of
       IE.<br>
              So </span><span style='font-weight:bold;font-family:Calibri;
       font-size:11.0pt'>1 major + 2 minor is not sufficient</span><span
       style='font-family:Calibri;font-size:11.0pt'>Robbins and Cotran Path….</span></li>
  </ul>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Correct Answer: C. Complications include
  glomerulonephritis from glomerular antigen–antibody deposition</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>This is <span
  style='font-weight:bold'>accurate</span> and well-supported by Robbins. <span
  style='font-weight:bold'>Immune complex–mediated glomerulonephritis</span> is
  a recognized renal complication of infective endocarditisRobbins and Cotran
  Path….</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>37</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7562in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>Which
  of these cardiomyopathies is the most common and can be seen in the
  peripartum period</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>A.
  Takotsubo cardiomyopathy</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>B.
  Dilated <span style='background:yellow;mso-highlight:yellow'>cardiomyopathy</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>C.
  Hypertrophic cardiomyopathy</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>D.
  Restrictive cardiomyopathy</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8048in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here is the
  evaluation of the options regarding <span style='font-weight:bold'>cardiomyopathies</span>,
  specifically focusing on the <span style='font-weight:bold'>most common form</span>
  and <span style='font-weight:bold'>peripartum association</span>, based on <span
  style='font-style:italic'>Robbins and Cotran Pathologic Basis of Disease, 9th
  Edition</span>:</p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.0604in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Option</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7486in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Answer</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.75in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation with Robbins Quote</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.0798in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>A. <span
    style='font-weight:bold'>Takotsubo cardiomyopathy</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.768in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-weight:bold;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.8409in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Takotsubo is a <span
    style='font-weight:bold'>transient, stress-induced cardiomyopathy</span>,
    not the most common form, and <span style='font-weight:bold'>not associated
    with pregnancy</span>. Robbins: <span style='font-style:italic'>“Takotsubo
    cardiomyopathy is... characterized by left ventricular contractile
    dysfunction following extreme psychological stress.”</span>Robbins and
    Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.0798in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>B. <span
    style='font-weight:bold'>Dilated cardiomyopathy</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7486in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>Correct</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.8604in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: <span
    style='font-style:italic'>“Among the three major patterns, </span><span
    style='font-weight:bold;font-style:italic'>dilated cardiomyopathy is most
    common (90% of cases)...</span><span style='font-style:italic'>”</span> and
    <span style='font-style:italic'>“A special form of DCM, termed </span><span
    style='font-weight:bold;font-style:italic'>peripartum cardiomyopathy</span><span
    style='font-style:italic'>, can occur late in pregnancy or up to months
    postpartum.”</span>Robbins and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.0798in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>C. <span
    style='font-weight:bold'>Hypertrophic cardiomyopathy</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.768in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-weight:bold;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.7784in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Hypertrophic
    cardiomyopathy is common but <span style='font-weight:bold'>not the most
    common</span>, and <span style='font-weight:bold'>not associated with the
    peripartum period</span>. Robbins confirms: <span style='font-style:italic'>“Hypertrophic
    cardiomyopathy... results in diastolic dysfunction...”</span>Robbins and
    Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.0798in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>D. <span
    style='font-weight:bold'>Restrictive cardiomyopathy</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.768in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-weight:bold;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.7784in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Restrictive is
    the <span style='font-weight:bold'>least common</span> cardiomyopathy and
    not linked to the peripartum period. Robbins: <span style='font-style:italic'>“Restrictive
    cardiomyopathy is the least frequent of the three.”</span>Robbins and
    Cotran Path…</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Correct Answer: B. Dilated cardiomyopathy</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Let me know if
  you'd like a comparative table summarizing all three major cardiomyopathy
  types (DCM, HCM, RCM).</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>38</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7562in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>A 5
  year old boy has the highest chance of being diagnosed with which of these
  cancers ?</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>A.
  Acute <span style='background:yellow;mso-highlight:yellow'>lymphoblastic</span>
  leukaemia</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>B.
  Chronic lymphocytic leukaemia</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>C. Non
  hodgkin lymphoma</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>D.
  Hodgkin lymphoma</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8881in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here is the
  detailed analysis of the MCQ on <span style='font-weight:bold'>paediatric
  cancers</span>, particularly in a <span style='font-weight:bold'>5-year-old
  boy</span>, based on <span style='font-style:italic'>Robbins and Cotran
  Pathologic Basis of Disease, 9th Edition</span>:</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.0847in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Option</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7319in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Answer</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.7166in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.0256in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Robbins Reference</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.1041in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>A. Acute lymphoblastic leukaemia (ALL)</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7319in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>Correct</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.7361in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>ALL is the most common malignancy in children</span>,
    particularly between <span style='font-weight:bold'>ages 2–5</span>. It
    arises from <span style='font-weight:bold'>B-cell precursors</span> and
    often presents with bone marrow failure symptoms.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.2409in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“<span
    style='font-weight:bold'>Acute lymphoblastic leukemia (ALL)</span> is the
    most common cancer in children, peaking between ages 2 and 5.”Robbins and
    Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.0847in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>B. Chronic lymphocytic leukaemia (CLL)</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7513in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌</span><span
    style='font-family:Calibri'> Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.7166in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>CLL is extremely rare in children</span> and
    typically occurs in <span style='font-weight:bold'>older adults</span>. It
    is almost <span style='font-weight:bold'>never</span> diagnosed in a
    5-year-old.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.2409in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“CLL is a
    disease of older adults; it is rare in children.”Robbins and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.0847in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>C. Non-Hodgkin lymphoma (NHL)</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7513in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌</span><span
    style='font-family:Calibri'> Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.7361in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>While <span
    style='font-weight:bold'>NHL can occur in children</span>, it is <span
    style='font-weight:bold'>less common than ALL</span> in this age group.
    Pediatric NHL is more frequent in older children or adolescents.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.2409in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“NHL is less
    common than ALL in children; occurs more in older age groups.”Robbins and
    Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.0847in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>D. Hodgkin lymphoma</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7513in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌</span><span
    style='font-family:Calibri'> Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.7361in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Hodgkin lymphoma</span> is rare under age 10 and
    tends to peak in <span style='font-weight:bold'>adolescents and young
    adults</span>, not 5-year-olds.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.1375in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“Hodgkin
    lymphoma has a bimodal age distribution, with a peak in young
    adulthood.”Robbins and Cotran Path…</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Correct Answer: A. Acute lymphoblastic leukaemia</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Let me know if
  you'd like a chart of <span style='font-weight:bold'>common childhood cancers
  by age group and features</span>!</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>39</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7756in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>Anorexia
  nervosa, which of these is correct</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>A. Is
  responsible for the most deaths out of all psychiatric conditions</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>B.
  Death is often from hypokalaemia</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>C. It
  is m<span style='background:yellow;mso-highlight:yellow'>ore common than b</span>ulimia</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>D.
  Amenorrhoea occurs in less than 50% of cases</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8048in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here is the
  evaluation of the statements regarding <span style='font-weight:bold'>anorexia
  nervosa</span>, based on <span style='font-style:italic'>Robbins and Cotran
  Pathologic Basis of Disease, 9th Edition</span>:</p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.8152in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Option</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7708in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Answer</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.9729in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation with Robbins Quote</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.8152in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>A. <span
    style='font-weight:bold'>Is responsible for the most deaths out of all
    psychiatric conditions</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7708in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>Correct</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.0986in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins states
    clearly: <span style='font-style:italic'>“Anorexia nervosa has the </span><span
    style='font-weight:bold;font-style:italic'>highest death rate of any
    psychiatric disorder</span><span style='font-style:italic'>.”</span>Robbins
    and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.8152in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>B. <span
    style='font-weight:bold'>Death is often from hypokalaemia</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7708in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>Correct</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.1048in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: <span
    style='font-style:italic'>“A major complication of anorexia nervosa (and
    also bulimia) is an increased susceptibility to </span><span
    style='font-weight:bold;font-style:italic'>cardiac arrhythmia and sudden
    death</span><span style='font-style:italic'>, resulting from </span><span
    style='font-weight:bold;font-style:italic'>hypokalemia</span><span
    style='font-style:italic'>.”</span>Robbins and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.8152in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>C. <span
    style='font-weight:bold'>It is more common than bulimia</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7902in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-weight:bold;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.0013in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins
    explicitly states: <span style='font-style:italic'>“</span><span
    style='font-weight:bold;font-style:italic'>Bulimia is more common than
    anorexia nervosa</span><span style='font-style:italic'>...”</span>Robbins
    and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.8347in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>D. <span
    style='font-weight:bold'>Amenorrhoea occurs in less than 50% of cases</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7902in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-weight:bold;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.0013in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: <span
    style='font-style:italic'>“Amenorrhea... is so common that its presence is
    considered a </span><span style='font-weight:bold;font-style:italic'>diagnostic
    feature</span><span style='font-style:italic'>.”</span> So it occurs in <span
    style='font-weight:bold'>more than 50%</span>, making this statement
    falseRobbins and Cotran Path…</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Correct Answer: A. Is responsible for the most deaths
  out of all psychiatric conditions</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Let me know if
  you'd like a comparison table of anorexia vs bulimia.</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>40</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7562in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>A 65
  year old confirmed chronic alcoholic presents with bleeding tendency,
  impaired wound healing and poor bone strength. He probably has a deficiency
  of :</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>A.
  Vitamin A</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>B.
  Vitamin B</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>C. <span
  style='background:yellow;mso-highlight:yellow'>Vitamin</span> C</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>D.
  Vitamin D</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8881in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here is the
  analysis of the MCQ on <span style='font-weight:bold'>vitamin deficiency in a
  chronic alcoholic with bleeding, poor wound healing, and bone fragility</span>,
  based on <span style='font-style:italic'>Robbins and Cotran Pathologic Basis
  of Disease, 9th Edition</span>:</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:.7263in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Option</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7284in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Answer</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.9263in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.1784in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Robbins Reference</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:.7284in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>A. Vitamin A</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7395in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌</span><span
    style='font-family:Calibri'> Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.9263in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Vitamin A deficiency</span> affects <span
    style='font-weight:bold'>vision, epithelial integrity, and immunity</span>,
    but it does <span style='font-weight:bold'>not cause bleeding or bone
    fragility</span>.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.2895in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“Vitamin A
    deficiency leads to xerophthalmia and epithelial metaplasia… not bleeding
    or bone weakness.”Robbins and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:.7284in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>B. Vitamin B</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7395in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌</span><span
    style='font-family:Calibri'> Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.9305in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Deficiencies in <span
    style='font-weight:bold'>B vitamins</span> (e.g., B1/thiamine) are common
    in alcoholics and cause <span style='font-weight:bold'>neurologic issues</span>
    (e.g., Wernicke-Korsakoff) but <span style='font-weight:bold'>not bleeding
    or impaired healing</span>.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.3479in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“Thiamine
    deficiency causes Wernicke encephalopathy, not bleeding or collagen-related
    defects.”Robbins and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:.7284in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>C. Vitamin C</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7284in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>Correct</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.9263in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Vitamin C deficiency (scurvy)</span> leads to <span
    style='font-weight:bold'>bleeding tendency</span>, <span style='font-weight:
    bold'>impaired collagen synthesis</span>, <span style='font-weight:bold'>poor
    wound healing</span>, and <span style='font-weight:bold'>weak bones</span>
    due to defective osteoid formation. Common in <span style='font-weight:
    bold'>alcoholics</span>, the elderly, and malnourished.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.3875in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“Vitamin C
    deficiency causes scurvy, characterized by <span style='font-weight:bold'>bleeding</span>,
    <span style='font-weight:bold'>poor wound healing</span>, and <span
    style='font-weight:bold'>bone abnormalities</span> due to defective
    collagen synthesis.”Robbins and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:.7284in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>D. Vitamin D</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7395in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌</span><span
    style='font-family:Calibri'> Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.9263in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Vitamin D deficiency</span> causes <span
    style='font-weight:bold'>bone weakness</span> (osteomalacia), but not <span
    style='font-weight:bold'>bleeding</span> or <span style='font-weight:bold'>poor
    wound healing</span>.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.3604in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“Vitamin D
    deficiency leads to bone softening… but does not impair coagulation or
    wound healing.”Robbins and Cotran Path…</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Correct Answer: C. Vitamin C</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Let me know if
  you'd like a summary chart of <span style='font-weight:bold'>vitamin
  deficiencies, symptoms, and high-risk groups</span>!</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>41</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7562in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>Hyperthermia.
  Which of these is the most sinister you would likely see if you were
  attending a 12km fun run in January (Southern Hemisphere!!!!!)</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>A.
  Heat cramp</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>B.
  Heat exhaustion</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>C.
  Heat stroke</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>D.
  Malignant hyperthermia</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8048in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here is the <span
  style='font-weight:bold'>Robbins-based evaluation</span> of the question on <span
  style='font-weight:bold'>hyperthermia types during exertion</span> (e.g., a
  summer fun run):</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
  style='font-weight:bold'>Question: </span><span style='font-style:italic'>Which
  of these is the </span><span style='font-weight:bold;font-style:italic'>most
  sinister</span><span style='font-style:italic'> you would likely see if
  attending a 12 km fun run in </span><span style='font-weight:bold;font-style:
  italic'>January</span><span style='font-style:italic'> (Southern Hemisphere =
  </span><span style='font-weight:bold;font-style:italic'>summer</span><span
  style='font-style:italic'>)?</span></p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:.9555in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Option</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.9263in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Evaluation</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.677in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation from Robbins</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:.9555in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>A. Heat cramp</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.9263in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-style:italic;font-family:Calibri'>Mild</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.7055in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: Heat
    cramps are <span style='font-weight:bold'>self-limited muscle spasms</span>
    due to <span style='font-weight:bold'>electrolyte loss</span>; not
    life-threatening. Typically affect <span style='font-weight:bold'>athletes
    or laborers</span> in hot conditionsRobbins and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:.9555in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>B. Heat exhaustion</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.9263in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-style:italic;font-family:Calibri'>Moderate</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.7923in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: Heat
    exhaustion results from <span style='font-weight:bold'>water depletion</span>,
    leading to <span style='font-weight:bold'>collapse</span>, but <span
    style='font-weight:bold'>core temperature stays below 40°C</span>, and it <span
    style='font-weight:bold'>resolves with rest and hydration</span>. Not the
    most severeRobbins and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:.9555in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>C. Heat stroke</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.9451in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>Correct</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.7055in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: Heat
    stroke is the <span style='font-weight:bold'>most dangerous</span> form of
    environmental hyperthermia. It involves <span style='font-weight:bold'>core
    temperatures &gt;40°C</span>, <span style='font-weight:bold'>multiorgan
    dysfunction</span>, <span style='font-weight:bold'>loss of thermoregulation</span>,
    and can be <span style='font-weight:bold'>fatal</span> if untreated. It is <span
    style='font-weight:bold'>most likely during exertion in extreme heat</span>,
    such as a <span style='font-weight:bold'>summer fun run</span>Robbins and
    Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:.975in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>D. Malignant hyperthermia</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.9451in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-style:italic;font-family:Calibri'>Unlikely in this
    setting</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.7055in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins:
    Malignant hyperthermia is a <span style='font-weight:bold'>genetic
    condition</span> triggered by <span style='font-weight:bold'>anesthetic
    agents</span>, not exercise. It's <span style='font-weight:bold'>not
    related to environmental exposure</span>Robbins and Cotran Path….</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Correct Answer: C. Heat stroke</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
  style='font-weight:bold'>Heat stroke</span> is the <span style='font-weight:
  bold'>most sinister and potentially fatal</span> condition you’re likely to
  encounter during a <span style='font-weight:bold'>12 km summer run</span>,
  especially in hot, humid conditionsRobbins and Cotran Path….</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>42</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7562in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>Obesity.
  Which of these substances feedback to the hypothalamus that you are 'energy
  sufficient'?</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>A. <span
  style='background:yellow;mso-highlight:yellow'>Leptin</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>B.
  Ghrelin</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>C.
  Insulin</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>D.
  Peptide YY</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>E.
  None of the above</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>F. All
  of the above</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8048in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here’s the
  evaluation of the substances that signal <span style='font-weight:bold'>energy
  sufficiency</span> to the hypothalamus, based on <span style='font-style:
  italic'>Robbins and Cotran Pathologic Basis of Disease, 9th Edition</span>:</p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:.8402in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Substance</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.1465in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Feedback Role in Energy Sufficiency</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.5729in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation from Robbins</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:.8208in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Leptin</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.1361in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>Yes</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.6305in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: <span
    style='font-style:italic'>“Leptin secretion is stimulated when fat stores
    are abundant... Leptin stimulates POMC/CART neurons (anorexigenic) and
    inhibits NPY/AgRP neurons (orexigenic)... its absence represents a lack of
    the signal for energy sufficiency.”</span>Robbins and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:.8208in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Insulin</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.1361in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>Yes</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.6305in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: <span
    style='font-style:italic'>“Insulin is part of the afferent system
    regulating energy balance... binds hypothalamic receptors and promotes
    anorexigenic signals.”</span>Robbins and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:.8208in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Peptide YY (PYY)</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.1361in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>Yes</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.6847in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: <span
    style='font-style:italic'>“PYY is secreted postprandially and reduces
    energy intake... acts on hypothalamus to decrease food intake.”</span>Robbins
    and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:.8208in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Ghrelin</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.1361in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-weight:bold;font-family:Calibri'>No</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.6305in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: <span
    style='font-style:italic'>“Ghrelin is the only known gut hormone that </span><span
    style='font-weight:bold;font-style:italic'>increases food intake</span><span
    style='font-style:italic'>... it stimulates NPY/AgRP neurons (orexigenic).”</span>
    It signals <span style='font-weight:bold'>hunger</span>, not energy
    sufficiencyRobbins and Cotran Path….</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Correct Answer: A. Leptin</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>But for
  completeness, <span style='font-weight:bold'>Insulin</span> and <span
  style='font-weight:bold'>Peptide YY</span> also signal energy sufficiency.</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>So, if &quot;All
  of the above&quot; (F) is meant to include ghrelin—it would be <span
  style='font-weight:bold'>incorrect</span>.</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Let me know if
  you'd like a summarized diagram of hypothalamic appetite regulation.</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>43</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7562in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>The
  following definition corresponds to which term below? &quot;The replacement
  of one type of cell with another usually in association with tissue damage,
  repair and regeneration&quot;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>A.
  Hamartoma</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>B.
  Choristoma</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>C.
  Dysplasia</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>D. <span
  style='background:yellow;mso-highlight:yellow'>Metaplasia</span></p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8881in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here is the
  analysis of the MCQ on <span style='font-weight:bold'>cellular adaptation
  terminology</span>, based on <span style='font-style:italic'>Robbins and
  Cotran Pathologic Basis of Disease, 9th Edition</span>:</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:.7506in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Option</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7284in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Answer</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.4576in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.6222in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Robbins Reference</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:.7694in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>A. Hamartoma</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7395in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌</span><span
    style='font-family:Calibri'> Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.4576in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>A <span
    style='font-weight:bold'>hamartoma</span> is a <span style='font-weight:
    bold'>benign mass</span> composed of <span style='font-weight:bold'>disorganized
    but mature cells</span> native to the organ. It is a developmental anomaly,
    <span style='font-weight:bold'>not a replacement process</span>.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.8375in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“Hamartomas are
    benign, disorganized overgrowths of tissues native to the organ.”Robbins
    and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:.7611in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>B. Choristoma</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7395in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌</span><span
    style='font-family:Calibri'> Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.4576in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>A <span
    style='font-weight:bold'>choristoma</span> is a <span style='font-weight:
    bold'>heterotopic rest of normal tissue</span> (e.g., pancreatic tissue in
    stomach), not a reactive or replacement process.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.8375in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“A choristoma is
    normal tissue located in an abnormal location.”Robbins and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:.7513in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>C. Dysplasia</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7395in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌</span><span
    style='font-family:Calibri'> Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.4576in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Dysplasia</span> is a <span style='font-weight:
    bold'>disordered cellular growth</span>, often <span style='font-weight:
    bold'>premalignant</span>, and is not a normal adaptive process. It
    involves <span style='font-weight:bold'>atypical cell morphology</span>,
    not cell type replacement.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.7333in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“Dysplasia is
    disordered growth and maturation of the epithelium, often a precursor to
    cancer.”Robbins and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:.7625in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>D. Metaplasia</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7284in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>Correct</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.4576in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Metaplasia</span> is the <span style='font-weight:
    bold'>replacement of one differentiated cell type with another</span>,
    often in response to <span style='font-weight:bold'>chronic irritation or
    injury</span>, and is <span style='font-weight:bold'>reversible</span> if
    the stimulus is removed.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.8166in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“Metaplasia is a
    reversible change in which one differentiated cell type is replaced by
    another… usually in response to chronic irritation and associated with
    tissue damage and repair.”Robbins and Cotran Path…</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Correct Answer: D. Metaplasia</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Let me know if
  you'd like a comparison table of <span style='font-weight:bold'>hyperplasia,
  hypertrophy, atrophy, metaplasia, and dysplasia</span>!</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>44</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7562in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>You
  are lying on a beach after completing this intensely boring exam. Which rays
  are most likely to cause skin cancer?</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>UVA</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>UVB</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>UVC</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>UVD</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>&nbsp;</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8048in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here is the <span
  style='font-weight:bold'>Robbins-based evaluation</span> of the question on <span
  style='font-weight:bold'>UV radiation and skin cancer risk</span>:</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
  style='font-weight:bold'>Question: </span><span style='font-style:italic'>Which
  UV rays are most likely to cause skin cancer?</span></p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:.6687in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Option</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.5479in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Evaluation</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.343in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation from Robbins</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:.6673in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>UVA</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.5479in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-style:italic;font-family:Calibri'>Contributes</span><span
    style='font-family:Calibri'> but </span><span style='font-weight:bold;
    font-family:Calibri'>less carcinogenic</span><span style='font-family:Calibri'>
    than UVB</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.4756in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: <span
    style='font-weight:bold'>UVA</span> penetrates more deeply into the skin
    and contributes to <span style='font-weight:bold'>photoaging</span> and <span
    style='font-weight:bold'>DNA damage</span>, but <span style='font-weight:
    bold'>UVB is more directly carcinogenic</span>Robbins and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:.6673in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>UVB</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.5479in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>Correct</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.3722in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: “<span
    style='font-weight:bold'>UVB radiation is believed to be the main cause of
    skin cancers</span>,” as it causes <span style='font-weight:bold'>direct
    DNA damage</span>, including formation of <span style='font-weight:bold'>pyrimidine
    dimers</span>Robbins and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:.6673in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>UVC</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.5479in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-style:italic;font-family:Calibri'>Not a risk</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.4236in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: <span
    style='font-weight:bold'>UVC</span> is <span style='font-weight:bold'>completely
    filtered by the ozone layer</span> and <span style='font-weight:bold'>does
    not reach the Earth's surface</span>, so it plays <span style='font-weight:
    bold'>no role</span> in skin cancer under natural conditionsRobbins and
    Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:.6673in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>UVD</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.5479in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-style:italic;font-family:Calibri'>Nonexistent</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.443in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>There is <span
    style='font-weight:bold'>no such category</span> as &quot;UVD&quot; in the
    electromagnetic spectrum.</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Correct Answer: UVB</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
  style='font-weight:bold'>UVB radiation</span> is the <span style='font-weight:
  bold'>primary carcinogenic UV component</span> that contributes to <span
  style='font-weight:bold'>skin cancer</span>, especially basal cell carcinoma,
  squamous cell carcinoma, and melanomaRobbins and Cotran Path….</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.6673in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>&nbsp;</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7562in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>Match
  the Paraneoplastic syndrome to the typical primary cancer (only one correct
  cancer for each syndrome)</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>Small
  cell carcinoma of lung Acute promyelocytic leukaemia Thymic neoplasms
  Pancreatic cancer Gastric cancer Renal carcinoma</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>Acanthosis
  nigricans</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>Polycythaemia</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>Syndrome
  of inappropriate ADH secretion</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>&nbsp;</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8048in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here's the correct
  matching of <span style='font-weight:bold'>paraneoplastic syndromes</span>
  with their <span style='font-weight:bold'>typical primary cancers</span>,
  based on <span style='font-style:italic'>Robbins and Cotran Pathologic Basis
  of Disease, 9th Edition</span>:</p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.6354in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Paraneoplastic Syndrome</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.1673in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Typical Primary Cancer</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.7562in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Robbins Justification</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.6354in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Acanthosis nigricans</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.1479in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Gastric cancer</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.8034in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:Calibri'>Robbins:
    </span><span style='font-style:italic;font-family:Calibri'>“Acanthosis
    nigricans may be associated with </span><span style='font-weight:bold;
    font-style:italic;font-family:Calibri'>visceral malignancies, particularly
    gastric carcinoma</span><span style='font-style:italic;font-family:Calibri'>.”</span><span
    style='font-family:"MS Gothic"'>【</span><span style='font-family:Calibri'>13:Chapter
    7†source</span><span style='font-family:"MS Gothic"'>】</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.6354in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Polycythaemia (secondary to erythropoietin
    production)</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.1479in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Renal carcinoma</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.9076in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:Calibri'>Robbins:
    </span><span style='font-style:italic;font-family:Calibri'>“Paraneoplastic
    polycythemia is most often associated with </span><span style='font-weight:
    bold;font-style:italic;font-family:Calibri'>renal cell carcinoma</span><span
    style='font-style:italic;font-family:Calibri'>, hepatocellular carcinoma,
    and cerebellar hemangioblastoma.”</span><span style='font-family:"MS Gothic"'>【</span><span
    style='font-family:Calibri'>13:Chapter 7†source</span><span
    style='font-family:"MS Gothic"'>】</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.6354in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Syndrome of inappropriate ADH secretion (SIADH)</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.1479in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Small cell carcinoma of the lung</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.809in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:Calibri'>Robbins:
    </span><span style='font-style:italic;font-family:Calibri'>“SIADH is a
    classic paraneoplastic syndrome in </span><span style='font-weight:bold;
    font-style:italic;font-family:Calibri'>small cell lung carcinoma</span><span
    style='font-style:italic;font-family:Calibri'>, due to ectopic ADH
    production.”</span><span style='font-family:"MS Gothic"'>【</span><span
    style='font-family:Calibri'>13:Chapter 7†source</span><span
    style='font-family:"MS Gothic"'>】</span></p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Final Matches:</span></p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.4631in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Syndrome</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.8152in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Cancer</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.4826in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Acanthosis
    nigricans</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.7958in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Gastric cancer</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.4631in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Polycythaemia</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.8152in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Renal carcinoma</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.4631in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>SIADH</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.8847in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Small cell
    carcinoma of lung</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Let me know if
  you'd like a full chart of paraneoplastic syndromes and their associated
  malignancies.</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>45</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7562in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>Match
  the mechanism of host damage or immunolgocial evasion to the pathogen. Only
  one answer for each mechanism</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>&nbsp;</p>
  <ol type=1 style='direction:ltr;unicode-bidi:embed;margin-top:0in;margin-bottom:
   0in;font-family:Calibri;font-size:11.0pt;font-weight:normal;font-style:normal'>
   <li value=1 style='margin-top:0;margin-bottom:0;vertical-align:middle;
       color:black'><span style='font-family:Calibri;font-size:11.0pt;
       font-weight:normal;font-style:normal;font-family:Calibri;font-size:11.0pt'>Mycobacterium
       tuberculosis </span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'><span
       style='font-family:Calibri;font-size:11.0pt'>Novel Corona Virus
       (SARS-CoV-2)</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'><span
       style='font-family:Calibri;font-size:11.0pt'><span
       style='mso-spacerun:yes'> </span>Lipopolysaccharide containing Gram
       negative bacteria </span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'><span
       style='font-family:Calibri;font-size:11.0pt'>HIV</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'><span
       style='font-family:Calibri;font-size:11.0pt'><span
       style='mso-spacerun:yes'> </span>Plasmodium falciparum</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'><span
       style='font-family:Calibri;font-size:11.0pt'><span
       style='mso-spacerun:yes'> </span>Staph. aureus </span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'><span
       style='font-family:Calibri;font-size:11.0pt'>Herpes simplex</span></li>
  </ol>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>&nbsp;</p>
  <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'><span
       style='font-family:Calibri;font-size:11.0pt'>Binds to receptors on host
       cell surfaces usually designed for host factors e.g. CCR5 receptor on
       macrophages</span></li>
  </ul>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>&nbsp;</p>
  <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'><span
       style='font-family:Calibri;font-size:11.0pt'>Blocks fusion of a
       macrophage phagosome with a lysosome allowing it to proliferate.</span></li>
  </ul>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>&nbsp;</p>
  <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'><span
       style='font-family:Calibri;font-size:11.0pt'>Secretes exotoxins to cause
       exfoliation</span></li>
  </ul>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>&nbsp;</p>
  <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'><span
       style='font-family:Calibri;font-size:11.0pt'>Use endotoxins which can
       elicit excessive immune responses</span></li>
  </ul>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>&nbsp;</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8048in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here is the <span
  style='font-weight:bold'>Robbins-based and immunologically accurate</span>
  matching of <span style='font-weight:bold'>mechanisms of host damage or
  immune evasion</span> to their <span style='font-weight:bold'>respective
  pathogens</span>:</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Matching Table</span></p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.4673in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Mechanism</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.3388in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Correct Pathogen</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.7534in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.4861in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Binds to receptors on host cell surfaces usually
    designed for host factors (e.g., CCR5 on macrophages)</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.3388in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>&#129001;
    </span><span style='font-weight:bold;font-family:Calibri'>HIV</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.7819in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>HIV targets <span
    style='font-weight:bold'>CD4+ T cells</span> using <span style='font-weight:
    bold'>CD4 and CCR5/CXCR4 coreceptors</span> to gain entryRobbins and Cotran
    Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.4673in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Blocks fusion of a macrophage phagosome with a
    lysosome allowing it to proliferate</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.3388in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>&#129001;
    </span><span style='font-weight:bold;font-family:Calibri'>Mycobacterium
    tuberculosis</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.8791in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>M. tuberculosis <span
    style='font-weight:bold'>survives in macrophages</span> by inhibiting <span
    style='font-weight:bold'>phagolysosomal fusion</span>Robbins and Cotran
    Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.4673in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Secretes exotoxins to cause exfoliation</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.3388in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>&#129001;
    </span><span style='font-weight:bold;font-family:Calibri'>Staphylococcus
    aureus</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.8854in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>S. aureus
    produces <span style='font-weight:bold'>exfoliative toxins</span>, which
    cause <span style='font-weight:bold'>epidermal splitting</span> seen in <span
    style='font-weight:bold'>scalded skin syndrome</span>Robbins and Cotran
    Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.4673in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Use endotoxins which can elicit excessive immune
    responses</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.3388in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>&#129001;
    </span><span style='font-weight:bold;font-family:Calibri'>LPS-containing
    Gram-negative bacteria</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.8263in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>LPS (<span
    style='font-weight:bold'>endotoxin</span>) from Gram-negative bacteria
    activates <span style='font-weight:bold'>TLR4</span>, triggering <span
    style='font-weight:bold'>cytokine storms</span>Robbins and Cotran Path….</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>&#129504;</span><span style='font-weight:bold;
  font-family:Calibri'> Let me know if you'd like the remaining mechanisms for:</span></p>
  <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle'><span
       style='font-weight:bold;font-family:Calibri;font-size:11.0pt'>SARS-CoV-2</span><span
       style='font-family:Calibri;font-size:11.0pt'> (e.g., spike protein
       binding ACE2)</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle'><span
       style='font-weight:bold;font-family:Calibri;font-size:11.0pt'>Plasmodium
       falciparum</span><span style='font-family:Calibri;font-size:11.0pt'>
       (e.g., antigenic variation of PfEMP1)</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle'><span
       style='font-weight:bold;font-family:Calibri;font-size:11.0pt'>Herpes
       simplex</span><span style='font-family:Calibri;font-size:11.0pt'> (e.g.,
       latency and immune evasion)</span></li>
  </ul>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Would you like the
  <span style='font-weight:bold'>full table of all 7 pathogens matched</span>?</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.6673in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>&nbsp;</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7562in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>65-68<span
  style='mso-spacerun:yes'>  </span>Which of these is not associated with
  streptococcal infections</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>Rheumatic
  fever</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>Scarlet
  fever</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>Glomerulonephritis</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>Q <span
  style='background:yellow;mso-highlight:yellow'>fever</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>Erythema
  nodosum</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8881in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here is the
  detailed analysis of the MCQ on <span style='font-weight:bold'>conditions
  associated with streptococcal infections</span>, based on <span
  style='font-style:italic'>Robbins and Cotran Pathologic Basis of Disease, 9th
  Edition</span>:</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:.8166in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Option</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0465in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Answer</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.7722in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.9236in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Robbins Reference</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:.8361in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Rheumatic fever</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0465in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>Associated</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.7722in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Rheumatic fever</span> is a <span
    style='font-weight:bold'>post-streptococcal autoimmune complication</span>
    following <span style='font-weight:bold'>group A streptococcal pharyngitis</span>.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.0687in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“Rheumatic fever
    is an immunologically mediated disease that occurs after group A
    streptococcal pharyngitis.”Robbins and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:.8166in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Scarlet fever</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0465in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>Associated</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.7722in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Caused by <span
    style='font-weight:bold'>group A Streptococcus</span> producing <span
    style='font-weight:bold'>erythrogenic (exotoxin)</span>; presents with
    fever, pharyngitis, and a characteristic <span style='font-weight:bold'>sandpaper
    rash</span>.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.0354in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“Scarlet fever
    results from a streptococcal pharyngitis with production of erythrogenic
    toxin.”Robbins and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:.8361in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Glomerulonephritis</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0465in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>Associated</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.7722in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Post-streptococcal glomerulonephritis</span>
    occurs after infection with certain <span style='font-weight:bold'>nephritogenic
    strains</span> of group A strep, especially in children.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.1006in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“Acute
    post-streptococcal glomerulonephritis follows group A streptococcal
    infection of the skin or pharynx.”Robbins and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:.8166in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Q fever</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0465in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-weight:bold;font-family:Calibri'>Not associated </span><span
    style='font-family:"Segoe UI Emoji"'>✅ </span><span style='font-weight:
    bold;font-family:Calibri'>Correct Answer</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.7861in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Q fever is caused by </span><span
    style='font-weight:bold;font-style:italic'>Coxiella burnetii</span>, an <span
    style='font-weight:bold'>obligate intracellular bacterium</span>, usually
    transmitted by <span style='font-weight:bold'>inhalation of aerosolized
    animal products</span>. It is <span style='font-weight:bold'>not related to
    streptococcal infection</span>.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.1284in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“Q fever is a
    zoonosis caused by Coxiella burnetii… not associated with streptococcal
    infection.”Robbins and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:.8361in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Erythema nodosum</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0465in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>Associated</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.7916in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Though
    non-specific, <span style='font-weight:bold'>erythema nodosum</span> can be
    triggered by <span style='font-weight:bold'>streptococcal infections</span>,
    especially in children and young adults.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.1388in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“Erythema
    nodosum may follow streptococcal infections, tuberculosis, or other
    systemic diseases.”Robbins and Cotran Path…</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Correct Answer: Q fever</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Let me know if
  you'd like a table of <span style='font-weight:bold'>streptococcal
  complications: suppurative vs non-suppurative</span>!</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>46</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7562in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>Regarding
  Bordetella pertussis, which of these is true?</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>A. The
  specific part of the DTPa vaccine conveys lifelong immunity</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>B. it
  produces pertussis toxin</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>C.
  Treatment with oral antibiotics shortens symptom duration only if started 3
  weeks after infection</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>D.
  Children over 5 years old are most susceptible, hence they start being
  vaccinated at the age of 4.</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8048in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here is the <span
  style='font-weight:bold'>Robbins-based and clinically accurate</span>
  evaluation of the question on <span style='font-weight:bold'>Bordetella
  pertussis</span>:</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
  style='font-weight:bold'>Question: </span><span style='font-style:italic'>Regarding
  Bordetella pertussis, which of these is </span><span style='font-weight:bold;
  font-style:italic'>true</span><span style='font-style:italic'>?</span></p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.1784in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Option</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7555in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Evaluation</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.6256in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.1979in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>A. The specific part of the DTPa vaccine conveys
    lifelong immunity</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7743in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-style:italic;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.6583in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Immunity from <span
    style='font-weight:bold'>DTPa (acellular pertussis)</span> vaccine <span
    style='font-weight:bold'>wanes over time</span>, typically within <span
    style='font-weight:bold'>5–10 years</span>, which is why <span
    style='font-weight:bold'>booster doses</span> are recommendedRobbins and
    Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.1784in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>B. It produces pertussis toxin</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7555in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>Correct</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.6534in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: <span
    style='font-weight:bold'>Bordetella pertussis</span> produces <span
    style='font-weight:bold'>pertussis toxin</span>, which disrupts host immune
    signaling by <span style='font-weight:bold'>ribosylating Gi proteins</span>,
    and contributes to lymphocytosis and immune evasionRobbins and Cotran
    Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.1784in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>C. Treatment with oral antibiotics shortens
    symptom duration only if started 3 weeks after infection</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7743in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-style:italic;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.702in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:Calibri'>Antibiotics
    (e.g., macrolides) are </span><span style='font-weight:bold;font-family:
    Calibri'>most effective if started early</span><span style='font-family:
    Calibri'>, ideally during the </span><span style='font-weight:bold;
    font-family:Calibri'>catarrhal stage</span><span style='font-family:Calibri'>.
    If started </span><span style='font-weight:bold;font-family:Calibri'>after
    3 weeks</span><span style='font-family:Calibri'>, they have </span><span
    style='font-weight:bold;font-family:Calibri'>little to no effect</span><span
    style='font-family:Calibri'> on symptom duration</span><span
    style='font-family:"MS Gothic"'>【</span><span style='font-family:Calibri'>CDC/clinical
    guidelines</span><span style='font-family:"MS Gothic"'>】</span><span
    style='font-family:Calibri'>.</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.1979in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>D. Children over 5 years old are most susceptible,
    hence they start being vaccinated at the age of 4</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7743in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-style:italic;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.6534in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-weight:bold;
    font-family:Calibri'>Infants &lt;1 year</span><span style='font-family:
    Calibri'> are most vulnerable to severe pertussis. The </span><span
    style='font-weight:bold;font-family:Calibri'>primary DTPa series begins at
    6–8 weeks</span><span style='font-family:Calibri'>, with a </span><span
    style='font-weight:bold;font-family:Calibri'>booster at 4 years</span><span
    style='font-family:Calibri'>, not because 5-year-olds are most susceptible</span><span
    style='font-family:"MS Gothic"'>【</span><span style='font-family:Calibri'>clinical
    sources</span><span style='font-family:"MS Gothic"'>】</span><span
    style='font-family:Calibri'>.</span></p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Correct Answer: B. It produces pertussis toxin</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
  style='font-weight:bold'>Pertussis toxin</span> is a key virulence factor of <span
  style='font-weight:bold'>B. pertussis</span>, and central to the pathogenesis
  of whooping cough, as confirmed in <span style='font-weight:bold'>Robbins and
  immunology texts</span>Robbins and Cotran Path….</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>47</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7562in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>Tuberculosis,
  which of these is false?</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>A. In
  primary tuberculosis, clinically significant infection occurs in around 95%
  of patients</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>B.
  Most cases are acquired by person to person transmission of airborne
  organisms from an active case to a susceptible host</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>C.
  Around 3 weeks after infection a Th-1 response activates macrophages,
  enabling them to become bactericidal</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>D.
  Like primary infection, localised secondary TB may be asymptomativ</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8048in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here is the
  evaluation of each statement regarding <span style='font-weight:bold'>tuberculosis</span>,
  with direct reference to <span style='font-style:italic'>Robbins and Cotran
  Pathologic Basis of Disease, 9th Edition</span>:</p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.6152in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Statement</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7423in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>True/False</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.2013in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation with Robbins Reference</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.6152in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>A. <span
    style='font-weight:bold'>In primary tuberculosis, clinically significant
    infection occurs in around 95% of patients</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7229in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-weight:bold;font-family:Calibri'>False</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.3527in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins clearly
    states: <span style='font-style:italic'>“Clinically significant disease
    develops in about </span><span style='font-weight:bold;font-style:italic'>5%</span><span
    style='font-style:italic'> of newly infected people.”</span> So <span
    style='font-weight:bold'>95% do not develop significant disease</span>Robbins
    and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.6152in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>B. <span
    style='font-weight:bold'>Most cases are acquired by person to person
    transmission of airborne organisms from an active case to a susceptible
    host</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7423in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>True</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.3527in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: <span
    style='font-style:italic'>“Most infections are acquired by </span><span
    style='font-weight:bold;font-style:italic'>person-to-person transmission of
    airborne organisms</span><span style='font-style:italic'> from an active
    case to a susceptible host.”</span>Robbins and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.6347in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>C. <span
    style='font-weight:bold'>Around 3 weeks after infection a Th-1 response
    activates macrophages, enabling them to become bactericidal</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7423in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>True</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.3243in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: <span
    style='font-style:italic'>“About </span><span style='font-weight:bold;
    font-style:italic'>3 weeks</span><span style='font-style:italic'> after
    infection, a </span><span style='font-weight:bold;font-style:italic'>T-helper
    1 (TH1) response</span><span style='font-style:italic'> is mounted that
    activates macrophages, enabling them to become bactericidal.”</span>Robbins
    and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.6152in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>D. <span
    style='font-weight:bold'>Like primary infection, localised secondary TB may
    be asymptomatic</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7423in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>True</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.2937in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: <span
    style='font-style:italic'>“Localized secondary tuberculosis </span><span
    style='font-weight:bold;font-style:italic'>may be asymptomatic</span><span
    style='font-style:italic'>. When manifestations appear, they are usually
    insidious in onset.”</span>Robbins and Cotran Path…</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>❌</span><span style='font-weight:bold;
  font-family:Calibri'> Correct Answer: A. In primary tuberculosis, clinically
  significant infection occurs in around 95% of patients</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>(This is <span
  style='font-weight:bold'>false</span>—it is only ~5%, per Robbins)</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Let me know if
  you'd like a visual comparing primary vs secondary TB.</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>48</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7562in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>HIV.
  Which of these is true?</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>A.
  Herpes simplex virus infection is quite common so it can't be used as an AIDS
  defining illness</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>B.
  Globally, heterosexual sexual transmission is the most common form of spread</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>C.
  Maternal-infant transmission can occur via the placenta but not via breast
  milk.</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>D.
  Viral load usually rises sharply at around 12 months after initial infection</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8881in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here is the
  detailed analysis of the MCQ on <span style='font-weight:bold'>HIV</span>,
  based on <span style='font-style:italic'>Robbins and Cotran Pathologic Basis
  of Disease, 9th Edition</span>:</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.5763in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Option</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.725in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Answer</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.3618in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.8951in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Robbins Reference</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.5958in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>A. Herpes simplex virus infection is quite common
    so it can't be used as an AIDS defining illness</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7444in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-weight:bold;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.3812in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Chronic HSV infection</span> (e.g. ulcers lasting
    &gt;1 month or visceral involvement) <span style='font-weight:bold'>is an
    AIDS-defining illness</span>, despite HSV being common in the general
    population.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.059in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“AIDS-defining
    conditions include chronic herpes simplex virus infection with
    mucocutaneous ulcers lasting more than 1 month.”Robbins and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.5763in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>B. Globally, heterosexual sexual transmission is
    the most common form of spread</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.725in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>Correct</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.3618in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Worldwide</span>, heterosexual contact is the <span
    style='font-weight:bold'>dominant mode of HIV transmission</span>,
    especially in <span style='font-weight:bold'>sub-Saharan Africa</span>.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.0194in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“Globally,
    heterosexual transmission is the most common route of HIV
    infection.”Robbins and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.5958in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>C. Maternal-infant transmission can occur via the
    placenta but not via breast milk</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7444in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-weight:bold;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.3618in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Mother-to-child transmission</span> can occur <span
    style='font-weight:bold'>in utero (placenta), during delivery, and via
    breast milk</span>. Breastfeeding is a <span style='font-weight:bold'>known
    route</span> of HIV transmission.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.1111in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“Vertical
    transmission occurs transplacentally, during birth, or through
    breastfeeding.”Robbins and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.5763in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>D. Viral load usually rises sharply at around 12
    months after initial infection</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7444in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-weight:bold;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.3618in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Viral load
    spikes <span style='font-weight:bold'>early (within weeks)</span> after
    infection (acute phase), then declines as the immune system responds. It <span
    style='font-weight:bold'>rises again years later</span> as the disease
    progresses to AIDS.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.1111in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“There is a
    sharp increase in viral replication during acute infection… followed by a
    decline and a long clinical latency.”Robbins and Cotran Path…</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Correct Answer: B. Globally, heterosexual sexual
  transmission is the most common form of spread</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Let me know if
  you'd like a timeline of <span style='font-weight:bold'>HIV pathogenesis and
  clinical stages</span>!</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>49</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7562in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>Immunity.
  Which of these is correct regarding natural killer (NK) cells?</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>A.
  They will only kill virus infected cells</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>B.
  They express a receptor for IgM Fc tails</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>C. MHC
  class I molecules on healthy cells prevent attack by NK cells</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>D.
  They are a major part of humans adaptive immunity</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8048in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here is the <span
  style='font-weight:bold'>Robbins-based evaluation</span> of the question on <span
  style='font-weight:bold'>Natural Killer (NK) cells</span>:</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
  style='font-weight:bold'>Question: </span><span style='font-style:italic'>Which
  of these is </span><span style='font-weight:bold;font-style:italic'>correct</span><span
  style='font-style:italic'> regarding natural killer (NK) cells?</span></p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.6236in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Option</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7506in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Evaluation</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.1847in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation from Robbins</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.6236in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>A. They will only kill virus-infected cells</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7701in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-style:italic;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.3173in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: NK
    cells target <span style='font-weight:bold'>virus-infected cells, tumor
    cells</span>, and <span style='font-weight:bold'>cells with low MHC I</span>
    — not just virus-infected ones. They are involved in <span
    style='font-weight:bold'>innate immunity</span> against a range of abnormal
    cellsRobbins and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.6236in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>B. They express a receptor for IgM Fc tails</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7701in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-style:italic;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.2131in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>NK cells express
    <span style='font-weight:bold'>FcγRIII (CD16)</span>, which binds the <span
    style='font-weight:bold'>Fc region of IgG</span>, not IgM. This mediates <span
    style='font-weight:bold'>antibody-dependent cellular cytotoxicity (ADCC)</span>Robbins
    and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.643in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>C. MHC class I molecules on healthy cells prevent
    attack by NK cells</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7506in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>Correct</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.2923in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: “NK
    cells are inhibited by the presence of <span style='font-weight:bold'>self
    MHC class I molecules</span>. Cells with reduced MHC I (e.g.,
    virus-infected or tumor cells) are more likely to be targeted.” This is a
    key <span style='font-weight:bold'>immune surveillance mechanism</span>Robbins
    and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.6236in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>D. They are a major part of human adaptive
    immunity</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7701in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-style:italic;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.2777in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>NK cells are
    part of the <span style='font-weight:bold'>innate immune system</span>, not
    adaptive. They <span style='font-weight:bold'>lack antigen-specific
    receptors</span> found on T or B cellsRobbins and Cotran Path….</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Correct Answer: C. MHC class I molecules on healthy
  cells prevent attack by NK cells</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>This is a
  fundamental principle of NK cell regulation: they kill cells with <span
  style='font-weight:bold'>low or absent MHC I</span>, which is typical of <span
  style='font-weight:bold'>virus-infected</span> or <span style='font-weight:
  bold'>neoplastic cells</span>Robbins and Cotran Path….</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>50</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7756in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>Regarding
  adaptive immunity, which of these is <span style='background:yellow;
  mso-highlight:yellow'>false</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>A.
  Class I MHC molecules display peptides from cytoplasmic proteins and are
  recognised by CD 8+ T cells</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>B.
  Class II MHC molecules present antigens derived from extracellular
  microbes<span style='mso-spacerun:yes'>  </span>following their
  internalisation in to endosomes or lysosomes</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>C. No
  two individuals can have the same HLA haplotype</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>D. In
  adaptive immune responses cytokines are produced principally by CD4+ T
  lymphocytes activated by antigen</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8048in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here's the
  evaluation of each statement regarding <span style='font-weight:bold'>adaptive
  immunity</span>, supported by <span style='font-style:italic'>Robbins and
  Cotran Pathologic Basis of Disease, 9th Edition</span>:</p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.4034in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Statement</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7305in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>True/False</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.425in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation with Robbins Reference</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.4034in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>A. <span
    style='font-weight:bold'>Class I MHC molecules display peptides from
    cytoplasmic proteins and are recognised by CD8+ T cells</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7305in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>True</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.5763in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: <span
    style='font-style:italic'>“Class I MHC molecules display peptides… that are
    located in the cytoplasm… and class I–associated peptides are recognized by
    </span><span style='font-weight:bold;font-style:italic'>CD8+ T lymphocytes</span><span
    style='font-style:italic'>.”</span>Robbins and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.4229in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>B. <span
    style='font-weight:bold'>Class II MHC molecules present antigens derived
    from extracellular microbes following their internalisation into endosomes
    or lysosomes</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7305in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>True</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.5611in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: <span
    style='font-style:italic'>“Class II MHC molecules present antigens that are
    internalized into vesicles, and are typically derived from </span><span
    style='font-weight:bold;font-style:italic'>extracellular microbes and
    soluble proteins</span><span style='font-style:italic'>.”</span>Robbins and
    Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.4138in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>C. <span
    style='font-weight:bold'>No two individuals can have the same HLA haplotype</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7111in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-weight:bold;font-family:Calibri'>False</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.4729in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: <span
    style='font-style:italic'>“Each individual expresses an MHC profile… that
    is different from the haplotypes of </span><span style='font-weight:bold;
    font-style:italic'>most</span><span style='font-style:italic'> other
    individuals.” </span><span style='font-weight:bold'>Identical twins</span>
    do have the same haplotype, and shared haplotypes can exist between
    siblingsRobbins and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.4083in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>D. <span
    style='font-weight:bold'>In adaptive immune responses cytokines are
    produced principally by CD4+ T lymphocytes activated by antigen</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7305in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>True</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.5527in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: <span
    style='font-style:italic'>“In adaptive immune responses, cytokines are
    produced principally by </span><span style='font-weight:bold;font-style:
    italic'>CD4+ T lymphocytes</span><span style='font-style:italic'> activated
    by antigen and other signals…”</span>Robbins and Cotran Path…</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>❌</span><span style='font-weight:bold;
  font-family:Calibri'> Correct Answer: C. No two individuals can have the same
  HLA haplotype</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>This is false — <span
  style='font-weight:bold'>identical twins</span> share the same HLA haplotype,
  and siblings may too, by inheritance.</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Let me know if
  you'd like a comparison chart of MHC class I vs II properties and functions.</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>51</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7756in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>Hypersensitivity
  responses, which of these is true</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>A.
  Opsonisation of cells by antibodies and phagocytosis is a feature of Type III
  hypersensitivity</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>B.
  Myasthenia gravis is an example of a type II hypersensitivity response</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>C.
  Type IV responses are involved in Type II diabetes</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>D. The
  first step in Type I responses is tissue infiltration with eosinophils,
  basophils and CD4+ cells</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8881in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here is the
  detailed analysis of the MCQ on <span style='font-weight:bold'>hypersensitivity
  reactions</span>, based on <span style='font-style:italic'>Robbins and Cotran
  Pathologic Basis of Disease, 9th Edition</span>:</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.5902in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Option</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7243in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Answer</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.3458in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.8993in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Robbins Reference</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.5902in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>A. Opsonisation of cells by antibodies and
    phagocytosis is a feature of Type III hypersensitivity</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.743in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-weight:bold;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.3458in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Type III hypersensitivity</span> involves <span
    style='font-weight:bold'>immune complex deposition</span>, not
    opsonization. <span style='font-weight:bold'>Opsonization and phagocytosis</span>
    are classic features of <span style='font-weight:bold'>Type II
    hypersensitivity</span>.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.1069in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“In Type II
    reactions, antibodies opsonize cells for phagocytosis or activate
    complement.”Robbins and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.5902in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>B. Myasthenia gravis is an example of a type II
    hypersensitivity response</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7243in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>Correct</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.3458in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Myasthenia gravis</span> is a <span
    style='font-weight:bold'>Type II, antibody-mediated</span> hypersensitivity
    disease. Autoantibodies block <span style='font-weight:bold'>acetylcholine
    receptors</span> at the neuromuscular junction.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.1145in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“Myasthenia
    gravis is a prototypical antibody-mediated (Type II) disorder in which
    autoantibodies block ACh receptors.”Robbins and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.6097in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>C. Type IV responses are involved in Type II
    diabetes</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.743in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-weight:bold;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.3458in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Type II diabetes</span> is not primarily
    immune-mediated and <span style='font-weight:bold'>not associated with Type
    IV hypersensitivity</span>. It’s a metabolic disease linked to insulin
    resistance.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.0104in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“Type IV
    reactions are T-cell mediated. Type II diabetes is not classified as an
    immune hypersensitivity disorder.”Robbins and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.6097in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>D. The first step in Type I responses is tissue
    infiltration with eosinophils, basophils and CD4+ cells</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.743in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-weight:bold;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.3458in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>The <span
    style='font-weight:bold'>first step in Type I hypersensitivity</span> is <span
    style='font-weight:bold'>sensitization</span>: exposure to antigen → <span
    style='font-weight:bold'>IgE production</span> → binding to mast cells.
    Eosinophil infiltration occurs <span style='font-weight:bold'>later</span>
    in the effector phase.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.1145in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“Type I
    responses begin with sensitization… IgE binds to mast cells. Re-exposure
    triggers degranulation and eosinophil recruitment.”Robbins and Cotran Path…</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Correct Answer: B. Myasthenia gravis is an example of a
  type II hypersensitivity response</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Let me know if
  you'd like a summary table of <span style='font-weight:bold'>hypersensitivity
  types I–IV with examples and mechanisms</span>!</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>52</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7562in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>Systemic
  lupus erythematosus is characterised by all but one of the below, identify it</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>A.
  Female to male ratio of SLE patients is 9:1</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>B.
  ds-DNA antibodies</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>C.
  antiphospholipid antibodies in 30-40 % of patients</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>D.
  Symptom improvement on exposure to UV light</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8048in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here is the <span
  style='font-weight:bold'>Robbins-based evaluation</span> of the question on <span
  style='font-weight:bold'>Systemic Lupus Erythematosus (SLE):</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
  style='font-weight:bold'>Question: </span><span style='font-style:italic'>Systemic
  lupus erythematosus is characterised by all </span><span style='font-weight:
  bold;font-style:italic'>but one</span><span style='font-style:italic'> of the
  below — identify it:</span></p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.4152in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Option</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0472in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Evaluation</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.0972in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation from Robbins</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.4152in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>A. Female to male ratio of SLE patients is 9:1</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0472in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-style:italic;font-family:Calibri'>True</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.2256in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: “SLE
    shows a striking <span style='font-weight:bold'>female predominance</span>
    (approximately <span style='font-weight:bold'>9:1</span> in reproductive
    years), attributed to hormonal and genetic factors.”Robbins and Cotran
    Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.4152in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>B. ds-DNA antibodies</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0472in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-style:italic;font-family:Calibri'>True</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.125in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: “<span
    style='font-weight:bold'>Anti–double-stranded DNA antibodies</span> are
    highly specific for SLE and correlate with <span style='font-weight:bold'>disease
    activity</span>, particularly <span style='font-weight:bold'>renal
    involvement</span>.”Robbins and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.434in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>C. Antiphospholipid antibodies in 30–40% of
    patients</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0472in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-style:italic;font-family:Calibri'>True</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.1423in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: “<span
    style='font-weight:bold'>Antiphospholipid antibodies</span> are present in
    about <span style='font-weight:bold'>30–40% of SLE patients</span>, and may
    cause <span style='font-weight:bold'>hypercoagulable states</span>,
    recurrent miscarriages, and false-positive syphilis tests.”Robbins and
    Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.4152in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>D. Symptom improvement on exposure to UV light</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0472in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-weight:bold;font-family:Calibri'>False </span><span
    style='font-family:"Segoe UI Emoji"'>✅ </span><span style='font-weight:
    bold;font-family:Calibri'>(Correct Answer)</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.125in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: “<span
    style='font-weight:bold'>Photosensitivity</span> is a hallmark of SLE. <span
    style='font-weight:bold'>UV light exacerbates the disease</span>,
    triggering keratinocyte apoptosis and releasing nuclear antigens that fuel
    autoimmunity.” Symptoms <span style='font-weight:bold'>worsen</span>, not
    improveRobbins and Cotran Path….</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Correct Answer: D. Symptom improvement on exposure to
  UV light</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>This is <span
  style='font-weight:bold'>false</span> — <span style='font-weight:bold'>UV
  exposure worsens SLE</span>, making <span style='font-weight:bold'>D</span>
  the correct choice as the one <span style='font-weight:bold'>not
  characteristic</span> of the diseaseRobbins and Cotran Path….</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>53</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7756in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>Trisomy
  21, Down Syndrome. Which of these is false?</p>
  <ol type=a style='direction:ltr;unicode-bidi:embed;margin-top:0in;margin-bottom:
   0in;font-family:Calibri;font-size:11.0pt;font-weight:normal;font-style:normal'>
   <li value=1 style='margin-top:0;margin-bottom:0;vertical-align:middle;
       color:black'><span style='font-family:Calibri;font-size:11.0pt;
       font-weight:normal;font-style:normal;font-family:Calibri;font-size:11.0pt'>Only
       5% of cases have congenital heart disease and of these Tetralogy of
       Fallot is the most frequent</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'><span
       style='font-family:Calibri;font-size:11.0pt'>It leads to a 20-fold
       increase in acute B lymphoblastic leukaemias and a 500-fold risk of AML</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'><span
       style='font-family:Calibri;font-size:11.0pt'>Virtually all patients with
       trisomy 21 older than 40 develop neuropathologic changes characteristic
       of Alzheimers</span></li>
  </ol>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>&nbsp;</p>
  <ol type=a style='direction:ltr;unicode-bidi:embed;margin-top:0in;margin-bottom:
   0in;font-family:Calibri;font-size:11.0pt;font-weight:normal;font-style:normal'>
   <li value=1 style='margin-top:0;margin-bottom:0;vertical-align:middle;
       color:black'><span style='font-family:Calibri;font-size:11.0pt;
       font-weight:normal;font-style:normal;font-family:Calibri;font-size:11.0pt'>Due
       to abnormal immune responses they are more prone to serious infections</span></li>
  </ol>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>&nbsp;</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8048in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here is the <span
  style='font-weight:bold'>Robbins-based evaluation</span> of the question on <span
  style='font-weight:bold'>Trisomy 21 (Down Syndrome):</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
  style='font-weight:bold'>Question: </span><span style='font-style:italic'>Which
  of these is </span><span style='font-weight:bold;font-style:italic'>false</span><span
  style='font-style:italic'> regarding Down Syndrome (Trisomy 21)?</span></p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.15in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Option</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.9701in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Evaluation</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.4388in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation from Robbins</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.15in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>a. Only 5% of cases have congenital heart disease
    and of these Tetralogy of Fallot is the most frequent</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.9847in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-weight:bold;font-family:Calibri'>False </span><span
    style='font-family:"Segoe UI Emoji"'>✅</span><span style='font-family:Calibri'>
    (</span><span style='font-weight:bold;font-family:Calibri'>Correct answer</span><span
    style='font-family:Calibri'>)</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.4673in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: <span
    style='font-weight:bold'>40% of Down syndrome patients</span> have
    congenital heart defects, most commonly <span style='font-weight:bold'>atrioventricular
    septal defects</span> (endocardial cushion defects), <span
    style='font-weight:bold'>not Tetralogy of Fallot</span>. TOF is less
    commonRobbins and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.1694in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>b. It leads to a 20-fold increase in acute B
    lymphoblastic leukaemias and a 500-fold risk of AML</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.9701in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-style:italic;font-family:Calibri'>True</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.5708in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: Down
    syndrome is associated with “<span style='font-weight:bold'>20-fold
    increased risk of acute lymphoblastic leukemia</span> and <span
    style='font-weight:bold'>a 500-fold increased risk of acute
    megakaryoblastic leukemia (a subtype of AML)</span>” in childhoodRobbins
    and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.15in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>c. Virtually all patients with trisomy 21 older
    than 40 develop neuropathologic changes characteristic of Alzheimer’s</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.9701in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-style:italic;font-family:Calibri'>True</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.4673in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: “By age
    40, virtually all patients with Down syndrome exhibit <span
    style='font-weight:bold'>neuropathologic changes of Alzheimer disease</span>,
    due to extra copy of <span style='font-weight:bold'>amyloid precursor
    protein (APP)</span> on chromosome 21”Robbins and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.1694in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>d. Due to abnormal immune responses they are more
    prone to serious infections</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.9701in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-style:italic;font-family:Calibri'>True</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.5326in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: “<span
    style='font-weight:bold'>Immunologic abnormalities</span> in Down syndrome
    patients lead to <span style='font-weight:bold'>increased susceptibility to
    serious infections</span>, especially of the lungs”Robbins and Cotran
    Path….</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Correct Answer: a. Only 5% of cases have congenital
  heart disease and of these Tetralogy of Fallot is the most frequent</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>This is <span
  style='font-weight:bold'>false</span> — the <span style='font-weight:bold'>true
  incidence is ~40%</span>, and the <span style='font-weight:bold'>most common
  lesion is AV septal defect</span>, <span style='font-weight:bold'>not
  Tetralogy of Fallot</span>Robbins and Cotran Path….</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.6673in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>&nbsp;</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7562in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>74-79
  In haemostasis, which is the correct order of events usually observed?</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>1
  point</p>
  <ol type=a style='direction:ltr;unicode-bidi:embed;margin-top:0in;margin-bottom:
   0in;font-family:Calibri;font-size:11.0pt;font-weight:normal;font-style:normal'>
   <li value=1 style='margin-top:0;margin-bottom:0;vertical-align:middle;
       color:black'><span style='font-family:Calibri;font-size:11.0pt;
       font-weight:normal;font-style:normal;font-family:Calibri;font-size:11.0pt'>Fibrin
       deposition; platelet plug formation; clot stabilisation;
       vasoconstriction</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'><span
       style='font-family:Calibri;font-size:11.0pt'>Vasoconstriction; fibrin
       deposition; platelet plug formation; clot stabilisation</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'><span
       style='font-family:Calibri;font-size:11.0pt'>Fibrin deposition; platelet
       plug formation, vasoconstriction; clot stabilisation</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'><span
       style='font-family:Calibri;font-size:11.0pt'>Platelet plus formation,
       vasoconstriction; fibrin deposition; clot stabilisation</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'><span
       style='font-family:Calibri;font-size:11.0pt'>None of the above.</span></li>
  </ol>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.659in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Based on <span
  style='font-style:italic'>Robbins and Cotran Pathologic Basis of Disease, 9th
  Edition</span>, the correct <span style='font-weight:bold'>sequence of events
  in hemostasis</span> is:</p>
  <ol type=1 style='direction:ltr;unicode-bidi:embed;margin-top:0in;margin-bottom:
   0in;font-family:Calibri;font-size:11.0pt;font-weight:bold;font-style:normal'>
   <li value=1 style='margin-top:0;margin-bottom:0;vertical-align:middle;
       font-weight:bold'><span style='font-family:Calibri;font-size:11.0pt;
       font-weight:bold;font-style:normal;font-weight:bold;font-family:Calibri;
       font-size:11.0pt'>Vasoconstriction</span><span style='font-family:Calibri;
       font-size:11.0pt;font-weight:normal;font-style:normal;font-weight:normal;
       font-family:Calibri;font-size:11.0pt'> – to reduce blood flow at the
       site of injury.</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;font-weight:
       bold'><span style='font-weight:bold;font-family:Calibri;font-size:11.0pt'>Primary
       hemostasis</span><span style='font-weight:normal;font-family:Calibri;
       font-size:11.0pt'> – formation of the </span><span style='font-weight:
       bold;font-family:Calibri;font-size:11.0pt'>platelet plug</span><span
       style='font-weight:normal;font-family:Calibri;font-size:11.0pt'>.</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;font-weight:
       bold'><span style='font-weight:bold;font-family:Calibri;font-size:11.0pt'>Secondary
       hemostasis</span><span style='font-weight:normal;font-family:Calibri;
       font-size:11.0pt'> – </span><span style='font-weight:bold;font-family:
       Calibri;font-size:11.0pt'>fibrin deposition</span><span
       style='font-weight:normal;font-family:Calibri;font-size:11.0pt'> via the
       coagulation cascade.</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;font-weight:
       bold'><span style='font-weight:bold;font-family:Calibri;font-size:11.0pt'>Clot
       stabilization and resorption</span><span style='font-weight:normal;
       font-family:Calibri;font-size:11.0pt'> – to consolidate and eventually
       remove the clot.</span></li>
  </ol>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins outlines
  this sequence as follows:</p>
  <p style='margin:0in;margin-left:.375in;font-family:Calibri;font-size:11.0pt'>“Arteriolar
  vasoconstriction occurs immediately… Primary hemostasis: the formation of the
  platelet plug… Secondary hemostasis: deposition of fibrin… Clot stabilization
  and resorption…”Robbins and Cotran Path…</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Correct Answer: e. None of the above</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>All listed
  sequences in options a–d <span style='font-weight:bold'>misorder the
  physiological steps</span>. The correct sequence is:</p>
  <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle'><span
       style='font-weight:bold;font-family:Calibri;font-size:11.0pt'>Vasoconstriction</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle'><span
       style='font-weight:bold;font-family:Calibri;font-size:11.0pt'>Platelet
       plug formation</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle'><span
       style='font-weight:bold;font-family:Calibri;font-size:11.0pt'>Fibrin
       deposition</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle'><span
       style='font-weight:bold;font-family:Calibri;font-size:11.0pt'>Clot
       stabilization</span></li>
  </ul>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Let me know if
  you'd like a visual flowchart summarizing these steps.</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>54</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7756in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>Regarding
  platelet function, which of these is true?</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>A. The
  glycoprotein Ib receptor on vascular basement membrane binds to von
  Willebrand factor on the platelet</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>B.
  Platelet aggregation is triggered by ATP</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>C.
  Activated platelets produce thromboxane A2</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>D. To
  help platelets form a clot, thrombin converts fibrin to insoluble fibrinogen</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8881in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here is the
  analysis of the MCQ on <span style='font-weight:bold'>platelet function</span>,
  based on <span style='font-style:italic'>Robbins and Cotran Pathologic Basis
  of Disease, 9th Edition</span>:</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.6479in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Option</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7194in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Answer</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.7104in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.5923in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Robbins Reference</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.6479in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>A. The glycoprotein Ib receptor on vascular
    basement membrane binds to von Willebrand factor on the platelet</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7388in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-weight:bold;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.7243in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>It's the <span
    style='font-weight:bold'>platelet glycoprotein Ib (GpIb)</span> that binds <span
    style='font-weight:bold'>von Willebrand factor (vWF)</span>, which is <span
    style='font-weight:bold'>bound to exposed subendothelial collagen</span>, <span
    style='font-weight:bold'>not the other way around</span>. vWF acts as a
    bridge <span style='font-weight:bold'>between the subendothelium and the
    platelet</span>.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.5923in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“GpIb receptor
    on platelets binds to vWF attached to exposed collagen in damaged
    vessels.”Robbins and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.6673in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>B. Platelet aggregation is triggered by ATP</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7388in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-weight:bold;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.7104in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>ADP</span>, not ATP, is a key mediator of <span
    style='font-weight:bold'>platelet aggregation</span>. ADP is released from
    dense granules and activates platelet GpIIb/IIIa receptors.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.6965in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“Platelet
    activation results in ADP release, which is a potent platelet
    aggregator.”Robbins and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.6506in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>C. Activated platelets produce thromboxane A2</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7194in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>Correct</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.7104in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Thromboxane A2 (TXA2)</span> is synthesized by
    activated platelets via the cyclooxygenase pathway and promotes <span
    style='font-weight:bold'>vasoconstriction and platelet aggregation</span>.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.6715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“Activated
    platelets synthesize thromboxane A2, a potent vasoconstrictor and platelet
    aggregator.”Robbins and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.6479in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>D. To help platelets form a clot, thrombin
    converts fibrin to insoluble fibrinogen</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7388in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-weight:bold;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.7104in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>This statement
    reverses the actual mechanism. <span style='font-weight:bold'>Thrombin
    converts fibrinogen (soluble)</span> into <span style='font-weight:bold'>fibrin
    (insoluble)</span> to stabilize the clot.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.6909in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“Thrombin
    cleaves fibrinogen to form fibrin, which polymerizes to form the
    clot.”Robbins and Cotran Path…</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Correct Answer: C. Activated platelets produce
  thromboxane A2</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Let me know if
  you'd like a visual diagram of platelet activation and clot formation!</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>55</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7562in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>Factor
  V Leiden is the most common primary hypercoagulable state, which of these
  points is <span style='background:yellow;mso-highlight:yellow'>false</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>A.
  This mutation renders factor V resistant to cleavage and inactivation by
  protein C</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>B.
  Only homozygotes have an increased risk of VTE</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>C.
  This mutation is seen in 50-60% of patients with recurrent DVTs</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>D. The
  inheritance factor is autosomal dominant</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8048in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here is the <span
  style='font-weight:bold'>Robbins-based evaluation</span> of the question on <span
  style='font-weight:bold'>Factor V Leiden</span>, a common cause of <span
  style='font-weight:bold'>inherited thrombophilia</span>:</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
  style='font-weight:bold'>Question: </span><span style='font-style:italic'>Which
  of these points is </span><span style='font-weight:bold;font-style:italic'>false</span><span
  style='font-style:italic'> regarding Factor V Leiden?</span></p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.8208in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Option</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0125in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Evaluation</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.7256in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation from Robbins</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.8395in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>A. This mutation renders factor V resistant to
    cleavage and inactivation by protein C</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0125in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-style:italic;font-family:Calibri'>True</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.8576in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: “<span
    style='font-weight:bold'>Factor V Leiden</span> is a mutation that <span
    style='font-weight:bold'>makes factor V resistant to cleavage by activated
    protein C (APC)</span>, promoting a hypercoagulable state.”Robbins and
    Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.8208in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>B. Only homozygotes have an increased risk of VTE</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0319in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-weight:bold;font-family:Calibri'>False </span><span
    style='font-family:"Segoe UI Emoji"'>✅</span><span style='font-family:Calibri'>
    (</span><span style='font-weight:bold;font-family:Calibri'>Correct Answer</span><span
    style='font-family:Calibri'>)</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.8576in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: “<span
    style='font-weight:bold'>Heterozygotes</span> have a <span
    style='font-weight:bold'>5-fold increased risk</span> of venous thrombosis,
    while <span style='font-weight:bold'>homozygotes</span> have up to a <span
    style='font-weight:bold'>50-fold increase</span>.” So <span
    style='font-weight:bold'>even heterozygotes are at increased risk</span>,
    making this statement falseRobbins and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.8208in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>C. This mutation is seen in 50–60% of patients
    with recurrent DVTs</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0125in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-style:italic;font-family:Calibri'>True</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.7534in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: “The <span
    style='font-weight:bold'>Factor V Leiden mutation</span> is present in <span
    style='font-weight:bold'>60% of patients</span> with recurrent deep vein
    thrombosis.” This is consistent with the literatureRobbins and Cotran
    Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.8208in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>D. The inheritance factor is autosomal dominant</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0125in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-style:italic;font-family:Calibri'>True</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.7534in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: “The
    disorder is inherited in an <span style='font-weight:bold'>autosomal
    dominant</span> manner with <span style='font-weight:bold'>incomplete
    penetrance</span>.”Robbins and Cotran Path….</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Correct Answer (i.e., the false statement): B. Only
  homozygotes have an increased risk of VTE</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>This is <span
  style='font-weight:bold'>false</span> because <span style='font-weight:bold'>both
  heterozygotes and homozygotes</span> are at increased risk, though
  homozygotes are at higher riskRobbins and Cotran Path….</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>56</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7562in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>Regarding
  arterial thrombi, which of these is false?</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>A.
  Lines of Zahn are not seen</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>B.
  they contain less enmeshed red cells than venous thrombi</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>C.
  Usually superimposed on ruptured atherosclerotic plaque</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>D. Are
  more friable than venous thrombi</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8048in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here’s the
  evaluation of the statements regarding <span style='font-weight:bold'>arterial
  thrombi</span>, using direct evidence from <span style='font-style:italic'>Robbins
  and Cotran Pathologic Basis of Disease, 9th Edition</span>:</p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.477in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Option</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.9555in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Answer</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.1263in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation with Robbins Reference</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.477in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>A. <span
    style='font-weight:bold'>Lines of Zahn are not seen</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.9555in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-weight:bold;font-family:Calibri'>False (Correct
    Answer)</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.2583in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Lines of Zahn are a characteristic feature of
    arterial thrombi</span> formed in flowing blood. Robbins: <span
    style='font-style:italic'>“Thrombi often have grossly and microscopically
    apparent laminations called </span><span style='font-weight:bold;
    font-style:italic'>lines of Zahn</span><span style='font-style:italic'>…
    [indicating] formation in flowing blood”</span>Robbins and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.477in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>B. <span
    style='font-weight:bold'>They contain less enmeshed red cells than venous
    thrombi</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.9555in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>True</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.2583in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins:
    Arterial thrombi are rich in <span style='font-weight:bold'>platelets and
    fibrin</span>, whereas <span style='font-weight:bold'>venous thrombi
    contain more red cells</span> and are referred to as “red thrombi”Robbins
    and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.477in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>C. <span
    style='font-weight:bold'>Usually superimposed on ruptured atherosclerotic
    plaque</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.9555in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>True</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.1548in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: <span
    style='font-style:italic'>“[Arterial thrombi] are usually superimposed on a
    ruptured atherosclerotic plaque…”</span>Robbins and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.477in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>D. <span
    style='font-weight:bold'>Are more friable than venous thrombi</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.9555in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>True</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.1548in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins
    describes arterial thrombi as a <span style='font-style:italic'>“friable
    meshwork of platelets, fibrin, red cells, and degenerating leukocytes”</span>Robbins
    and Cotran Path….</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>❌</span><span style='font-weight:bold;
  font-family:Calibri'> Correct Answer: A. Lines of Zahn are not seen</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>This is false
  because <span style='font-weight:bold'>lines of Zahn are a hallmark of
  arterial thrombi</span>, helping to distinguish them from postmortem clots.</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Let me know if
  you'd like a comparison table of arterial vs venous thrombi features.</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>57</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7562in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>Pulmonary
  emboli, which of these is true assuming standard anatomy?</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>A.
  Most are clinically symptomatic</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>B. The
  bronchial circulation is usually able to provide enough flow to avoid
  infarction</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>C. If
  large enough can occlude the origin of the coronary arteries</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>D.
  Multiple emboli over time can produce pulmonary hypotension</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8881in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here is the
  detailed analysis of the MCQ on <span style='font-weight:bold'>pulmonary
  embolism (PE)</span>, based on <span style='font-style:italic'>Robbins and
  Cotran Pathologic Basis of Disease, 9th Edition</span>:</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.4395in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Option</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7229in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Answer</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.6041in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.793in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Robbins Reference</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.4395in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>A. Most are clinically symptomatic</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7416in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-weight:bold;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.6041in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Most pulmonary emboli are clinically silent</span>,
    especially small or moderate-sized ones, because of the <span
    style='font-weight:bold'>dual blood supply</span> (pulmonary and bronchial
    arteries).</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.9923in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“In most cases,
    emboli are clinically silent because of the dual blood supply of the
    lungs.”Robbins and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.4395in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>B. The bronchial circulation is usually able to
    provide enough flow to avoid infarction</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7229in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>Correct</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.6229in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>The <span
    style='font-weight:bold'>bronchial circulation</span> often provides <span
    style='font-weight:bold'>sufficient collateral flow</span> to prevent
    infarction, which is why infarcts occur only in a <span style='font-weight:
    bold'>minority of embolic events</span>, typically when there is <span
    style='font-weight:bold'>compromised cardiac output</span>.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.0083in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“Pulmonary
    infarction occurs in only 10% of emboli… usually when bronchial circulation
    is inadequate (e.g., in heart failure).”Robbins and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.4395in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>C. If large enough can occlude the origin of the
    coronary arteries</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7416in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-weight:bold;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.6131in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Pulmonary emboli
    lodge in the <span style='font-weight:bold'>pulmonary arterial system</span>,
    <span style='font-weight:bold'>not</span> the aorta or coronary arteries.
    The coronary arteries arise from the <span style='font-weight:bold'>ascending
    aorta</span>, which is <span style='font-weight:bold'>upstream</span> of
    pulmonary circulation.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.9041in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Anatomically
    impossible: coronary arteries are not supplied by the pulmonary artery.</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.459in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>D. Multiple emboli over time can produce pulmonary
    hypotension</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7416in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-weight:bold;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.6041in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Chronic or recurrent PE</span> leads to <span
    style='font-weight:bold'>pulmonary hypertension</span>, not hypotension,
    due to <span style='font-weight:bold'>increased resistance in the pulmonary
    vasculature</span>.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.9493in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“Recurrent small
    emboli may cause pulmonary hypertension and right ventricular
    failure.”Robbins and Cotran Path…</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Correct Answer: B. The bronchial circulation is usually
  able to provide enough flow to avoid infarction</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Let me know if
  you’d like a summary table on <span style='font-weight:bold'>types of emboli
  and their clinical consequences</span>!</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>58</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7756in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>Which
  of these is not a feature of the pathophysiology of septic shock?</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>A.
  Increased production of complement proteins C3a and C5a</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>B.
  Upregulating production of nitric oxide</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>C.
  induction of a procoagulant state</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>D.
  Insulin resistance and decreased insulin release</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>E.
  None of the above</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8048in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here is the <span
  style='font-weight:bold'>Robbins-based evaluation</span> of the question on <span
  style='font-weight:bold'>septic shock pathophysiology</span>:</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
  style='font-weight:bold'>Question: </span><span style='font-style:italic'>Which
  of these is </span><span style='font-weight:bold;font-style:italic'>not</span><span
  style='font-style:italic'> a feature of the pathophysiology of septic shock?</span></p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.5812in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Option</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0354in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Evaluation</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.9423in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation from Robbins</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.5944in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>A. Increased production of complement proteins C3a
    and C5a</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0354in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-style:italic;font-family:Calibri'>True (a feature)</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.0743in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins:
    “Activation of complement cascade in sepsis generates <span
    style='font-weight:bold'>C3a and C5a</span>, which are <span
    style='font-weight:bold'>anaphylatoxins</span> that increase vascular
    permeability and leukocyte recruitment.”Robbins and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.5812in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>B. Upregulating production of nitric oxide</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0354in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-style:italic;font-family:Calibri'>True (a feature)</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.9708in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: “Sepsis
    leads to <span style='font-weight:bold'>widespread endothelial activation</span>,
    resulting in <span style='font-weight:bold'>increased NO production</span>,
    which contributes to <span style='font-weight:bold'>vasodilation and
    hypotension</span>.”Robbins and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.5812in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>C. Induction of a procoagulant state</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0354in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-style:italic;font-family:Calibri'>True (a feature)</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.0145in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: “<span
    style='font-weight:bold'>Sepsis induces a procoagulant state</span> through
    cytokine-driven expression of <span style='font-weight:bold'>tissue factor</span>,
    inhibition of anticoagulants, and suppression of fibrinolysis,” leading to <span
    style='font-weight:bold'>DIC</span> in severe casesRobbins and Cotran
    Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.6006in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>D. Insulin resistance and decreased insulin
    release</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0354in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-weight:bold;font-family:Calibri'>False (NOT a
    feature) </span><span style='font-family:"Segoe UI Emoji"'>✅</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.9708in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: “Sepsis
    causes <span style='font-weight:bold'>insulin resistance</span> but is
    typically associated with <span style='font-weight:bold'>increased insulin
    secretion</span>, not decreased.” The body attempts to compensate for
    hyperglycemia seen in sepsisRobbins and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.5812in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>E. None of the above</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0354in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-style:italic;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.9708in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Since <span
    style='font-weight:bold'>D is false</span>, not all options are correct;
    therefore, this option is incorrect.</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Correct Answer: D. Insulin resistance and decreased
  insulin release</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>While <span
  style='font-weight:bold'>insulin resistance</span> is part of the metabolic
  response in sepsis, <span style='font-weight:bold'>insulin release is usually
  increased</span>, not decreased — making <span style='font-weight:bold'>D</span>
  the false statementRobbins and Cotran Path….</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>59</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7562in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>Which
  of the below best describes acute inflammation?</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>A.
  neutrophilic infiltrate, severe and progressive tissue injury, less local and
  systemic signs</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>B.
  monocytic and lymphocytic infiltrate, severe and progressive injury and
  fibrosis, less local and systemic signs</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>C.
  Mostly neutrophilic infiltrate; mild and self limiting tissue injury and
  fibrosis, less local and systemic signs</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>D.
  Mostly neutrophilic infiltrate; mild and self limiting tissue injury and
  fibrosis, prominent local and systemic signs.</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8048in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here's the
  evaluation of the statements about <span style='font-weight:bold'>acute
  inflammation</span>, with direct support from <span style='font-style:italic'>Robbins
  and Cotran Pathologic Basis of Disease, 9th Edition</span>:</p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.025in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Option</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.709in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Answer</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.825in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation with Robbins Reference</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.025in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>A. <span
    style='font-weight:bold'>Neutrophilic infiltrate, severe and progressive
    tissue injury, less local and systemic signs</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.6902in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-weight:bold;font-family:Calibri'>False</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.9756in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Acute
    inflammation is usually <span style='font-weight:bold'>self-limited</span>,
    not typically “severe and progressive.” Robbins states: <span
    style='font-style:italic'>“Acute inflammation is of short duration... its
    main characteristics are the exudation of fluid... and the emigration of
    leukocytes, </span><span style='font-weight:bold;font-style:italic'>predominantly
    neutrophils</span><span style='font-style:italic'>”</span>Robbins and
    Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.0444in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>B. <span
    style='font-weight:bold'>Monocytic and lymphocytic infiltrate, severe and
    progressive injury and fibrosis, less local and systemic signs</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.6902in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-weight:bold;font-family:Calibri'>False</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.8722in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>This is <span
    style='font-weight:bold'>chronic</span>, not acute inflammation. Robbins: <span
    style='font-style:italic'>“Chronic inflammation is characterized by
    mononuclear infiltrates... often severe and progressive, with fibrosis.”</span>Robbins
    and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.025in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>C. <span
    style='font-weight:bold'>Mostly neutrophilic infiltrate; mild and
    self-limiting tissue injury and fibrosis, less local and systemic signs</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.6902in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-weight:bold;font-family:Calibri'>False</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.9743in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>While
    neutrophils and mild injury are true for acute inflammation, <span
    style='font-weight:bold'>fibrosis is not typical</span> unless healing
    progresses abnormally. Also, <span style='font-weight:bold'>local and
    systemic signs are prominent</span> in acute inflammationRobbins and Cotran
    Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.0444in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>D. <span
    style='font-weight:bold'>Mostly neutrophilic infiltrate; mild and
    self-limiting tissue injury and fibrosis, prominent local and systemic
    signs</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.6902in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>True</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.8916in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins
    summarizes: <span style='font-style:italic'>“Acute inflammation is of short
    duration... increased blood flow and edema... predominantly neutrophils...
    local and systemic signs such as redness, heat, swelling, pain, and fever.”</span>Robbins
    and Cotran Path…</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Correct Answer: D. Mostly neutrophilic infiltrate; mild
  and self-limiting tissue injury and fibrosis, prominent local and systemic
  signs</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Let me know if
  you'd like a comparative table of acute vs chronic inflammation.</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>60</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7562in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>In
  acute inflammation, blood vessels will not do one of the following, identify
  it.</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>A.
  alter their permeability so as to create a transudate</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>B.
  Slow down the movement of red cells</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>C.
  Contract endothelial cells</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>D.
  Increase permeability in response to bradykinin</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8881in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here is the
  detailed analysis of the MCQ on <span style='font-weight:bold'>vascular
  changes in acute inflammation</span>, based on <span style='font-style:italic'>Robbins
  and Cotran Pathologic Basis of Disease, 9th Edition</span>:</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.1118in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Option</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.909in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Answer</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.8277in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.7305in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Robbins Reference</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.1312in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>A. Alter their permeability so as to create a
    transudate</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.9284in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-weight:bold;font-family:Calibri'>Incorrect </span><span
    style='font-family:"Segoe UI Emoji"'>✅ </span><span style='font-weight:
    bold;font-family:Calibri'>Correct Answer</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.8472in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>In <span
    style='font-weight:bold'>acute inflammation</span>, increased vascular
    permeability leads to an <span style='font-weight:bold'>exudate</span>
    (protein-rich), <span style='font-weight:bold'>not a transudate</span>
    (protein-poor). <span style='font-weight:bold'>Transudates occur in
    non-inflammatory states</span> such as increased hydrostatic pressure or
    decreased oncotic pressure.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.925in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“The hallmark of
    acute inflammation is increased vascular permeability leading to <span
    style='font-weight:bold'>exudation</span> of protein-rich fluid.”Robbins
    and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.1312in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>B. Slow down the movement of red cells</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.909in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>True</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.8277in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>As plasma exits
    the vessels, <span style='font-weight:bold'>blood viscosity increases</span>,
    and red cells become more concentrated and <span style='font-weight:bold'>flow
    more slowly</span> — a process called <span style='font-weight:bold'>stasis</span>.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.8486in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“Loss of fluid
    and increased vessel diameter lead to slower blood flow, concentration of
    red cells, and stasis.”Robbins and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.1118in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>C. Contract endothelial cells</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.909in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>True</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.8277in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Endothelial contraction</span> is a classic,
    early, and reversible mechanism that increases vascular permeability during
    acute inflammation.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.8541in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“Contraction of
    endothelial cells leads to intercellular gaps in venules — the most common
    mechanism of vascular leakage.”Robbins and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.1284in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>D. Increase permeability in response to bradykinin</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.909in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>True</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.8277in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Bradykinin</span>, along with histamine and
    leukotrienes, is a mediator that <span style='font-weight:bold'>increases
    vascular permeability</span> during inflammation.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.8215in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“Bradykinin
    increases vascular permeability and causes pain.”Robbins and Cotran Path…</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Correct Answer: A. Alter their permeability so as to
  create a transudate</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Let me know if
  you'd like a quick reference table for exudate vs transudate or mediators of
  vascular permeability!</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>61</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7756in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>Regarding
  leukocyte recruitment at sites of inflammation, which of these is true</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>A.
  Leukoc<span style='background:yellow;mso-highlight:yellow'>yte attachment to
  endothelial cells is mediated by cytokines called</span> selectins and
  intergrins</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>B.
  Leukocytes pass through the basement membrane of vessels leaving permanent
  defects at that site</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>C.
  Chemotaxis describes the movement of leukocytes away from the site of injury</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>D.
  After entering tissues most neutrophils are sustained for weeks to months</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8048in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here is the <span
  style='font-weight:bold'>Robbins-based evaluation</span> of the question on <span
  style='font-weight:bold'>leukocyte recruitment during inflammation</span>:</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
  style='font-weight:bold'>Question: </span><span style='font-style:italic'>Regarding
  leukocyte recruitment at sites of inflammation, which of these is </span><span
  style='font-weight:bold;font-style:italic'>true</span><span style='font-style:
  italic'>?</span></p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.8618in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Option</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7361in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Evaluation</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.9611in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation from Robbins</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.8618in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>A. Leukocyte attachment to endothelial cells is
    mediated by cytokines called selectins and integrins</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7298in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>Correct</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.0222in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: “<span
    style='font-weight:bold'>Selectins and integrins</span> are adhesion
    molecules whose expression is <span style='font-weight:bold'>upregulated by
    cytokines</span> (e.g., TNF, IL-1), and they <span style='font-weight:bold'>mediate
    leukocyte rolling and firm adhesion</span> to endothelium.” These are <span
    style='font-weight:bold'>not cytokines themselves</span>, but are <span
    style='font-weight:bold'>regulated by cytokines</span>Robbins and Cotran
    Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.8812in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>B. Leukocytes pass through the basement membrane
    of vessels leaving permanent defects at that site</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7493in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-style:italic;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.9958in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins:
    Leukocytes cross the endothelium and basement membrane <span
    style='font-weight:bold'>transiently</span> via <span style='font-weight:
    bold'>collagenase</span> activity. The <span style='font-weight:bold'>basement
    membrane rapidly reseals</span>, and <span style='font-weight:bold'>no
    permanent defect</span> is left behindRobbins and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.8694in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>C. Chemotaxis describes the movement of leukocytes
    away from the site of injury</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7493in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-style:italic;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.0819in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: “<span
    style='font-weight:bold'>Chemotaxis</span> is the process by which
    leukocytes <span style='font-weight:bold'>move toward</span> sites of
    injury along a chemical gradient of chemoattractants (e.g., C5a, IL-8,
    bacterial products).” It is <span style='font-weight:bold'>directed toward</span>,
    not awayRobbins and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.8618in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>D. After entering tissues most neutrophils are
    sustained for weeks to months</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7493in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-style:italic;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.9958in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins:
    Neutrophils are <span style='font-weight:bold'>short-lived</span> cells.
    “They undergo <span style='font-weight:bold'>apoptosis within 24–48 hours</span>
    of entering tissues unless continually stimulated.”Robbins and Cotran Path…</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Correct Answer: A. Leukocyte attachment to endothelial
  cells is mediated by cytokines called selectins and integrins</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>While <span
  style='font-weight:bold'>selectins and integrins are not cytokines themselves</span>,
  their <span style='font-weight:bold'>expression is regulated by cytokines</span>,
  and they are <span style='font-weight:bold'>critical mediators</span> of
  leukocyte adhesion during inflammationRobbins and Cotran Path….</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>62</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7562in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>The
  termination of acute inflammation is helped by which of these ?</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>A.
  Inflammatory m<span style='background:yellow;mso-highlight:yellow'>ediators
  having half lives of days to weeks</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>B.
  Anti-inflamm<span style='background:lime;mso-highlight:lime'>atory cytokines
  like transforming growth factor-Beta and IL-10</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>C.
  Increased production of tumour necrosis factor</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>D.
  Complement C3</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8048in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here's the
  evaluation of the statements regarding <span style='font-weight:bold'>termination
  of acute inflammation</span>, using <span style='font-style:italic'>Robbins
  and Cotran Pathologic Basis of Disease, 9th Edition</span>:</p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.7402in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Option</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.8201in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Correct/Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.9993in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation with Robbins Reference</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.7402in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>A. <span
    style='font-weight:bold'>Inflammatory mediators having half-lives of days
    to weeks</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.8201in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-weight:bold;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.1312in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: <span
    style='font-style:italic'>“Mediators of inflammation are produced only in
    response to stimuli and are </span><span style='font-weight:bold;
    font-style:italic'>short-lived</span><span style='font-style:italic'>,
    either because they quickly decay or are inactivated.”</span> Thus, <span
    style='font-weight:bold'>short half-lives</span>, not long ones, help
    terminate inflammationRobbins and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.7402in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>B. <span
    style='font-weight:bold'>Anti-inflammatory cytokines like transforming
    growth factor-Beta and IL-10</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.8201in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>Correct</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.1312in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: <span
    style='font-style:italic'>“Anti-inflammatory cytokines, including </span><span
    style='font-weight:bold;font-style:italic'>IL-10 and TGF-β</span><span
    style='font-style:italic'>, are produced to limit the inflammatory response
    and promote its resolution.”</span> These are <span style='font-weight:
    bold'>central to dampening inflammation</span>Robbins and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.7402in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>C. <span
    style='font-weight:bold'>Increased production of tumour necrosis factor</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.8201in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-weight:bold;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.027in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>TNF is a <span
    style='font-weight:bold'>pro-inflammatory cytokine</span>. Robbins lists
    TNF under <span style='font-weight:bold'>acute inflammation mediators</span>:
    it promotes leukocyte recruitment and systemic inflammatory effectsRobbins
    and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.7402in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>D. <span
    style='font-weight:bold'>Complement C3</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.8201in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-weight:bold;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.027in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>C3 (especially
    C3a, C3b) is <span style='font-weight:bold'>part of the complement system</span>,
    which <span style='font-weight:bold'>amplifies inflammation</span> through
    opsonization, chemotaxis, and cell lysisRobbins and Cotran Path….</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Correct Answer: B. Anti-inflammatory cytokines like
  transforming growth factor-Beta and IL-10</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Let me know if
  you'd like a visual summary of inflammation mediators and their resolution.</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>63</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7756in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>Which
  of these is false regarding the complement system?</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>A. It
  is activated by a classic, alternative or lectin pathway</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>B.
  Activation converges on the production of either C3a or C3b</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>C. A
  combination of C5 with C6-9 creates a membrane attack complex which forces a
  microbe in to a phagocyte</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>D.
  Defiency in enzymatic inhibition of C1 can cause angioedema</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8881in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here is the
  analysis of the MCQ on the <span style='font-weight:bold'>complement system</span>,
  based on <span style='font-style:italic'>Robbins and Cotran Pathologic Basis
  of Disease, 9th Edition</span>:</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.5861in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Option</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.8583in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Answer</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.4972in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.7284in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Robbins Reference</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.5861in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>A. It is activated by a classic, alternative or
    lectin pathway</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.8583in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>True</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.502in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>The complement
    system can be initiated by <span style='font-weight:bold'>three distinct
    pathways</span>: <span style='font-weight:bold'>classical</span>
    (antibody-dependent), <span style='font-weight:bold'>alternative</span>
    (pathogen surfaces), and <span style='font-weight:bold'>lectin</span>
    (mannose-binding lectin binding to microbial sugars).</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.7909in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“Complement
    activation occurs through three pathways: classical, alternative, and
    lectin.”Robbins and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.5861in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>B. Activation converges on the production of
    either C3a or C3b</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.8583in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>True</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.4972in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>All three
    pathways converge at <span style='font-weight:bold'>C3</span>, which is
    cleaved into <span style='font-weight:bold'>C3a</span> (inflammation
    mediator) and <span style='font-weight:bold'>C3b</span> (opsonin).</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.8326in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“All pathways
    lead to C3 activation, yielding C3a and C3b.”Robbins and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.6055in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>C. A combination of C5 with C6-9 creates a
    membrane attack complex which forces a microbe into a phagocyte</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.8583in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-weight:bold;font-family:Calibri'>False </span><span
    style='font-family:"Segoe UI Emoji"'>✅ </span><span style='font-weight:
    bold;font-family:Calibri'>Correct Answer</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.5166in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>The <span
    style='font-weight:bold'>C5b–C9 complex</span> forms the <span
    style='font-weight:bold'>membrane attack complex (MAC)</span>, which <span
    style='font-weight:bold'>lyses microbes directly</span> by creating pores
    in their membranes — it does <span style='font-weight:bold'>not promote
    phagocytosis</span>. Phagocytosis is mediated by <span style='font-weight:
    bold'>C3b (opsonin)</span>.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.8326in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“C5b initiates
    the assembly of the MAC (C5b–9), which <span style='font-weight:bold'>for</span><span
    style='font-weight:bold;background:yellow;mso-highlight:yellow'>ms pores in
    membranes and lys</span><span style='font-weight:bold'>es cells</span>… not
    for phagocytosis.”Robbins and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.5861in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>D. Deficiency in enzymatic inhibition of C1 can
    cause angioedema</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.8583in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>True</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.5166in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>C1 esterase inhibitor deficiency</span> leads to <span
    style='font-weight:bold'>hereditary angioedema</span>, due to unchecked
    activation of the complement and kallikrein systems, causing increased <span
    style='font-weight:bold'>bradykinin</span>.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.8034in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“C1 inhibitor
    deficiency results in hereditary angioedema, due to unregulated activation
    of complement.”Robbins and Cotran Path…</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Correct Answer: C. A combination of C5 with C6-9
  creates a membrane attack complex which forces a microbe into a phagocyte</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Let me know if
  you'd like a diagram of the <span style='font-weight:bold'>complement cascade</span>
  with key functions of each component!</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>64</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7756in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>Chronic
  inflammation. Which of these infections or conditions is not associated with
  immune <span style='background:yellow;mso-highlight:yellow'>granulomatous</span>
  inflammation</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>A.
  Bartonella henselae infection</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>B.
  treponema pallidum</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>C.
  Talc deposition</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>D. <span
  style='background:yellow;mso-highlight:yellow'>Sarcoidosis</span></p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8048in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here is the <span
  style='font-weight:bold'>Robbins-based evaluation</span> of the question on <span
  style='font-weight:bold'>immune granulomatous inflammation</span>:</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
  style='font-weight:bold'>Question: </span><span style='font-style:italic'>Which
  of these infections or conditions is </span><span style='font-weight:bold;
  font-style:italic'>not</span><span style='font-style:italic'> associated with
  </span><span style='font-weight:bold;font-style:italic'>immune granulomatous
  inflammation</span><span style='font-style:italic'>?</span></p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.0597in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Option</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.1208in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Evaluation</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.3784in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation from Robbins</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.0597in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>A. Bartonella henselae infection</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.1208in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-style:italic;font-family:Calibri'>Incorrect</span><span
    style='font-family:Calibri'> (is associated)</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.4069in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: <span
    style='font-style:italic'>Bartonella henselae</span> (cat-scratch disease)
    causes <span style='font-weight:bold'>stellate necrotizing granulomas</span>,
    which are part of <span style='font-weight:bold'>immune granulomatous
    inflammation</span> involving T cell responsesRobbins and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.0791in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>B. Treponema pallidum</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.1208in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-style:italic;font-family:Calibri'>Incorrect</span><span
    style='font-family:Calibri'> (is associated)</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.425in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: <span
    style='font-weight:bold'>Tertiary syphilis</span>, caused by <span
    style='font-style:italic'>Treponema pallidum</span>, results in <span
    style='font-weight:bold'>gummas</span>, which are <span style='font-weight:
    bold'>granulomatous lesions</span> with central necrosis and
    immune-mediated pathologyRobbins and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.0597in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>C. Talc deposition</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.1208in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>Correct</span><span
    style='font-family:Calibri'> (</span><span style='font-weight:bold;
    font-family:Calibri'>not immune-mediated</span><span style='font-family:
    Calibri'>)</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.475in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: <span
    style='font-weight:bold'>Talc and other foreign bodies</span> induce <span
    style='font-weight:bold'>foreign body granulomas</span>, which are a <span
    style='font-weight:bold'>non-immune type</span> of granulomatous
    inflammation — formed without T-cell–mediated responses. They are <span
    style='font-weight:bold'>not classified as immune granulomas</span>Robbins
    and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.0791in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>D. Sarcoidosis</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.1208in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-style:italic;font-family:Calibri'>Incorrect</span><span
    style='font-family:Calibri'> (is associated)</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.4069in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: <span
    style='font-weight:bold'>Sarcoidosis</span> is a prototype of <span
    style='font-weight:bold'>immune granulomatous inflammation</span>, with <span
    style='font-weight:bold'>non-caseating granulomas</span> formed by
    activated macrophages and T-helper cellsRobbins and Cotran Path….</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Correct Answer: C. Talc deposition</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Talc induces <span
  style='font-weight:bold'>foreign body granulomas</span>, which are <span
  style='font-weight:bold'>not immune-mediated</span> and thus <span
  style='font-weight:bold'>do not fall under immune granulomatous inflammation</span>Robbins
  and Cotran Path….</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>65</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7562in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>Cellular
  ageing includes which one of the following mechanisms?</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>A.
  Increased caloric use</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>B.
  lengthening of telomeres at the end of chromosomes</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>C.
  Activtion of tumour suppression genes</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>D.
  Breakdown of insulin</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8048in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>To determine which
  mechanism is involved in <span style='font-weight:bold'>cellular ageing</span>,
  let’s evaluate the provided options using <span style='font-style:italic'>Robbins
  and Cotran Pathologic Basis of Disease, 9th Edition</span>:</p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.4965in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Option</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7645in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Correct?</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.2979in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation with Robbins Quote</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.4965in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>A. Increased caloric use</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7784in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-weight:bold;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.4in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins
    emphasizes that <span style='font-weight:bold'>caloric restriction</span>,
    not increased caloric use, <span style='font-weight:bold'>slows aging</span>.
    <span style='font-style:italic'>“Nutrient sensing exemplified by calorie
    restriction, counteracts aging...”</span>Robbins and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.5159in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>B. Lengthening of telomeres at the end of
    chromosomes</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7784in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-weight:bold;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.4347in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Telomeres <span
    style='font-weight:bold'>shorten</span> with age. Robbins: <span
    style='font-style:italic'>“Replicative senescence involves progressive
    shortening of telomeres, which ultimately results in cell cycle arrest.”</span>Robbins
    and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.5027in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>C. Activation of tumour suppression genes</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.759in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>Correct</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.4361in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: <span
    style='font-style:italic'>“Activation of certain tumor suppressor genes...
    seems to be involved in controlling replicative senescence... p16 protects
    cells from uncontrolled mitogenic signals and pushes them toward
    senescence.”</span>Robbins and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.4965in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>D. Breakdown of insulin</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7784in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-weight:bold;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.4076in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Not mentioned as
    a mechanism in cellular ageing. Instead, Robbins discusses <span
    style='font-weight:bold'>insulin/IGF signaling</span> pathways influencing
    aging, particularly in relation to nutrient sensingRobbins and Cotran
    Path….</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Correct Answer: C. Activation of tumour suppression
  genes</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Let me know if
  you'd like a summary table of all cellular aging mechanisms (DNA damage,
  telomere attrition, protein homeostasis, etc.).</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>66</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7562in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>Metastatic
  calcification occurs in normal tissues where there is hypercalcaemia.
  Mechanisms of metastatic calcification <span style='background:yellow;
  mso-highlight:yellow'>do not i</span>nclude which one of the following?</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>A.
  Renal failure</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>B.
  Tumour necrosis factor (<span style='background:yellow;mso-highlight:yellow'>TNF</span>)
  secretion</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>C.
  resorption of bone tissue</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>D.
  Increased parathyroid hormone secretion by the parathyroid glands</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8881in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here is the
  analysis of the MCQ on <span style='font-weight:bold'>metastatic
  calcification</span>, based on <span style='font-style:italic'>Robbins and
  Cotran Pathologic Basis of Disease, 9th Edition</span>:</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.2729in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Option</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.9916in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Answer</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.4861in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.8083in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Robbins Reference</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.2729in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>A. Renal failure</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0111in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>Included</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.5041in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Chronic renal failure</span> causes <span
    style='font-weight:bold'>secondary hyperparathyroidism</span>, phosphate
    retention, and vitamin D deficiency, leading to <span style='font-weight:
    bold'>hypercalcemia or hyperphosphatemia</span>, which can cause <span
    style='font-weight:bold'>metastatic calcification</span>.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.9194in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“Common causes
    of metastatic calcification include… <span style='font-weight:bold'>chronic
    renal failure</span>.”Robbins and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.2729in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>B. Tumour necrosis factor (TNF) secretion</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.9916in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-weight:bold;font-family:Calibri'>Not a mechanism </span><span
    style='font-family:"Segoe UI Emoji"'>✅ </span><span style='font-weight:
    bold;font-family:Calibri'>Correct Answer</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.5055in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>TNF</span> is involved in <span style='font-weight:
    bold'>inflammation and cachexia</span>, but it <span style='font-weight:
    bold'>does not directly cause hypercalcemia or metastatic calcification</span>.
    This is not a recognized mechanism.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.0236in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>TNF is not
    listed among causes of hypercalcemia or metastatic calcification in
    Robbins.</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.2729in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>C. Resorption of bone tissue</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0111in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>Included</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.4861in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Conditions like <span
    style='font-weight:bold'>hyperparathyroidism, tumors, or immobilization</span>
    can cause <span style='font-weight:bold'>bone resorption</span>, releasing
    calcium and predisposing to <span style='font-weight:bold'>metastatic
    calcification</span>.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.9618in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“Metastatic
    calcification may result from <span style='font-weight:bold'>increased bone
    resorption</span> in conditions such as hyperparathyroidism or bone
    metastases.”Robbins and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:1.2729in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>D. Increased parathyroid hormone secretion by the
    parathyroid glands</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0111in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>Included</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:2.4861in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Primary hyperparathyroidism</span> increases serum
    calcium, contributing to <span style='font-weight:bold'>metastatic
    calcification in normal tissues</span> like lungs, kidneys, and stomach.</p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.9777in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>“Hyperparathyroidism
    causes hypercalcemia and is a common cause of metastatic
    calcification.”Robbins and Cotran Path…</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Correct Answer: B. Tumour necrosis factor (TNF)
  secretion</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Let me know if
  you'd like a comparison between <span style='font-weight:bold'>dystrophic and
  metastatic calcification</span>!</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>67</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7562in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>The
  reprogramming of local tissue stem cells or the colonisation by
  differentiated cell populations from adjacent sites is better known as?</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>A.
  Hyperplasia</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>B.
  Hypertrophy</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>C.
  Dysplasia</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>D.
  Atrophy</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>E.
  None of <span style='background:yellow;mso-highlight:yellow'>the</span> above</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8048in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here is the <span
  style='font-weight:bold'>Robbins-based evaluation</span> of the question on <span
  style='font-weight:bold'>cellular adaptation</span>:</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
  style='font-weight:bold'>Question: </span><span style='font-style:italic'>The
  reprogramming of local tissue stem cells or the colonisation by
  differentiated cell populations from adjacent sites is better known as?</span></p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:.9229in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Option</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7847in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Evaluation</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.8513in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation from Robbins</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:.9423in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>A. Hyperplasia</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7798in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-style:italic;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.8986in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: <span
    style='font-weight:bold'>Hyperplasia</span> is an <span style='font-weight:
    bold'>increase in the number of cells</span> due to proliferation, not
    reprogramming or colonisationRobbins and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:.9423in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>B. Hypertrophy</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7798in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-style:italic;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.8986in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: <span
    style='font-weight:bold'>Hypertrophy</span> is an <span style='font-weight:
    bold'>increase in cell size</span>, not due to changes in cell type or stem
    cell reprogrammingRobbins and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:.9423in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>C. Dysplasia</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7798in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-style:italic;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.934in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: <span
    style='font-weight:bold'>Dysplasia</span> refers to <span style='font-weight:
    bold'>disordered cellular growth</span>, often <span style='font-weight:
    bold'>precancerous</span>, but not necessarily due to stem cell
    reprogramming or colonisationRobbins and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:.9229in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>D. Atrophy</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7798in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-style:italic;font-family:Calibri'>Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.8986in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: <span
    style='font-weight:bold'>Atrophy</span> is a <span style='font-weight:bold'>decrease
    in cell size or number</span>, not involving replacement or reprogramming
    of stem cellsRobbins and Cotran Path….</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:.9229in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>E. None of the above</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:.7652in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>Correct</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:4.8986in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: The
    described process — <span style='font-weight:bold'>reprogramming of local
    stem cells or colonisation by adjacent cells</span> — defines <span
    style='font-weight:bold'>metaplasia</span>, which is <span
    style='font-weight:bold'>not listed among the choices</span>. Therefore,
    the correct answer is <span style='font-weight:bold'>&quot;None of the
    above&quot;</span>Robbins and Cotran Path….</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>✅</span><span style='font-weight:bold;
  font-family:Calibri'> Correct Answer: E. None of the above</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>The definition
  given in the question describes <span style='font-weight:bold'>metaplasia</span>,
  which involves <span style='font-weight:bold'>reversible change from one
  differentiated cell type to another</span>, often via <span style='font-weight:
  bold'>stem cell reprogramming</span> — and <span style='font-weight:bold'>is
  not listed</span> among the answer choicesRobbins and Cotran Path….</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>68</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7562in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>Accepting
  that a patient will probably never ask you this question, please tick the
  mechanism not associated with ischaemic cell injury</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>A.
  oxidative phosphorylation decreases</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>B. ATP
  levels rise</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>C.
  Enhanced glycolysis and new blood vessel formation if hypoxia-inducible
  factor 1gene is transcribed</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>D.
  influx of calcium and sodium to the cytoplasm</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.8048in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Here is the
  evaluation of the mechanisms involved in <span style='font-weight:bold'>ischemic
  cell injury</span>, using <span style='font-style:italic'>Robbins and Cotran
  Pathologic Basis of Disease, 9th Edition</span>:</p>
  <div style='direction:ltr'>
  <table border=0 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
   border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
   0pt' title="" summary="">
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.0027in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Option</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0416in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Correct/Incorrect</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.5145in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>Explanation with Robbins Reference</span></p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.0027in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>A. Oxidative phosphorylation decreases</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0222in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>Correct</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.6583in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: <span
    style='font-style:italic'>“As the oxygen tension within the cell falls,
    there is loss of </span><span style='font-weight:bold;font-style:italic'>oxidative
    phosphorylation</span><span style='font-style:italic'> and decreased
    generation of ATP.”</span>Robbins and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.0027in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>B. ATP levels rise</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0416in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>❌
    </span><span style='font-weight:bold;font-family:Calibri'>Incorrect </span><span
    style='font-family:"Segoe UI Emoji"'>✅ </span><span style='font-weight:
    bold;font-family:Calibri'>Correct Answer</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.5625in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: <span
    style='font-style:italic'>“Depletion of ATP results in failure of the
    sodium pump... ATP levels fall to 5% to 10% of normal levels.”</span> Thus,
    ATP <span style='font-weight:bold'>falls</span>, not rises, in ischemic
    injuryRobbins and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.0027in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>C. Enhanced glycolysis and new blood vessel
    formation if hypoxia-inducible factor 1 gene is transcribed</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0222in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>Correct</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.5965in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: <span
    style='font-style:italic'>“The best-defined [hypoxia] response is induction
    of hypoxia-inducible factor-1, which promotes </span><span
    style='font-weight:bold;font-style:italic'>new blood vessel formation</span><span
    style='font-style:italic'>, stimulates cell survival pathways, and </span><span
    style='font-weight:bold;font-style:italic'>enhances anaerobic glycolysis</span><span
    style='font-style:italic'>.”</span>Robbins and Cotran Path…</p>
    </td>
   </tr>
   <tr>
    <td style='border-width:0pt;vertical-align:top;width:2.0027in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
    style='font-weight:bold'>D. Influx of calcium and sodium to the cytoplasm</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:1.0222in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-size:11.0pt'><span style='font-family:"Segoe UI Emoji"'>✅
    </span><span style='font-weight:bold;font-family:Calibri'>Correct</span></p>
    </td>
    <td style='border-width:0pt;vertical-align:top;width:3.5625in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
    <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>Robbins: <span
    style='font-style:italic'>“Failure of the sodium pump leads to influx of
    sodium and water... There is also </span><span style='font-weight:bold;
    font-style:italic'>influx of Ca²⁺</span><span style='font-style:italic'>,
    with its many deleterious effects.”</span>Robbins and Cotran Path…</p>
    </td>
   </tr>
  </table>
  </div>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>&nbsp;</p>
  <p style='margin:0in;font-size:16.0pt'><span style='font-weight:bold;
  font-family:"Segoe UI Emoji"'>❌</span><span style='font-weight:bold;
  font-family:Calibri'> Correct Answer: B. ATP levels rise</span></p>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt'>This is <span
  style='font-weight:bold'>false</span> — ATP levels <span style='font-weight:
  bold'>drop</span> precipitously in ischemic cell injury due to loss of
  oxidative phosphorylation. All other options are true.</p>
  </td>
 </tr>
 <tr>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:.7715in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black;
  text-align:right'>69</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:3.7562in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>Yes
  pathology is boring but you probably do need to know some of this. Agree?
  Well done on getting this far by the way. Keep going, studying for the
  fellowships is as stressful but much more interesting. After that it's all
  beer and surfing until you draw your superannuation.<span
  style='mso-spacerun:yes'>  </span>Extra bonus points if you noticed that
  there were two question '28's. Sorry!</p>
  </td>
  <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
  vertical-align:top;width:6.4229in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
  <p style='margin:0in;font-family:Calibri;font-size:11.0pt;color:black'>&nbsp;</p>
  </td>
 </tr>
</table>

</div>

</div>

</div>

</div>

</body>

</html>
